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Objectives: Physical activity (PA) is beneficial to men with prostate cancer in several ways and is associated 
with better survival outcomes. I aimed to examine factors related to PA behaviour in men with prostate 
cancer, and design and test an intervention to promote PA amongst men with prostate cancer, as part of 
standard clinical care. 
Methods: Prior to the design of the intervention, a systematic review of barriers and facilitators to PA in men 
with prostate cancer was undertaken. Two analyses of local clinical data relating to the local existing PA 
pathway were also undertaken. The findings of the review and analyses informed the design of the 
intervention, which was undertaken with the input of key clinical stakeholders and followed the Behaviour 
Change Wheel process framework for designing interventions. 
A PA intervention was designed based on persuasive peer-support, to be delivered to potentially all prostate 
cancer patients scheduled for a radical prostatectomy in existing educational seminars. The intervention 
consisted of a 10-minute presentation about PA, delivered by a former patient and in a narrative style. It took 
place immediately following an existing 20-minute PA presentation by a cancer exercise specialist. 
The intervention was tested in a pilot study that delivered the intervention in both pre-treatment and post-
treatment seminars, alternating between seminars containing either: both a 20-minute cancer exercise 
specialist presentation + 10-minute patient presentation; or a 20-minute cancer exercise specialist 
presentation only. The pilot study was a mixed methods design. It quantitatively examined the effect of the 
intervention on self-reported physical activity (SQUASH), exercise motivation (BREQ-3), quality of life (EQ-
5D-5L), and fatigue (FACIT-fatigue). Quantitative measures were taken for all participants immediately 
before, and 90 days after the intervention. Data were accrued on n=148 men undergoing radical 
prostatectomy for the quantitative aspect (n=79 control; n=69 intervention). Qualitative interviews were 
undertaken with 14 men who had attended an intervention seminar. Interview transcripts were analysed using 
thematic analysis with elements of a grounded theory approach. 
Results: The systematic review included 17 quantitative reports, and 15 qualitative reports. The review found 
that a range of psychosocial factors can influence physical activity in men with prostate cancer, including the 
degree to which advice is provided by the clinical care team, and who is providing it; individual preferences 
for physical activity between patients and needs that can differ by treatment pathway; and psychological 
factors relating to peer-support and an individual’s sense of self-determination. 
The results from the analyses of local clinical data indicated that: 1) men undergoing curative treatment on 
the local physical activity pathway (n=120, change in PA at 12 months: p=0.53) were less likely to increase 
and maintain physical activity than men on systematic treatment (n=76, change in PA at 12 months: p=0.04); 
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and 2) the existing local physical activity pathway is less likely to be participated in by men who are older 
(adjusted OR: 0.97 per year; 95% CI: 0.95–0.98), live further from the hospital (adjusted OR: 0.94 per mile; 
95% CI: 0.90–0.99), or are of a lower socioeconomic status (adjusted OR: 1.09 per deprivation rank decile 
increase; 95% CI: 1.03–1.16). 
Results from the pilot study, following analysis using repeated measures ANOVA models to test Group*Time 
interaction effects, showed that the intervention did not increase self-reported PA (p=0.38) or exercise 
behavioural regulations (p-values range: 0.12–0.95; median p-value: 0.87) at 90 days follow up, compared 
with the control group. However, the intervention did have beneficial effects on quality of life (difference in 
mean change: +5.3 points, p=0.04) and fatigue (difference in mean change: -2.8 points, p=0.01) compared 
with the control group. Post hoc analyses indicated that more individuals in the intervention group 
experienced clinically significant benefits to both quality of life and fatigue (p=0.04 and p=0.06 respectively). 
Insights from the qualitative analysis described how the patients found the intervention to be beneficial to 
psychological wellbeing, due to a sense of reassurance about the future being provided by a trusted authority. 
Qualitative data included reports by some patients that they had increased their physical activity behaviour 
due to their experience with the intervention. Patients who qualitatively reported increased physical activity 
due to the intervention all appeared to have a tendency toward optimism. 
Conclusions: Peer-support interventions for men with prostate cancer that are brief, delivered to many 
patients simultaneously, and integrated into clinical care pathways, can still yield benefits to quality of life for 
patients that are clinically meaningful. The use of peer-support interventions to promote physical activity in 
men with prostate cancer may only be effective for a certain type of individual with a tendency toward 
optimism. Supervised, hospital-based exercise programmes may be less likely to be accessed by those who 
are of a lower socioeconomic status, or who live further from the hospital site. 
Future work: Further examination of this style of intervention could investigate the use of more than one 
patient speaker and examine training needs; consistency of delivery and outcomes; and logistics of sustained 
delivery. Such investigations could also examine information needs, to discern whether the intervention 
confers benefits to quality of life by meeting previously unmet information needs of patients. 
Furthermore, it is possible that the existing findings of PA behaviour change research in prostate cancer are 
limited due to systemic self-selection biases. Examination of this question and any related confounders could 
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Chapter 1: Introduction 
Prostate cancer is the most common cancer in men, and the fifth most common cause of cancer 
death in men worldwide.[1] Within the United Kingdom, there are approximately 47,000 new cases 
of prostate cancer annually, resulting in roughly 12,000 deaths.[2] The yearly cost to the UK 
taxpayer of the management of prostate cancer has been estimated to be in the region of £180 
million.[3] Furthermore, the societal burden of prostate cancer is increasing in the UK: prostate 
cancer incidence rates are estimated to increase to around 78,000 cases annually by 2035, 
primarily due to the UK’s growing and ageing population.[4] 
In addition to these economic and mortality costs, a prostate cancer diagnosis can have profoundly 
negative psychosocial effects upon an individual and those close to them, especially their 
partner.[5,6] In addition to the anxiety caused by the diagnosis, treatments for prostate cancer often 
produce bodily side-effects that can have profound consequences for an individual’s masculine 
self-identity.[5,7] These psychological effects often have implications for individual’s relationship 
with their partner.[7] 
A body of research has accumulated showing that post-diagnosis engagement with moderate-to-
vigorous physical activity (PA) can be effective at ameliorating some of the side effects associated 
with prostate cancer treatment.[8–11] Post-diagnosis PA has also been associated with improved 
oncologic outcomes in men with prostate cancer.[12–17] Despite these findings, many men with 
prostate cancer do not meet the recommended levels of PA for people with cancer[18] and provision 
of PA support in the National Health Service (NHS) remains sparse.[19] 
This doctoral project therefore aimed to design and test an intervention to promote PA in men 
diagnosed with prostate cancer, that could be implemented as part of NHS standard care. The 
next chapter, Chapter 2, presents the relevant background to this project. Chapter 3 then describes 
the intervention design process, including the process of collecting evidence to inform the 
intervention design. Chapter 3 will also describe the intervention’s proposed mechanism of action. 
Chapter 4 describes the methods and results of a pilot study that was designed and undertaken to 
test the intervention. Finally, Chapter 5 contains an overall discussion. 
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Overall research objectives: 
 
1) Identify issues relevant to the design of a PA intervention for men with prostate cancer, 
both locally and generally. 
2) Design a PA intervention for men with prostate cancer that could be implemented as part 
of NHS standard care. 
3) Collect and analyse original data to examine whether the PA intervention is effective; 




Chapter 2: Background 
In this chapter, the relevant background will be described. This begins with a description of prostate 
cancer biology, epidemiology of prostate cancer, and treatments for prostate cancer. Then, a 
summary of the physical and psychological benefits of physical activity is provided. This is followed 
by a description of the relationship between physical activity and cancer, with examples of 
mechanisms via which physical activity might benefit someone with cancer; before focusing 
specifically on physical activity and prostate cancer, including epidemiological studies and 
intervention studies.  Finally, some key psychological concepts relevant to exercise behaviour are 
introduced. 
2.1. Prostate cancer 
2.1.1. Anatomy and function of the prostate 




The human prostate gland is approximately the size of a walnut, is around 20–30g in mass, and 
lies directly inferior to the bladder neck, superior to the external urethral sphincter, and directly 
anterior to the rectum. The urethra runs through the prostate, from the bladder on the superior side 
and into the penile tissue on the inferior side. The urethra is joined within the prostate by the 
ejaculatory ducts, which originate from the seminal vesicles that lie just posterior to the bladder 
(see Figure 1).[21]  
The prostate gland is made up of roughly two thirds glandular tissue, which surrounds the urethra 
and ejaculatory ducts. The remaining third consists of fibromuscular stroma, situated on the 
anterior side of the prostate. Histologically, the glandular area of the prostate is divided into three 
zones: 
• The central zone. This zone surrounds the ejaculatory ducts and accounts for around 
25% of the glandular tissue. 
• The transitional zone. This zone surrounds the urethra and accounts for around 5–
10% of the glandular tissue. 
• The peripheral zone. This zone resides on the posterior side of the prostate and 
accounts for the main body of the gland, around 65% of the glandular tissue. Most 
prostate carcinomas are found within this zone. 
The prostate gland is an accessory male sexual organ. It contributes to ejaculate, supporting 
the lifespan and motility of spermatozoa.[22] Aside from this sexual function, its main clinical 
relevance resides in its tendency to prostate cancer. The prostate’s location, adjacent to 
nervous and vascular structures that are vital to erectile function and continence, furthermore 
means that radical treatment for prostate cancer can be detrimental to these functions.[23] 
2.1.2. Prostate cancer epidemiology 
It is estimated that there were almost 1.3 million new cases of prostate cancer worldwide in 2018, 
resulting in an estimated 359,000 deaths (i.e. 7.1% of all new cancer cases, resulting in 3.8% of 
all cancer deaths). Prostate cancer is the most common cancer in men, and the fifth most common 
cause of cancer death in men worldwide. Incidence of prostate cancer is highest in the regions of 
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Northern and Western Europe, North America, and Australasia, but this higher incidence rate has 
been partly attributed to the application of prostate-specific antigen (PSA) testing.[1] 
2.1.3. Prostate-specific antigen (PSA) testing 
Prostate-specific antigen (PSA) testing is a method of identifying the potential presence of prostate 
cancer using analysis of a blood sample.[22] PSA is a protein produced in the prostate tissue, that 
facilitates sperm migration by liquefying ejaculate.[24] Abnormal leakage of PSA into the circulatory 
system can be caused either by PSA expression by malignant prostate epithelium; or by distortion 
of the glandular architecture of the prostate. The PSA test consists of the retrieval of a blood 
sample and a test for serum concentrations of PSA. Therefore, the test does not specify between 
the presence of invasive malignancy, or other conditions such as benign prostatic hyperplasia or 
urinary tract infection. However, in general a higher PSA result does indicate a higher likelihood of 
a clinically significant malignancy.[24] 
The US Food and Drug Administration approved the use of PSA testing for detecting prostate 
cancer in 1994. Since then, empirical evidence has emerged raising the prospect that routine PSA 
screening may, at a population level, do more indirect harm than good.[25,26] This is because low-
grade prostate malignancies can often be so slow growing as to be clinically insignificant – these 
are defined as ‘indolent’ prostate cancers.[22] Therefore, widespread PSA testing in the population 
can lead to a situation of ‘overtreatment’, i.e. many individuals with clinically insignificant disease 
receiving treatment which ultimately offers little or no clinical benefit, but which may impair the 
individual’s quality of life through the treatment’s side-effects.[25] In reflection of these limitations of 
PSA testing as a method for prostate cancer screening, National Institute for Clinical Excellence 
(NICE) guidelines in the UK state that “routine screening for prostate cancer is not national policy 
because the benefits have not been shown to clearly outweigh the harms”.[27] Active surveillance, 





2.1.4. Risk factors 
Relatively little is understood about prostate cancer aetiology, despite its high incidence.[1] Whilst 
the evidence for pre-dispositional risk factors is strongest, there is also some evidence for 
modifiable risk factors. 
2.1.4.1. Pre-dispositional risk factors 
2.1.4.1.1. Age 
Prostate cancer is a disease associated with aging. It is rarely diagnosed in men under 50 years 
old, and incidence rates increase exponentially with increasing age, to a stronger extent than any 
other malignancy.[29] Research examining the presence of incidental prostate cancer in American 
organ donors has found that the likelihood of prostate adenocarcinoma approaches 50% once a 
man reaches 80 years old.[30] As noted above, many of these cases are clinically insignificant. 
2.1.4.1.2. Adult attained height 
The World Cancer Research Fund’s Continuous Update Project (WCRF CUP) noted in their 2018 
report that there is strong evidence, based on 42 published studies, that increased adult attained 
height is a risk factor for prostate cancer.[31] However, the authors noted that it is unlikely to be 
height per se that is associated with prostate cancer risk, but developmental factors that are both 
associated with height and prostate cancer. 
2.1.4.1.3. Ethnicity 
According to data from Public Health England (PHE), there is a significant discrepancy in the UK 
in incidence rates of prostate cancer across ethnicities. In the UK, Black men have the highest risk 
of developing prostate cancer (29% lifetime risk, or 1 in 4); they are twice as likely to develop 
prostate cancer than Caucasian men (13.3% lifetime risk, or 1 in 8). Asian men appear to have a 
relatively lower prostate cancer risk (7.9% lifetime risk, or 1 in 13).[32] There is a strong indication 
from data from migrant and native populations that environmental factors are interacting with 
ethnicity to influence prostate cancer incidence. However, differences in practice between 
countries make it challenging to identify the causes of discrepancy.[33] 
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The PHE study referenced above concluded that increased mortality rates from prostate cancer 
amongst Black men may be in part reflective of their higher incidence rates.[32] However, this 
conclusion does not account for evidence from autopsy studies and the wider literature suggesting 
that prostate cancer does in fact grow more aggressively in Black men than in Caucasian men.[34] 
2.1.4.1.4. Family history 
Certain genotypes are thought to be associated with prostate cancer risk,[35] and a family history 
of prostate cancer is a significant risk factor.[36] An illustration of the link was reported in a Swedish 
nationwide study utilising the Prostate Cancer DataBase Sweden (PCBaSe), which demonstrated 
that men with one affected brother were approximately three times more likely to develop non-low 
risk (i.e. Gleason score ≥7) prostate cancer.[37] Further corroborating evidence for this risk factor 
has been presented by a large Nordic study of 203,691 mono- and dizygotic twin individuals, which 
found concordance of prostate cancer in 38% of monozygotic twin pairs (increased absolute risk 
from having a twin with prostate cancer: 14%), and 22% of dizygotic twin pairs (increased absolute 
risk from having a twin with prostate cancer: 5%).[38] There is evidence that familial risk can even 
extend to the presence of prostate cancer in third-degree relatives.[39] This risk factor is not thought 
to be modified by ethnicity.[40]  
2.1.4.2. Behavioural risk factors 
2.1.4.2.1. Physical activity 
The most recent and comprehensive review of the relationship between physical activity and 
prostate cancer risk showed that studies have yielded inconsistent findings.[41] A review of reviews, 
conducted for the American College of Sports Medicine and published in 2019, concluded that the 
evidence for an association between physical activity and risk of prostate cancer is currently 
“limited”. This conclusion mirrors that of the WCRF CUP 2018 report.[31] The lack of clarity in this 
area is compounded by methodological issues that undermine confidence in conclusions, 
particularly the issue of screening bias (i.e. health-conscious men who are more physically active 
may also have a higher tendency to seek a PSA test). The situation was perhaps exemplified by a 
2016 meta-analysis by Moore et al. that observed that more physically active men were slightly 
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more likely to be diagnosed with any type of prostate cancer; but that the association did not hold 
when examining people with advanced prostate cancers only.[42] Conversely, a prospective cohort 
study that was not included in that analysis has shown an inverse association between physical 
activity and prostate cancer risk, but only for advanced prostate cancer.[43] Hence, there is currently 
no consistent evidence that physical (in)activity is a risk factor for the development of prostate 
cancer. 
2.1.4.2.2. Other behavioural risk factors 
Smoking. Smoking is a risk factor for many cancers.[44] A meta-analysis of 24 cohort studies 
involving 21,579 participants in total has demonstrated a link between increased smoking 
behaviour and risk of both developing prostate cancer, and of prostate cancer death.[45] In this 
study, an analysis of studies that stratified participants by the amount they smoked showed people 
who smoked more to be at higher risk of developing prostate cancer, with 22% increased relative 
risk amongst those in the heaviest category of smokers. However, two limitations to this analysis 
– ill-defined exposure categories, and the possibility of screening bias – implied that the true effect 
may have been underestimated. There is evidence that the link between smoking and prostate 
cancer could be moderated by functional polymorphisms in genes that are associated with the 
metabolism of cigarette smoke products.[46] Such an explanation would help to explain conflicting 
results between studies of this relationship.[47]  
Two meta-analyses have confirmed that current smoking is related to higher rates of death in those 
already diagnosed with prostate cancer.[48,49] Although, there is evidence that smoking is inversely 
associated with circulating PSA levels,[50] which could be an explanatory factor. 
Alcohol. The WCRF CUP 2018 report concluded that evidence of an association between 
alcoholic drinks and prostate cancer risk is inconclusive.[31] Individual studies that have examined 
the relationship between alcohol intake and prostate cancer risk have yielded inconsistent 
findings[47] and where positive relationships have been found, they have been noted to be 
inconsequentially small (e.g. [51]). 
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Diet. The WCRF CUP 2018 report concluded that there is limited, suggestive evidence that dairy 
products and a diet high in calcium are both associated with increased prostate cancer risk.[31] The 
same report concluded that there is currently no conclusive evidence for an association between 
any other dietary factors and prostate cancer risk.[31] 
Ejaculatory frequency. There is good evidence from the Health Professionals Follow-Up study 
that ejaculation frequency is inversely associated with prostate cancer risk. This association was 
first reported in 2004[52] and has since been confirmed within the same study, but with 10 additional 
years of follow up.[53] It has been theorised that frequent ejaculation could result in less prostate 




2.1.5. Diagnosis and management 
2.1.5.1. Diagnosis of prostate cancer 
Prostate cancer is usually diagnosed via biopsy of the prostate, following an elevated PSA test 
result and suspicion of a prostate tumour upon digital rectal examination. Almost all (around 95%) 
of prostate cancers are adenocarcinomas. Other types of prostate cancer are ductal 
adenocarcinoma (0.4–0.8%), transitional cell carcinoma (1–4%), squamous cell carcinoma 
(around 0.5%), and very rarely, neuroendocrine carcinoma (<0.1%).[54] An invasive prostate 
malignancy is histologically characterised using the Gleason scoring system, which was developed 
by Donald Gleason in the 1960’s. A Gleason score is a representation of how well or how poorly 
differentiated the tumour cells are, and thus gives an indication as to how aggressive the 
malignancy is likely to be. There are five Gleason grades (see Figure 2). The total Gleason score 
is produced by adding the most commonly observed grade in the specimen, with the second mostly 




commonly observed grade in the specimen (for example, Gleason grade 3 + Gleason grade 4 = 
Gleason score 7). Using this system, Gleason scores range from 2 to 10. 
The Gleason scoring system was updated in 2016 by Epstein et al., with the aim of bringing the 
classification system more in line with clinical prognoses; and also to create more clarity of 
communication between physicians and patients with regards to severity of disease, in the hope 
of reducing cases of unnecessary treatment.[55] Following a study of >20,000 prostate cancer 
cases treated with radical prostatectomy, and >5,000 cases treated with radiotherapy, Epstein et 




Figure 3 Example microscopic images of prostate glandular tissue in accordance with the 




As with other cancers, once diagnosed a system called TNM staging is used to characterise the 
morphology of a prostate cancer. The TNM staging system was updated in 1992.[56] The T-stage 
is the extent to which the primary tumour has grown and invaded tissue adjacent to the tumour’s 
origin. The N-stage is indicative of whether lymph nodes appear to have been invaded by 
malignant cells. The M-stage is indicative of whether the malignancy appears to have spread to a 
distant site, such as the lungs, liver, or bones, through the process of metastasis (see Table 1). 
  





TX Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
T1 Tumour is neither palpable nor visible via imaging 
     T1a      Tumour is an incidental finding in 5% or less of tissue resected 
     T1b      Tumour is an incidental finding in more than 5% of tissue resected 
     T1c      Tumour identified via needle biopsy 
T2 Tumour is confined within the prostate 
     T2a      Tumour involved one half of one lobe, or less 
     T2b      Tumour involves more the one half of one lobe, but is contained within one lobe 
     T2c      Tumour involves both lobes 
T3 Tumour extends beyond the prostate capsule 
     T3a      Any extension beyond the prostate capsule 
     T3b      Tumour invades seminal vesicle(s) 
T4 Tumour invades adjacent structures other than seminal vesicles, e.g. rectum 
N staging 
NX Regional lymph nodes not assessed 
N0 No regional lymph node metastasis 
N1 Metastasis present in regional lymph node(s) 
M staging 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis present 
M1 Distant metastasis present 
     M1a      Metastasis present in non-regional lymph node(s) 
     M1b      Metastasis present in bone(s) 
     M1c      Metastasis present in other distant sites, with or without bone disease 
 




Prostate cancers can also be classified into broader stage groups by combining the T, N, and M 
classifications, resulting in overall stage groupings of ‘Stage I’, ‘Stage II’, ‘Stage III’, ‘Stage IV’, and 
‘Recurrent’ (see Table 2). This classification system is used to confer risk and prognosis and is 
more commonly used in epidemiology studies, such as those discussed in Section 2.3.3.1 below. 
Stage Stage criteria 
Stage I 
The tumour cannot be felt and involves one-half of 1 side of the prostate or even less than that. PSA 
levels are low. The cancer cells are well differentiated, meaning they look like healthy cells. 
Stage II The tumour is found only in the prostate. PSA levels are medium or low. 
   Stage IIA 
The tumour cannot be felt and involves half of 1 side of the prostate or even less than that. PSA levels 
are medium, and the cancer cells are well differentiated. 
   Stage IIB 
The tumour is found only inside the prostate, and it may be large enough to be felt during DRE. The 
PSA level is medium. The cancer cells are moderately differentiated. 
   Stage IIC 
The tumour is found only inside the prostate, and it may be large enough to be felt during DRE. The 
PSA level is medium. The cancer cells may be moderately or poorly differentiated. 
Stage III PSA levels are high, the tumour is growing, or the cancer is high grade. 
   Stage IIIA 
The cancer has spread beyond the outer layer of the prostate into nearby tissues. It may also have 
spread to the seminal vesicles. The PSA level is high. 
   Stage IIIB 
The tumour has grown outside of the prostate gland and may have invaded nearby structures, such as 
the bladder or rectum. 
   Stage IIIC 
The cancer cells across the tumour are poorly differentiated, meaning they look very different from 
healthy cells. 
Stage IV The cancer has spread beyond the prostate. 
   Stage IVA The cancer has spread to the regional lymph nodes. 
   Stage IVB The cancer has spread to distant lymph nodes, other parts of the body, or to the bones. 
Recurrent The cancer has returned after treatment. 
 
Table 2 Stages of prostate cancer. Modified from https://cancerstaging.org/references-
tools/quickreferences/Documents/ProstateSmall.pdf 
 
2.1.5.2. Management of prostate cancer 
Management of prostate cancer can take various forms, depending on the clinical and pathological 
characteristics of the individual diagnosis. As this thesis is primarily concerned with human 
behaviour, the following section does not discuss prostate cancer management in detail; but rather 




2.1.5.2.1. Active surveillance 
Prostate cancers of a low grade are relatively slow growing and, as noted above, many will be 
ultimately clinically insignificant. Thus, one option for men diagnosed with low grade (i.e. low risk) 
prostate cancer is to be put onto a regimen of active surveillance. Active surveillance involves 
monitoring the cancer until it is deemed necessary to progress to curative treatment. It is therefore 
an option for men who have a life expectancy of at least 10 years in whom curative treatment is 
clinically viable. Recently updated guidelines in the United Kingdom suggest that an active 
surveillance protocol should consist of PSA tests in the first year following diagnosis, with a digital 
rectal examination at 12 months, and a multiparametric MRI examination between 12 and 18 
months. This would then be followed by 6-monthly PSA tests and 12-montly digital rectal 
examinations until the active surveillance regimen ceases (i.e. the patient transitions to active 
treatment). PSA kinetics and imaging are monitored throughout this time, in order to continually 
assess the need for radical treatment.[27] Active surveillance protocols are an attempt to reduce 
overtreatment of low-risk prostate cancer. The lack of active treatment can be a source of anxiety 
for patients, however, which can be an antecedent to them requesting active treatment.[57] 
2.1.5.2.2. Radical prostatectomy 
Radical prostatectomy is a treatment option for prostate cancer that is localised to the prostate 
gland (men who have undergone this treatment are the focus of the mixed methods study 
described in Chapter 4). Radical prostatectomy is the surgical removal of the whole prostate. In 
the UK, this is typically done laparoscopically. In current practice, this procedure can be performed 
either directly at the hands of a surgeon; or with the assistance of a surgical robot, which is 
controlled by the surgeon via a local console.[58] All prostatectomies that have been performed on 
the men examined in this thesis were robotic assisted. 
During removal of the prostate, the bladder is reattached to the urethra via anastomotic suture. 
During this process, the lower urinary sphincter is removed. Removal of the lower urinary sphincter 
can have potentially severe implications for the patient’s continence post-operatively. The time that 
it takes to regain continence varies considerably from patient to patient, with some regaining 
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continence a matter of weeks after surgery; and others not regaining continence for many 
months.[59] 
Another significant side-effect of radical prostatectomy is erectile dysfunction, which is related to 
the extent of the local excision performed. Wider excision can affect the cavernous nerves, which 
are responsible for triggering the chemical reaction that precipitates penile erection, and sit in two 
bundles directly proximal to the prostate capsule on the left and right side.[23] Ensuring the removal 
of all cancerous prostate tissue can require a wide excision that results in removal of one or both 
cavernous nerve bundles.[59] 
2.1.5.2.3. External beam radiotherapy 
External beam radiotherapy is another radical treatment option for men with localised prostate 
cancer. Radiotherapy targets the DNA residing in the prostate tumour cells, and thus kills these 
cells through the dysfunction of typical cell division and regulation mechanisms. The extent of 
destruction of malignant cells during radiotherapy varies as a function of the degree to which 
oxygen is available to these cells, and therefore could theoretically be influenced by the amount of 
physical activity the patient is habitually engaging with.[60] 
Potential side effects immediately following radiotherapy treatment are dysuria, haematuria, 
urinary frequency, urinary urgency, diarrhoea, and proctitis. Longer term side effects can include 
increased frequency of bowel movements, rectal ulceration, rectal bleeding, erectile dysfunction, 
and urinary incontinence.[60] 
2.1.5.2.4. Brachytherapy 
Brachytherapy is another form of radical radiotherapy available for men with localised prostate 
cancer. It utilises the same biological principles as above, using a different delivery method. In 
brachytherapy, several metal ‘seeds’ containing radioactive isotopes are surgically inserted into 
the prostate, around the tumour site. The seeds omit a radioactive dose to the surrounding tissue 




2.1.5.2.5. Androgen deprivation therapy 
Androgen deprivation therapy (ADT) is a systemic treatment option for men with prostate 
cancer. ADT aims to slow the progression of a malignancy originated from the prostate, by reducing 
testicular androgen levels to castrate level (<50ng/dL). Androgen deprivation is commonly 
achieved medically, but in rare cases can be achieved surgically, via orchiectomy. Meta-analysis 
has shown survival outcomes from each method to be the same.[62] Medical castration can be 
achieved by pharmacological intervention at numerous stages in the process of androgen 
production and signalling. Some of the ways this is commonly achieved are 1) administration of a 
gonadotropin-releasing hormone (GnRH) agonist, which has the effect of reducing the secretion 
of luteinising hormone (LH) from the pituitary, and so the production of androgen is inhibited; 2) 
administration of a GnRH antagonist, which has the effect of creating competition for the natural 
GnRH to bind to the GnRH receptors of the pituitary gland[22]; or 3) disruption of the biosynthesis 
of endogenous androgen[63] (see Section 2.1.5.2.5.1 below). 
Side effects of long-term ADT can include mood swings, osteoporosis, sarcopenia, metabolic 
syndrome, increased cardiovascular risk, mild cognitive decline, fatigue, hot flushes, 
gynaecomastia, and loss of libido.[22,64,65] 
2.1.5.2.5.1.  Second-generation hormonal treatments 
More recently, a newer class of hormonal treatments have emerged that have been termed 
second-generation hormonal treatments.[63] These compounds have attempted to surmount a 
problem posed by prostate cancers that have become resistant to hormonal therapy, in which 
excessive amounts of androgen receptor can render ‘first-line’ hormonal treatments ineffective (or 
possibly even counterproductive). One of these second-generation hormonal treatments, 
abiraterone acetate, reduces the production of endogenous androgen via inhibition of the enzyme 
CYP17, which is necessary for the conversion of testosterone to dihydrotestosterone. Other 
second-generation hormonal treatments aim to prevent nuclear translocation of androgen receptor 
in order to prevent signalling to androgen receptor target genes (e.g. enzalutamide).[63] 
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Side-effects of abiraterone acetate can include hypokalemia, fluid retention, and hypertension. 
These side-effects can however be ameliorated with prednisone, which is issued in combination 
with abiraterone as standard. Side-effects of enzalutamide can include fatigue, arthralgia, 
constipation, and seizures.[63] 
2.1.5.2.6. Chemotherapy (neoadjuvant) 
For some time, chemotherapy has been used as a second line of treatment for prostate cancer 
that has become resistant to ADT.[66] Following a large randomised controlled trial that was recently 
reported (STAMPEDE), it has been recommended that neoadjuvant chemotherapy be 
prescribed alongside ADT treatment for men with advanced prostate cancer, who are deemed fit 
enough.[67] The trial demonstrated a survival benefit for this approach, alongside an increase in 
adverse events. Chemotherapy is the intravenous administration of cytotoxic agents that are 
synthetically designed to kill cancer cells. However, the cytotoxic agent’s systemic mode of 
administration can often also cause damage to healthy organ tissue. Potential side effects of 
chemotherapy include fatigue, nausea, neutropenia, anaemia, appetite loss, peripheral 
neuropathy, alopecia, diarrhoea, and constipation.[22] 
 
2.2. Exercise and physical activity 
Before proceeding, a clarification will be made with regards to the terminology of physical activity 
and exercise. The discipline of exercise physiology has coalesced around the argument that these 
two terms are physiologically interchangeable, and that to divide them semantically perpetuates 
an unhelpful scientific fallacy.[68] However, this thesis is centrally concerned with behaviour, not 
physiology, and therefore a distinction between the two terms will be necessary, given their distinct 
behavioural antecedents. The thesis will apply the definitions of these terms proposed by 
Caspersen et al.[69] Thus, the term physical activity is defined as “any bodily movement produced 
by skeletal muscles that results in energy expenditure”[p.126]. The term exercise is defined as 
“physical activity that is planned, structured, repetitive, and purposive in the sense that 
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improvement or maintenance of one or more components of physical fitness is an objective”[p.128]. 
These definitions situate exercise as a subset of physical activity; hence the term physical activity 
will be used by default, unless referring specifically to “planned, structured” activity, in which case 
exercise will be used. 
2.2.1. Physical benefits of physical activity 
It is well established that physical activity is beneficial to physical health overall.[70] It has been 
suggested that this is due to the human genome having been evolutionarily shaped by 
environments that required physical activity for survival.[71] Sustained engagement with physical 
activity improves physical fitness and muscular strength.[72] Clinical research into physical activity 
began in the 1950s, when the epidemiologists Jeremy Morris and Ralph Paffenbarger studied the 
association between occupational physical activity levels and coronary heart disease, finding that 
those who worked in physically active professions were significantly less likely to experience, or 
die from, coronary heart disease later in life. Since that time, the yearly rate of research publications 
on physical activity and physical fitness has exploded, increasing 100-fold in the intervening 
decades.[73] The evidence that engaging in enough physical activity can reduce the risk of all-cause 
and cardiovascular-related death is undisputed[74] and continues to accumulate.[75] Physical activity 
also reduces the risk of some types of cancer.[76–79] Furthermore, it has been suggested that 
exercise could be utilised by medical professionals as a therapy in 26 different chronic diseases, 
ranging in nature across cardiovascular diseases, pulmonary diseases, musculo-skeletal 
disorders, metabolic diseases, cancer, neurological diseases, and psychiatric disorders.[80]  
2.2.2. Psychological and cognitive health benefits of physical 
activity 
It is generally accepted among investigators that physical activity is beneficial to psychological 
wellbeing in the normal population.[81] Physical activity appears to have a protective effect against 
depression, when taking together findings from prospective cohort studies (e.g. Harvey et al.[82]) 
and clinical intervention studies.[83] Underlying this finding, there is some evidence that exercise 
can improve emotional resilience to stress, with a lack of prior exercise found to be associated with 
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lower coping self-efficacy and more rumination.[84] Aerobic exercise has also been shown to 
alleviate anxiety, particularly in the immediate aftermath of the exercise session, but also 
cumulatively as a result of chronic exercise. Trials in clinically anxious populations have found that 
the effect of aerobic exercise is comparable to that of established pharmacological treatments. 
Resistance exercise, on the other hand, appears to be associated with short-term increases in 
anxiety immediately following the exercise session.[85] However, unlike depression, exercise does 
not appear to have a protective effect against the onset of anxiety.[82] 
It is possible that some degree of improvement in psychological wellbeing observed in physical 
activity studies could result from concurrent exposure to beneficial social[86] or natural[87,88] 
environments. However, studies using animal models demonstrating the enhancing effects of 
simple aerobic exercise on circulating levels of the neurotransmitters serotonin,[89] dopamine,[90] 
and acetylcholine[91] would suggest some degree of direct biological effect of exercise on 
psychological functioning. Thus, it is plausible that it is the physical activity itself that is responsible 
for at least some benefits to psychological functioning. 
2.2.2.1. The role of physical activity in promoting wellbeing 
In addition to having protective effects against psychological ill-health as described above, PA 
appears to promote psychological wellbeing, and facilitate individual flourishing.[92] Benefits of PA 
engagement for psychological wellbeing are perhaps best understood qualitatively. There is good 
evidence that many of the psychological benefits are existential in nature, manifested via cognitive 
appraisals of such constructs as self-worth,[93] environmental mastery,[94] autonomy,[95] and 
purpose.[96] It is primarily in this domain that there is an overlap in the research literature between 




2.3. Physical activity and cancer 
Since the first randomised controlled trial of exercise training for breast cancer patients undergoing 
chemotherapy in the late 1980s,[97] there has been an exponentially growing interest in the 
research field now known as exercise oncology. There has been a notable surge in the number of 
published reports in exercise oncology since 2013, and this high level of interest has persisted 
since (see Figure 4).[98] Most exercise intervention studies in the cancer survivorship context have 
examined breast cancer patients, but there has also been significant research into cancers of the 
prostate, lung, and colon.[98] 
 
Figure 4 Historic overview of exercise intervention studies in cancer patients. Reproduced 
from Christensen, Simonsen, & Hojman.[98] 
 
The sustained level of research interest illustrated by Figure 4 has been warranted because many 
studies have shown exercise to have several benefits to people in a cancer survivorship context. 
Engagement with physical activity and/or exercise can lead to improvements in both psychosocial 
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and physiological domains in people diagnosed with cancer. Furthermore, it has been associated 
with better survival outcomes (for a review, see Christensen, Simonsen, & Hojman[98]). Whilst the 
mechanisms underlying this association are still under study, it is thought that exercise could lead 
to better survival outcomes in cancer patients through a few different candidate pathways. 
2.3.1. Potential effects of physical activity on cancer 
There are a number of ways in which it is thought that physical activity could be beneficial to cancer 
from a biological perspective.[98–100] A discussion of these numerous candidate pathways is beyond 
the scope of this thesis, but some examples will be briefly summarised here. For instance, it has 
been proposed that exercise could benefit survival outcomes in cancer by creating physical and 
physiological conditions that are favourable to treatment efficacy.[98] Some ways in which this could 
occur have been suggested: 
Preoperative optimisation. Research has suggested that preoperative optimisation via 
exercise intervention may lead to better oncological outcomes, as surgical stress and 
inflammatory responses can facilitate subsequent metastatic progression.[98] Also, exercise 
intervention in the setting of neoadjuvant (chemo)radiotherapy can increase the chances of 
maintaining a strong enough physiological condition to undergo radical surgery, reducing 
the likelihood of delay to surgery, and therefore increasing the likelihood of a favourable 
surgical outcome.[98] 
Chemotherapy completion rates. Some randomised studies of individuals with breast 
cancer undergoing chemotherapy have demonstrated that exercise is associated with 
increased rates of treatment completion in these patients.[101,102] In a more recently 
published randomised study on women with breast cancer, there was no effect of exercise 
on completion rate, but there was a beneficial effect on rates of hospitalisation during 
treatment.[103] It has been suggested that a feedback response, triggered by immune cell 
mobilisation, may result in an increase in newly created immune cells, resulting in an 
attenuation of the decrease in immune cells caused by the chemotherapeutic agent.[104] 
Another possibility is that participation in exercise, and/or a favourable bodily composition, 
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can decrease chemotherapy toxicity through pharmacokinetic mechanisms. That is, 1) the 
use of skeletal muscle increases blood perfusion to muscles, potentially resulting in less 
toxicity to organs; and 2) a lower body fat percentage may reduce the concentration of the 
chemotherapeutic agent in other parts of the body – i.e. the organs – as adipose tissue is 
poorly perfused with vasculature.[98] 
Increased treatment effectiveness. It has been proposed that exercise could increase 
the efficacy of various cancer therapies via a common mechanism of intratumoural vascular 
normalisation.[98,99] Normalisation of intratumoural vascular structures has the effect of 
reducing hypoxia in the tumour.[99] In the context of chemotherapy, vascular normalisation 
in the tumour could improve the delivery of cytotoxic agents to the interior of the tumour. 
Results from experiments using mice are consistent with this idea, having shown that 
combining chemotherapy delivery and treadmill/wheel running enhances treatment 
response[105,106] and delivery of chemotherapy to tumour cells.[107] In the radiotherapy 
context, reduced hypoxia in the tumour would promote the formation of reactive oxygen 
species (ROS) that drive the therapeutic effect of radiation.[22,99] However, there are no 
studies to date that have investigated the combination of radiotherapy alone and exercise 
in humans. In the context of immunotherapy, vascular normalisation may facilitate the 
infiltration of cytotoxic immune cells into the tumour, which is associated with a more 
favourable disease outcome.[99,108] 
2.3.2. Metabolic syndrome and prostate cancer 
Metabolic syndrome (MetS) is a state of physiological dysregulation characterised by a complex 
interplay of physiological risk factors, which include dysglycaemia, elevated triglycerides, low high-
density lipoprotein cholesterol levels, raised blood pressure, and obesity. The presence of MetS 
can be identified by the simultaneous presence of at least three of these risk factors.[109] 
The presence of MetS has been suggested to be associated with more aggressive prostate cancer 
and worse oncologic outcomes.[110] To complicate matters, an association has been observed 
between treatment with ADT and the subsequent development of MetS.[64] Hence, addressing 
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MetS through lifestyle changes, including exercise, could result in more favourable oncologic 
outcomes; and complementing ADT with exercise could result in more favourable non-oncologic 
outcomes.[111] The relationship between MetS and prostate cancer illustrates how biological 
mechanisms underlying the relationship between physical activity and prostate cancer may be 
complex and systemically interwoven. 
2.3.3. Physical activity and exercise in prostate cancer 
As noted above, there is no consistent evidence that physical (in)activity behaviour is a risk factor 
for developing prostate cancer. However, there is a substantial amount of epidemiological 
evidence demonstrating that engagement with exercise post-diagnosis is inversely associated with 
subsequent signs of disease progression, or prostate cancer-specific death. In addition to this, 
there have been numerous exercise intervention studies examining the clinical benefits of exercise 
for men with prostate cancer. 
2.3.3.1. Epidemiological research on post-diagnosis physical activity in 
prostate cancer 
To date, six epidemiological studies have been published examining the relationship between post-
diagnosis physical activity and disease progression, or cancer-specific survival, in men with 
prostate cancer. The findings of these studies are summarised in Table 3 and elaborated upon 
below. 
In 2011, Kenfield et al. reported an analysis performed within the prospective Health Professionals 
Follow-Up Study, on 2,705 men diagnosed with nonmetastatic prostate cancer between 1990 and 
2008.[13] They found an inverse association between level of self-reported vigorous physical 
activity, and prostate cancer death. Those reporting more than three hours of vigorous physical 
activity per week were 61% less likely to have died from their prostate cancer, compared with those 
reporting less than one hour per week (HR 0.39, 95% CI 0.18–0.84). No such relationship was 
observed for non-vigorous physical activity. A trend was also observed for total self-reported 
physical activity, such that risk of prostate cancer death decreased with increasing total physical 
activity (ptrend=0.04). The investigators recognised the potential for reverse causation to be a 
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misleading factor in their analysis (i.e. men with undiagnosed metastases performing less physical 
activity as a result). They tried to account for this by excluding men with metastases at diagnosis, 
and at any time up to two years after their first post-diagnosis assessment; and any men who died 
within four years of first post-diagnosis assessment.[13] 
That study was followed soon after by an analysis by Richman et al.[12]. Aiming to reduce the 
likelihood of reverse causation, this retrospective analysis examined self-reported vigorous 
physical activity and brisk walking in relation to prostate cancer progression, rather than prostate 
cancer death. Disease progression was defined as either prostate cancer death, diagnosis of bone 
metastases from prostate cancer, biochemical recurrence (i.e. a progressive increase in PSA), or 
secondary treatment. Participants included in the analysis were 1,455 men with biopsy-proven 
prostate cancer who had completed physical activity questionnaires between 2004 and 2005, as 
part of the wider CaPSURE study.[112] Data were not available on pre-diagnosis physical activity. 
Participants were followed up until either disease progression, death, last contact, or 21st August 
2009. Men with non-localised disease at diagnosis were excluded. It was observed that men who 
walked briskly for more than three hours per week were 57% less likely to exhibit disease 
progression during follow-up (HR 0.43, 95% CI 0.21–0.91). A similar association for vigorous 
physical activity was not observed. However, the authors noted that the very small number of cases 
of progression in men engaging with vigorous activity could have undermined efforts to establish 
a statistical effect.[12] 
The relationship between post-diagnosis physical activity and prostate cancer mortality, or all-
cause mortality, was reported on again in 2015 by Bonn and colleagues[16]. Using a dataset derived 
from the Swedish National Prostate Cancer Register (NPCR), they retrospectively analysed data 
from 4,623 men diagnosed with localised prostate cancer from 1997 through 2002. Men with 
diagnosed regional or distant metastases, and men ≤70 years of age, were excluded. Included 
were those that had answered a lifestyle questionnaire in 2007 or 2008, which asked about 
physical activity after diagnosis. Data on pre-diagnosis physical activity were unavailable. The 
results showed that men who exercised ≥1 hour/week were 32% less likely to have died from their 
prostate cancer than less active men (HR 0.68, 95% CI 0.48–0.94). A similar association was 
39 
 
observed for men who walked or cycled ≥20 minutes/day compared with less active men (HR 0.61, 
95% CI 0.43–0.87). In order to address the reverse causality hypothesis, a sensitivity analysis was 
performed, which applied a lag time by excluding men who died within 18 months of completing 
the lifestyle questionnaire. Results were mildly attenuated: the confidence interval for men doing 
≥1 hour/week widened across the significance threshold (HR 0.73, 95% CI 0.50–1.05). The authors 
attributed this widening to a loss of statistical power in the sensitivity analysis. 
These findings were corroborated by work from Friedenreich et al.[14], who used prospectively 
collected data to conduct a survival analysis on 830 cases of men with stage II, III, or IV prostate 
cancer. Self-reported pre-diagnosis physical activity was assessed in the few months after 
diagnosis. Their results showed that men who participated in ≥13 MET hours/week of recreational 
physical activity were 39% less likely to die from prostate cancer than men who participated in ≤4 
MET hours of recreational activity per week (HR 0.61; 95% CI 0.39–0.95). No significant 
associations were found between total, occupational, or household physical activity and prostate 
cancer death. Results of a sensitivity analysis, excluding 68 physical activity assessments that 
were performed within 12 months of death, did not support the reverse causation hypothesis. 
Wang et al.[15] then conducted a prospective cohort study on 5,319 men diagnosed with 
nonmetastatic prostate cancer between 1992 and 2011, from the CPS-II Nutrition Cohort[113]. They 
examined prostate cancer-specific mortality in relation to post-diagnosis recreational physical 
activity, following men for up to 20 years, to 2012. To address the reverse causation hypothesis, 
they excluded men who completed their physical activity assessment within four years of their 
death. Due to their study design, they were also able to control for pre-diagnosis physical activity 
in the model. Their analysis showed that prostate cancer death was 31% less likely in men who 
engaged with ≥17.5 MET hours/week, compared with men who engaged with ≤8.75 MET 
hours/week (HR 0.69, 95% CI 0.49–0.95). An inverse association between pre-diagnosis 
recreational physical activity and prostate cancer mortality was also observed in participants with 
lower risk tumours, which weakens support for the reverse causation hypothesis by lending 
credence to the alternative hypothesis that physical activity could affect tumour progression. 
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Most recently, Dickerman et al. sought to use observational data from the Health Professionals 
Follow-Up Study to emulate a theoretical target trial.[17] Their proposed target trial would examine 
the effect of a physical activity intervention initiated at prostate cancer diagnosis and continued 
until death, the end of the follow up period, or the onset of a physically limiting medical condition 
e.g. a cardiovascular event. The analysis used data from 2,299 men from the study that had been 
diagnosed with nonmetastatic prostate cancer between 1998 and 2010. The investigators used 
the parametric g-formula to estimate the risk difference at 10 years of follow-up, had participants 
engaged in various specified levels of physical activity. The g-formula enables conditional 
standardisation and generalisation of time-varying covariates. Using these standardised values, 
one can produce a simulation of the probability of the outcome in a certain timeframe, given 
sequential effects between the time-varying covariates, that are calculated using the standardised 
values produced by the formula. One can therefore emulate a target trial by fixing certain 
parameters within the model at certain values (e.g. physical activity level) and calculating the 
ultimate effect of this manipulation on the probability of the outcome of interest, after a specified 
time period in which covariates influence one another sequentially, in line with their standardised 
effect values.[114] Dickerman et al.’s analysis estimated 13–16% of all-cause deaths in the cohort 
would be prevented, were individuals engaging with recommended levels of vigorous activity; and 
5–10% would be prevented, were individuals engaging with recommended levels of moderate 
activity. A sensitivity analysis which applied a two-year lag time to the exposure data, to account 
for unknown clinical confounders, attenuated the observed risk ratios by 3 percentage points 
(vigorous activity) and 5 percentage points (moderate activity), but the statistical significance of 













HR (95% CI) 
 
Kenfield et al. (2011) 2,705 
>3hrs/week vigorous activity vs. 
<1hr/week vigorous activity 
PCa-specific mortality 18 years 0.39 (0.18–0.84) 
Richman et al. (2011) 1,455 
>3hrs/week brisk walking vs. 
<3hrs/week easy pace walking 
PCa progression ~22 months 0.43 (0.21–0.91) 








Friedenreich et al. (2016) 830 
>26 MET-hours/week per year 
vs. <4 MET-hours 
PCa-specific mortality 14-17 years 0.56 (0.35–0.90) 
Wang et al. (2017) 5,319 
>17.5 MET-hours/week vs. 3.5-
<8.75 MET-hours 
PCa-specific mortality 1-20 years 0.69 (0.49–0.95) 
     RR (95% CI) 
Dickerman et al. (2019) 2,299 
≥1.25 hours/week of moderate 
activity 
or 
≥2.5 hours/week of vigorous 
activity 
vs. no intervention 




Table 3 Summary of epidemiological studies demonstrating the relationship between postdiagnosis physical activity, and disease progression or prostate 
cancer-specific survival. CI, confidence interval; HR, hazard ratio; RR, risk ratio. 
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It has been argued by Downer[115] that the analyses described above are likely to have 
underestimated the magnitude of the relationship between post-diagnosis physical activity and 
prostate cancer death. Three reasons are proposed by Downer: 
1. Given common issues in self-reported measurement of physical activity, there may 
exist a differential bias in physical activity reporting between men who are relatively 
healthier, and men who are sicker due to progression of their disease. Downer 
argues that the healthier men are more likely to underestimate MET hours of 
physical activity undertaken; whereas conversely, sicker men are more likely to 
overestimate MET hours of physical activity undertaken. Such differential bias 
would reduce the observed magnitude of the physical activity–prostate cancer 
death relationship. 
2. Lag-time procedures to address potential reverse causation, as described above, 
could be masking the magnitude of the true relationship, by eliminating cases in 
which a reverse causation effect was not present. 
3. Selection bias could have been introduced into the case-only samples, as those 
with both high physical activity levels and prostate cancer may possess more pre-
dispositional risk factors for prostate cancer, that could theoretically then be 
associated with a higher likelihood of disease progression and death (i.e. collider 
bias). 
The assumption underlying this final point is that physical inactivity might actually be a risk factor 
for developing prostate cancer. As described in Section 2.1.4.2.1, there is no consistent evidence 
of this. However, Downer could be correct on both points 1 and 2, which would suggest that the 
true magnitude of the observed relationship between post-diagnosis physical activity and prostate 
cancer death is likely to be substantial. 
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2.3.3.2. Exercise intervention research in prostate cancer 
2.3.3.2.1. Exercise intervention and disease progression or survival 
Although efforts are in progress,[116] there is currently no published data from a randomised trial on 
the effect of exercise training on disease progression or survival in men with prostate cancer. 
2.3.3.2.2. Exercise intervention and physical wellbeing in prostate cancer 
Two reviews with meta-analyses have been reported examining the effect of exercise intervention 
on quality of life and fatigue in men with prostate cancer. One of these, by Vashistha et al., 
analysed 13 RCTs involving a total of 1,057 participants.[10] The other, by Bourke et al., also 
reported on physical functioning, disease progression, cardiovascular health, and sexual function, 
analysing 16 RCTs involving a total of 1,574 patients.[117] Both analyses found that exercise 
interventions were successful at improving both quality of life and fatigue in prostate cancer 
patients. The Bourke et al. review also found that exercise interventions were successful at 
improving physical fitness; however, they did not find a significantly beneficial effect for disease 
progression, blood pressure, or sexual function.[117] 
It was noted by Bourke et al. that inter-study heterogeneity of treatments received by study 
participants may have undermined attempts to find statistical benefits for certain parameters,[117] a 
point which could also be extended to the Vashistha et al. study.[10] It was also observed by Bourke 
et al. that intervention adherence and participant attrition were the primary causes of bias risk 
amongst the studies examined.[117] Such potential risk of bias is somewhat of a systemic issue 
throughout exercise oncology literature, as variations in intervention intensity are likely to produce 
differential pressure on sample selection and adherence/attrition rates (this point is further 
examined in Chapters 3 and 4). However, it is clear from the wealth of studies available that 
physical activity interventions are beneficial to men with prostate cancer. 
Exercise has been shown to be particularly beneficial in the context of ADT, having positive effects 
on aerobic fitness, muscular strength, body composition, fatigue, mental wellbeing, sexual 
wellbeing, social function, quality of life, and comorbid disease risk factors. Exercise may also be 
useful for managing bone density loss, cognitive decline, and urinary problems in these patients.[9] 
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These benefits are particularly key to men undergoing ADT, given the therapy’s systemic physical 
side-effects. Studies of safety have established that carefully delivered exercise interventions are 
safe for this patient population, including for men with advanced disease and bone metastases.[118] 
2.3.3.3. Physical activity and psychological wellbeing in prostate cancer 
A systematic review and meta-analysis estimating the prevalence of depression and anxiety in 
men diagnosed with prostate cancer has noted that prevalence is relatively high[119] (see Table 4). 
 Prevalence (%, 95% CI) 
 
Pre-treatment On treatment Post-treatment 
Depression 17.3 (15.1–19.7) 14.7 (11.9–18.0) 18.4 (15.2–22.2) 
Anxiety 27.0 (24.3–30.0) 15.1 (12.2–18.6) 18.5 (13.8–24.3) 
 
Table 4 Estimated prevalence of depression and anxiety amongst men diagnosed with prostate 
cancer. Modified from Watts et al.[120] 
 
Notwithstanding the psychological impacts of a cancer diagnosis generally, which are well 
documented,[121] there are special considerations with regards to prostate cancer. For instance, 
men on active surveillance who report higher levels of cancer anxiety are more likely to transition 
into active treatment,[57] which could drive overtreatment. Furthermore, men undergoing treatment 
for prostate cancer often experience alienation from socially entrenched ideas about masculinity, 
which can drive psychological stress[7]; and it has even been observed that cancer-related 
masculine threat can exacerbate subsequent declines in urinary, bowel, or sexual functioning.[122] 
Exercise interventions for men with prostate cancer can exert a therapeutic effect on men’s sense 
of masculine identity.[8] The resulting alleviation of psychological distress has been posited as one 
of many reasons to integrate exercise into clinical practice.[123] Despite these propositions, reviews 
of quantitative psychological wellbeing outcomes in exercise intervention studies in men with 
prostate cancer have reported null effects overall,[10,124] as has a subsequently published RCT.[125] 
45 
 
2.4. Psychology of exercise behaviour 
Given the strong empirical bases for the benefits of physical activity for men with prostate cancer, 
interventions are required that will promote physical activity behaviour in this patient population. 
Such interventions should be theory-based. The theoretical basis underpinning the mechanism for 
the intervention studied in this thesis is outlined in Chapter 3. The psychological bases of exercise 
behaviour are very complex, involving the interaction of personal cognitions with social and 
environmental factors that are both immediate, and systemic to society.[126] Key constructs, 
relevant to PA, that are referred to in this thesis are presented and described below. These 
constructs are self-efficacy, attitude, motivation, intention, and environment. 
2.4.1. Key psychosocial factors 
Bandura’s concept of self-efficacy[127] is central to understanding the behavioural dynamics of 
physical activity engagement. It forms a significant pillar of the most commonly used and 
empirically supported theory in physical activity research, the theory of planned behaviour[128] (see 
Section 3.5.1). Self-efficacy is defined by Bandura as “people’s judgements of their capabilities to 
organise and execute courses of action required to attain designated types of 
performances”[127][p.391]. It is influenced by a combination of personal experience of the behaviour; 
observation of others demonstrating the behaviour; verbal and social persuasive messages; and 
physiological states.[129] As such, it is a concept that both drives engagement behaviour, but is also 
strongly influenced by it – an example of what Bandura terms reciprocal determinism. Self-efficacy 
has been empirically demonstrated to be a consistent predictor of physical activity participation in 
both clinical and non-clinical populations. It has been shown to be modifiable via intervention, and 
successful physical activity intervention studies have implicated changes in self-efficacy as a 
mediator of positive behavioural change.[129] 
Attitude represents an individual’s overall beliefs toward, and evaluation of a given behaviour. 
Attitude is also heavily implicated in behavioural intention, according to the theory of planned 
behaviour.[130] Two explicit cognitive processes are strongly involved in the formation of an attitude 
toward a given behaviour. First, behavioural beliefs: the degree to which an individual believes that 
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the behaviour will result in a particular outcome. Second, outcome expectations: the degree to 
which the perceived outcome is salient to that individual. It is now widely acknowledged that 
explicit, deliberative process are only one dimension of attitude formation, however. Attitudes are 
also constructed via automatic, unconscious, implicit processes, as has been demonstrated by 
many studies examining implicit attitudes, which have been shown to be an independent predictor 
of physical activity behaviour.[131] Implicit attitude research aligns with a contemporary view of 
behaviour that describes two qualitatively distinct types of psychological system, which are thought 
to have reciprocal influence upon one another[132,133] (further detail is provided in Section 3.5). 
Motivation is an individual’s willingness to engage in a behaviour. It is a key element of physical 
activity behaviour.[95] In the domain of physical activity, it is thought to be closely related with 
attitude.[129] The key conceptual distinction between these two constructs is that motivation is an 
experience, not a disposition. It is thought that motivation has a strong affective dimension.[134] 
Motivation has been described as taking several differing forms, each accompanied by a greater 
or lesser sense of autonomy.[135] It has been proposed that this understanding of motivation could 
supplement our social cognitive understanding of attitudes, leading to a more integrated 
understanding of behaviour[136] (further detail is provided in Section 3.5). 
Intention to engage in a behaviour is the primary precursor to behavioural action, according to the 
theory of planned behaviour,[128] where it is described as a moderator of the above prerequisites. 
Intention is commonly measured by asking individuals directly about their intention to engage in a 
behaviour within a given timeframe. It is consistently the strongest predictor of actual health 
behaviour.[137] Despite this, the predictive relationship between intention and actual behaviour has 
long been observed to be problematically weak; this observation is known as the intention-
behaviour gap. Physical activity behaviour has been shown to be subject to the intention-behaviour 
gap.[138] It is thought, however, that the construct of perceived behavioural control – an individual’s 
perception of their ability and opportunity to engage with the behaviour – may play a concurrent 
role in predicting actual behaviour, unmediated by intention.[128] 
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Finally, it is becoming increasingly recognised in the behavioural sciences that behaviour, including 
physical activity behaviour, is substantially determined by an individual’s wider physical and social 
environment. The recognition of this has been termed the ecological framework.[139] The 
ecological framework posits that human behaviour is influenced at multiple levels: the intrapersonal 
level, the interpersonal level, the organisational level, the community level, and the public policy 
level.[140] The approach assumes that the more such levels that are targeted by a public health 
intervention, the more effective that intervention will be. Physical activity behaviour is thought to 
be an area that is particularly suited to such an ecological approach.[141] 
2.4.2. Physical activity behaviour in the prostate cancer 
context 
Numerous studies have examined the impact of intervention on physical activity behaviour, and 
barriers or facilitators to the behaviour, in men with prostate cancer. These are described in 
Chapter 3, which begins by reporting on a systematic review and qualitative synthesis that has 
been undertaken as part of this thesis. 
2.5. Chapter summary 
Prostate cancer is the most common cancer in men. There are approximately 1.3 million new cases 
of prostate cancer diagnosed per year and approximately 350,000 deaths per year from prostate 
cancer. Furthermore, treatments for prostate cancer often have undesirable side-effects. PA has 
been shown to alleviate the side effects of prostate cancer treatment and contribute to less cancer-
specific fatigue and cancer-specific quality of life. Several epidemiological studies have shown that, 
following a prostate cancer diagnosis, engagement with PA is associated with lower risk of death 
from prostate cancer. Mechanisms via which PA influences cancer are not fully known, but several 
candidate mechanisms have been suggested, including the creation of physiological conditions 
that favour better outcomes from cancer therapy. The promotion of PA in men with prostate cancer 
is thus desirable, but general factors influencing PA behaviour are complex and multifaceted. Due 
to this complexity, I have undertaken a review of factors associated with PA in men with prostate 
cancer, which is reported in the next chapter.  
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Chapter 3: Intervention design 
This chapter is concerned with research objectives 1 and 2: 
1) Identify issues relevant to the design of a PA intervention for men with prostate cancer, 
both locally and generally. 
2) Design a PA intervention for men with prostate cancer that could be implemented as part 
of NHS standard care. 
The chapter commences by outlining the rationale for the approach that I took to the intervention 
design process, by referencing existing guidance for the development of interventions. Following 
this, the remainder of the chapter is concerned with the intervention design process itself, which is 
divided into four parts. 
The first two parts address research objective 1: 
• In Part A, broader issues relating to engagement with physical activity (PA) in men with 
prostate cancer are described, by reporting the findings of a systematic review that I 
undertook, that aimed to identify barriers and facilitators to PA experienced by men with 
prostate cancer.[142] 
• In Part B, local issues relating to engagement with PA in men with prostate cancer are 
described, by reporting the findings of two analyses of clinical data from the local setting, 
that aimed to examine the uptake and the effectiveness of the existing local PA pathway. 
Part B also includes a short summary of an empirical observation, related to peer support, 
that fed into the intervention design process. 
The third and fourth parts address research objective 2: 
• In Part C, I describe the approach taken to designing the intervention, which utilised an 
existing framework for intervention design, the Behaviour Change Wheel.[143] 
• In Part D, I outline the psychological theories underlying the intervention and describe a 
working mechanism via which the intervention described in Part C could promote PA. 
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Throughout this chapter, some specific observations that fed into the intervention design process 
are highlighted. The observations are denoted by the symbol ▲ and are then collated and 
summarised towards the end of the chapter, where the intervention itself is described. 
3.1. Existing guidance for the development of 
interventions 
The Medical Research Council (MRC) has developed guidance for the development and 
evaluation of complex interventions, which have been influential.[144] The MRC guidance has four 
key stages: development; feasibility and modelling; evaluation; and implementation. The guidance 
emphasises the importance of using an iterative, cyclical approach to moving through these 
stages.[144] 
My thesis is concerned with the first stage in the above process: development. The development 
stage of the MRC guidance recommends: 1) identifying the evidence base; 2) identifying or 
developing theory; and 3) modelling process and outcomes.[144] Recently, efforts have been 
undertaken to expand on the MRC guidance for the development stage in more detail.[145,146] An 
extension of the development stage was deemed necessary to assist healthcare researchers in 
reducing ‘research waste’, i.e. resources being needlessly wasted on fruitless endeavours 
resulting from inadequate preliminary investigation.[147] 
To this end, O’Cathain and colleagues have produced additional guidance for researchers who 
aim to develop an intervention.[145] Their guidance was produced following a consensus exercise 
involving reviews and qualitative interviews with experts. It is intended to provide more detailed 
advice on the development stage than is provided by the MRC framework. O’Cathain et al. present 
recommendations for actions to be taken during the development phase.[145] Their 
recommendations include: 
• Reviewing published research evidence 
• Understanding context 
• Drawing on existing theories 
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• Articulating a programme theory (i.e. a theory that is specific to the intervention being 
developed) 
I took these four actions in order to design, and begin development of, the PA intervention 
described in this thesis. The remainder of this chapter will contain four parts – Parts A, B, C and D 
– that correspond to each of the above four actions that were taken to aid design and development. 
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PART A Reviewing published research evidence 
In order to review the published research evidence on PA behaviour in men with prostate cancer, 
I undertook a systematic review examining barriers and facilitators to PA in this population. The 
review has been published in Psycho-Oncology.[142] 
3.2. A systematic review of barriers and facilitators to 
physical activity in men with prostate cancer 
3.2.1. Introduction 
A significant proportion of men diagnosed with prostate cancer do not meet the recommended PA 
guidelines for people with cancer.[18,148] As noted in Chapter 2, issues with adherence to PA 
interventions are hindering a robust scientific investigation of the appropriate dosage of PA 
necessary to confer a clinical benefit to men with prostate cancer.[117] Therefore, it is useful to 
identify specific barriers and facilitators to PA in this patient population, in order to effectively apply 
behaviour change methods and consider contextual factors. The review reported here focused on 
the experience of the individual patient and their direct environment – e.g. internal psychological 
experience; or interaction with peers, partners, clinical care team, or physical environment – as 
opposed to any wider structural barriers or facilitators. 
Previously conducted reviews in this area have reported primarily on quantitative research 
examining theoretical constructs, such as perceived behavioural control,[18,149] or general factors 
associated with PA, non-specific to the cancer experience.[150] A recent review by Hallward et al., 
of PA interventions for men with prostate cancer, aimed to describe the behaviour change 
techniques (BCTs)[151] used within interventions, and evaluate their promise.[152] The review found 
the BCTs social support, information about antecedents [of PA], and prompts and cues to be 
common amongst interventions that appeared more promising at changing behaviour. 
Whilst experimental approaches are important for assessing interventions, experimenters could be 
assisted through the delineation of the real-world experiential factors influencing PA engagement 
in cancer patients. Knowledge of such factors could assist intervention designers to improve 
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uptake and adherence to PA interventions. Understanding this requires an examination of both 
quantitatively and qualitatively identified factors in PA engagement in this population. A good 
example of this approach has been reported by Clifford et al., who conducted a mixed methods 
systematic review of barriers and facilitators to PA in cancer patients (inclusive of all cancer 
types).[153] They reported that cancer treatment-related side effects were commonly cited in the 
literature as a key barrier to PA. In terms of prostate cancer, they reported that incontinence was 
a key barrier to PA. 
The present review was similar in approach to that of Clifford and colleagues, but instead aimed 
to focus specifically on prostate cancer. There are two empirical reasons for this prostate-specific 
approach: 
1. Different cancer types involve differing experiences and differing treatments, that 
may exert differential effects on PA behaviour.[154,155] 
2. Male PA behaviour is subject to gender-specific socio-cultural influences.[156] 
Consistent with the first point, there is now emerging evidence (partly due to work done as part of 
this thesis; see Section 3.3.1) suggesting that prostate cancer patients undergoing different 
treatments may adhere differently to established PA behaviour change pathways.[157,158] Hence, it 
seems that different treatment types should be considered when examining barriers and facilitators 
to PA in this patient population. 
The present review aimed to: a) examine barriers and facilitators to PA reported in the literature, 
with a specific focus on those experienced (or reported as not experienced) by men with prostate 
cancer; b) examine the extent to which particular barriers or facilitators are co-reported with 
particular treatments in the literature; and c) identify gaps in knowledge or methodological quality 
in this area. In order to address these aims, a quantitative and qualitative systematic review was 
conducted, consisting of a narrative presentation of quantitative studies, and a thematic synthesis 





3.2.2.1. Search strategy 
The review methods were registered on the PROSPERO database of review protocols 
(https://www.crd.york.ac.uk/prospero/; ID: CRD42018115130) in November 2018, when the 
literature search initially commenced. MEDLINE, Embase, PsycINFO, Web of Knowledge, 
CINAHL, PEDro, and the OATD and WorldCat libraries of theses and dissertations, were queried 
up to June 2019. A comprehensive set of terms were used that included, but were not limited to 
((prostate OR prostatic) AND (cancer OR neoplas* OR malinan* OR tumour OR tumor OR 
carcinoma)) AND (exercise* OR “physical activity” OR lifestyle OR “aerobic training” OR 
“resistance training”) AND (barrier* OR facilitat* OR attitud* OR experien* OR motivat* OR 
perspective* OR perception* OR psycho* OR behav*) AND (qualitative OR interview* OR “focus 
group*”) (see Appendix 1 for the full search strategy). Reference lists of included articles were also 
checked for additional articles. 
3.2.2.2. Inclusion and exclusion criteria 
Both quantitative and qualitative studies were considered for inclusion. The inclusion and exclusion 
criteria are specified in Table 5. Studies using samples that included individuals with cancers other 




Inclusion criteria Exclusion criteria 
  




Published at any time up to October 2018  
Quantitative or qualitative  
Includes participants (all studies):  
• Men diagnosed with prostate cancer 
• Disease status: any 
• Treatment received: any 
• Age, ethnicity, nationality: any 
• Studies in which the data pertaining to men with 
prostate cancer cannot be isolated 
 
Quantitative studies 
     Design: 
 
• randomised controlled trial 
• prospective cohort 
• non-randomised controlled trial 
• cross-sectional 
     Variables examined: 
• causes of PA or exercise 
• predictors of PA or exercise 
• prevalence of pre-specified barriers or 
facilitators to PA or exercise 
• Cross-sectional studies that do not examine 
barriers or facilitators directly as one of the 
variables of interest, i.e. that report only on 






     Study type: 
 
• any 
     Analysis method: 
• any 
     Data reported: 
• any insights into barriers or facilitators to PA 
or exercise provided by men who have been 





• Study only contains insights from individuals who 
have not been diagnosed with prostate cancer 
  
 







3.2.2.3. Selection procedure 
All duplicates were removed, and reports screened by title, abstract, and full-text, by myself. Full-
text reports in which a robust judgement could not be passed on whether they should be excluded 
were discussed with an additional second reviewer. Where there was any further dissention, a third 
reviewer was involved. 
3.2.2.4. Quality assessment 
Study quality was assessed using quality appraisal tools provided by the Joanna Briggs Institute 
(JBI) (http://joannabriggs.org/research/critical-appraisal-tools.html). The JBI has developed tools 
for critically appraising various types of study design, including qualitative studies. Eight of the 
appraised studies (four quantitative, four qualitative) were selected at random and appraised by a 
second reviewer. A subsequent discussion of these eight studies between the author and the 
second reviewer did not present any divergence of views regarding study appraisal. Due to the 
varying study designs, studies were not categorised by quality; instead, a visual representation of 
study appraisal was created to facilitate methodological appraisal of the literature (see Appendix 
2). 
3.2.2.5. Data presentation and qualitative synthesis 
Quantitative results are presented in a narrative style, as a lack of homogenous studies in this area 
did not permit a meaningful quantitative synthesis. Qualitative studies were subjected to a thematic 
synthesis[159] that considered the following questions: 1) What barriers and facilitators to PA exist 
in men with prostate cancer, and how might these differ between individuals? 2) How do particular 
barriers or facilitators fit into the context of the experience of prostate cancer diagnosis and the 
pathway of prostate cancer treatment? 
The qualitative synthesis method was informed by the process of thematic synthesis proposed by 
Thomas and Harden.[159] Thematic synthesis was deemed suitable for this context, given its 
original formulation as a process for investigating experiences of health promotion and public 
health interventions. The method has three primary steps: 1) initial coding of text; 2) developing 
descriptive themes; and 3) developing analytical themes. In this synthesis, the text of the included 
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research reports were initially deductively coded by the author for barriers and facilitators to PA, 
with memos constructed following the coding of each report, which detailed context, and clinical 
and demographic characteristics of study participants. The codes were then refined, by discarding 
those which were not adequately accounted for in the data, and redefining all codes to create the 
best descriptive fit to the textual data they represented. The refined codes were spatially organised 
according to their relationships with one another, before being grouped into descriptive themes 
(see Figure 6). The descriptive themes were used to construct third-order analytical themes. 
Construction of the analytical themes was undertaken in collaboration with another researcher with 
experience of qualitative research, and a cancer exercise physiotherapist, with the assistance of 
the primary data and the memos. Key overarching themes that were deemed representative of the 
accounts presented in the primary data were constructed.[159] The resulting analytical themes are 
presented below. 
3.2.3. Results 













Figure 6 Refined codes (right) and descriptive themes (left) resulting from the 
thematic synthesis (final analytical themes not shown). B, barrier; F, facilitator. 
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3.2.3.1. Quantitative results 
Tables containing the details of all included studies can be found in Appendix 3. Ten RCTs,[125,160–
168] four prospective cohort studies,[169–172] one non-randomised controlled trial,[173] and two cross-
sectional studies[174,175] were included in this review and are summarised below. 
3.2.3.1.1. Randomised controlled trials 
Two of the included RCT reports were of the same study (one of these was a mediation 
analysis),[125,161] and so a total of nine interventions were included as RCTs. Three of these 
interventions were variations on a similar basic premise of a 12-week supervised PA intervention, 
in which participants engaged in supervised PA 2-3 times per week.[125,160–162] All three of these 
interventions also applied a behavioural component, utilising techniques based in social cognitive 
theory; one of these interventions delivered the behavioural component via a group setting.[162] Six 
of the included interventions consisted of remote behavioural components only, involving no 
supervised PA.[163–168] Two of these applied personalised messaging as the primary component of 
the intervention.[164,165] One utilised regular technology-facilitated peer support and PA advice.[163] 
One applied an implementation intention intervention.[167] The other two consisted of home-based 
PA programmes that were facilitated with via regular telephone contact with the study team.[166,168] 
Some noteworthy observations were made upon examination of the included RCTs. First, all three 
of the interventions that consisted of a supervised PA programme[125,160,162] reported increases in 
PA behaviour compared with controls. Two of these reported maintenance of PA increases six 
months after baseline[125,160] (Focht et al.[162] did not report beyond three months). Of these two 
studies, one reported follow-up at 12 months,[125] at which increases in PA were not maintained. 
Of the six RCTs that provided remote behavioural support only, two reported increases in PA 
behaviour six months after baseline.[163,164] One of these studies[163] reported data at 12 months 
follow-up, at which PA gains were not maintained. In sum, all the studies included in this review 
that examined supervised interventions were effective at changing PA behaviour to some degree; 
whereas this was not the case for studies examining remote behavioural interventions only. 
Second, the five RCTs that reported apparent improvements in PA behaviour tended to have larger 
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sample sizes (n=100, 147, 463, 292, 32) compared with those that reported no behaviour change 
(n=64, 41, 423, 86). 
3.2.3.1.2. Prospective cohort studies 
Of the four analyses of prospective cohort studies included in this review, three were situated in 
the context of an RCT,[169,170,172] and one was an original cohort.[171] Two analyses have been 
reported in the context of 12-week PA programmes, by Courneya et al.[169] and Craike et al.[170]. 
Courneya et al. examined 82 men on ADT participating in three weekly sessions of supervised 
resistance training, and observed that cancer stage; time since diagnosis; time receiving ADT; 
treatment intent; previous receipt of radiotherapy; and previous receipt of radical prostatectomy 
were not predictors of adherence to the PA programme. They found that treatment with combined 
therapy (as opposed to monotherapy), fatigue, and overall quality of life did approach significance 
as independent predictors of adherence (p=.064, p=.059, and p=.064 respectively). Craike et al. 
used an identical outcome measure (% of PA sessions attended) to determine the predictive 
capability of several quality of life measures among 52 men undergoing curative treatment and, 
despite a small sample size, found that role functioning (p=.019) and hormonal symptoms (p=.054) 
did independently predict adherence. They observed that the following psychosocial measures did 
not significantly predict adherence: anxiety; depression; global quality of life; emotional functioning; 
cognitive functions; social functioning; insomnia; and financial difficulties. The following clinical 
measures were also not significant predictors in their model: physical functioning; pain; dyspnoea; 
diarrhoea; constipation; appetite loss; sexual functioning; urinary symptoms; bowel symptoms; 
cancer stage; whether received radical prostatectomy or radiotherapy; and whether received 
treatment with ADT. 
The other analysis situated within an RCT was reported by Ottenbacher et al.,[172] who examined 
whether cancer-specific concerns, quantified by the FACT-P,[176] predicted self-reported PA 1 year 
after baseline, in 193 men with stage I or II prostate cancer. It was found that none of the cancer-
specific concerns on the FACT-P were significant predictors of self-reported PA at 1 year in their 




Geraerts et al.[171] followed up a cohort of 240 men who had undergone radical prostatectomy for 
1 year, and found incontinence (measured by first day post-catheter removal urine loss) to be 
associated with lower self-reported total and household PA over the course of the year. 
Incontinence measured this way was not found to be associated with self-reported occupational or 
sports PA. Radical prostatectomy type (open/robotic); nerve-sparing status; surgical margin status; 
adjuvant RT in the year post-op did not significantly predict PA in their sample. 
3.2.3.1.3. Non-randomised, controlled trials 
Carmack Taylor et al.[173] used adaptive allocation to assign 134 men who had undergone 
androgen suppression, via either pharmacological or surgical intervention, to three groups in a 
behavioural intervention study. The first group (n=46) participated in a 6-month lifestyle support 
programme consisting of weekly sessions, lasting 1.5 hours and including 50 minutes of delivery 
of a PA curriculum (modified Project Active curriculum[173]), which taught participants cognitive 
behavioural skills and applied self-monitoring, goal setting, and reflection on PA barriers. The 
Project Active group also involved brief periods of walking lasting around 5 minutes. The second 
group (n=51) participated in a 6-month educational support programme of a similar format but 
focusing on various non-PA topics. The third group (n=37) were provided with information materials 
detailing available community resources for prostate cancer patients only (participants in all groups 
received these). The investigators found that none of the groups reported significant increases in 
self-reported PA; this was the case both 6 months after baseline, and 12 months after baseline. 
3.2.3.1.4. Cross-sectional studies 
Ottenbacher et al.[175] conducted a cross-sectional analysis on 193 men with prostate cancer, 
examining the associations between self-reported PA, and participants’ responses to whether 14 
different PA barriers applied to them, or not. The barriers suggested to participants were personal, 
social, and environmental in nature, and were informed by previous literature. Barriers reported by 
>20% of the sample were ‘too busy’; ‘no willpower’; ‘don’t like to in bad weather’; ‘don’t enjoy it’; 
‘have responsibilities at home’; and ‘no-one to exercise with’. Significant differences in self-
reported PA were observed in men reporting the barriers ‘no access to gym or exercise equipment’; 
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‘not sure about what to do’; ‘worry about injury’; ‘don’t like to sweat’; and ‘no willpower’. There was 
no significant association between self-reported PA and men reporting the barriers ‘too busy’; ‘don’t 
like to in bad weather’; ‘don’t enjoy it’; ‘have responsibilities at home’; ‘no-one to exercise with’; 
‘feel self-conscious’; ‘no-one helps or support me’; ‘don’t want to get sore’; and ‘nowhere to do it’. 
Min et al.[174] cross-sectionally examined PA barriers, and self-reported PA behaviour, in 111 
Korean prostate cancer survivors. Participants were administered a modified version of the 
Exercise Barrier Questionnaire for Older Adults,[177] and assessed as to whether they were meeting 
recommended PA guidelines according to self-reported PA behaviour. Barriers reported by >20% 
of the sample were ‘lack of time’ and ‘poor health’, yet neither of these barriers were associated 
with likelihood of meeting PA guidelines. Barriers reported by >10% of the sample that were also 
associated with a lower likelihood of meeting PA guidelines were: ‘lack of exercise skill’ and 
‘fatigue’. The cancer-related barriers of ‘fear of adverse effect on cancer site or treatment’, and 
‘pain at site of surgery during exercise’, were reported by 13.6% and 12.6% of participants 
respectively, but were not associated with the likelihood of meeting PA guidelines. 
3.2.3.2. Qualitative synthesis results 
Five insights emerged from the thematic synthesis[159] of the fifteen included qualitative studies. 
The overarching analytical themes that emerged were: 1) individual needs by treatment pathway; 
2) self-determination and its relationship with prostate-cancer related events; 3) co-ordination and 
support of the clinical care team; 4) individual preferences in discrete aspects of PA engagement 
style; and 5) the potential for a bidirectional facilitative relationship between structured group PA 
and spontaneous peer support. 
3.2.3.2.1. Theme 1: Individual needs by treatment pathway 
There is a need to consider each individual’s treatment plan when trying to engage that individual 
with PA.[19,178–185] The treatment-related barriers consistently reported by men with prostate cancer 
in the reviewed studies were incontinence caused by radiotherapy or radical prostatectomy[178–
180,182–185]; and treatment-related fatigue, primarily relating to treatment with chemotherapy or 
63 
 
hormone therapy, but occasionally also associated with receipt of radiotherapy or radical 
prostatectomy.[19,178,180,181,183]  
3.2.3.2.2. Theme 2: Self-determination and its relationship with prostate 
cancer-related events 
Theme 2 did not so much pertain to a direct facilitator or barrier, instead describing an experiential 
process that was deemed a relevant concept that was well-grounded in the primary data. 
Participants in these reviewed studies often reported that their PA levels dropped significantly 
when they were diagnosed with prostate cancer and received treatment,[19,178,180,181,183,186,187] 
accompanied by a loss of PA self-efficacy.[178,181,186] Concerns about whether PA is contraindicated 
for them as cancer patients, and barriers caused by treatment (both of which also emerged from 
this synthesis), seem to be drivers of this diminished sense of self-efficacy. Some men struggled 
to re-engage with PA following diagnosis and treatment.[178,181,183] 
Engaging pro-actively with PA can be experienced by men with prostate cancer as one of 
metaphorically ‘taking control’.[181,182,186,187] The ‘taking control’ metaphor is alluded to a number of 
times in these studies, and is theoretically consistent with concurrent insights from the reviewed 
data that pro-active PA engagement can be associated with a cognitive reframing of the individual’s 
cancer experience, that makes them less inclined toward emotions of a negative 
valence.[178,181,186,187] The ‘taking control’ metaphor is relevant when considering that the above 
factors that seem to diminish self-efficacy (cancer diagnosis, treatment side-effects) are external 
to the individual (i.e. they are not under the individual’s control). Post-operative incontinence would 
be a good example of this. 
3.2.3.2.3. Theme 3: Co-ordination and support of the clinical care team 
Theme 3 brings together descriptive themes that illustrated the need for a co-ordinated approach 
to engaging prostate cancer patients with PA. The consultant, nursing team, exercise 
physiotherapy team, and accredited exercise physiologists all have potential roles to play in this 
regard. Men with prostate cancer in these studies sometimes describe a need to have the benefits 
of PA communicated to them by someone that they consider a medical authority.[19,180,181,184,186] 
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Moreover as described above, this is sometimes related to a concern that PA is contraindicated 
for someone with a prostate cancer diagnosis.[180,184,186,187] These are two areas of cognition that 
the patient’s consultant would be well-situated to address. 
Men with prostate cancer in these studies also sometimes reported that they required help from 
others to be motivated[186,188]; that ongoing social support in planning and engaging with PA is a 
facilitator[181,187]; that they needed physical concerns to be addressed during PA 
engagement[186,187,189]; that their PA programme needed to be individualised[19]; and that they 
valued objective feedback as a motivator.[181,186–188,190] These are all areas that, according to the 
reviewed studies, can come under the remit of the exercise physiotherapist/specialist. Given that 
the data reviewed here suggest that different professionals in the patient’s care team may be 
particularly well-situated to address certain aspects of the patient’s social cognition, co-ordination 
of the care team in this regard appears to be sensible to maximise facilitation of PA. 
3.2.3.2.4. Theme 4: Individual preferences in discrete aspects of PA 
engagement style 
It was clear from the studies reviewed that some men preferred structured PA 
intervention[181,183,190,191]; whilst others preferred to do PA unsupervised[181,191]. It was also clear 
that some men preferred to do PA socially[19,179,186,187,191]; whilst others preferred to do PA 
alone.[179,181] For some, partner involvement – as a PA partner, or as a ‘confidant’ – appeared to 
be a facilitator[180,181,189]; whereas others preferred that their partner were not involved, and that it 
is only other men they were exercising with.[190] Given these insights, it should not be assumed 
that there is a particular style of PA programme that is the most effective – these qualitative data 
indicate that the ideal complex PA intervention for this patient population would be dynamic in 
nature, perhaps offering PA facilitation through a modular style of pathway, from which the patient 
can choose their preferences. 
3.2.3.2.5. Theme 5: The potential for a bidirectional facilitative relationship 
between structured group PA and spontaneous peer support 
Although structured group PA was the preference only for some, the reviewed data suggest that 
one of the ways in which it offers a unique facilitative effect on PA maintenance is through 
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spontaneous peer support. Data from the reviewed studies suggest that structured group PA 
intervention that places men with prostate cancer together can provide a space in which peer 
support relating to cancer, and unrelated to PA, can occur.[181,186,187,190,191] Furthermore, there 
seemed to be a reciprocal facilitative relationship between attending structured group PA and 
spontaneous peer support. In other words, structured group PA facilitates spontaneous peer 
support and, simultaneously, this spontaneous peer support facilitates PA engagement, by making 
attendance at the group PA session both a source of unique social support and an enjoyable social 
opportunity, and therefore a motivator for  patients.[178,179,186,187,189,191] Maintenance of these social 
relationships beyond the conclusion of the supervised group class can occur, and may have a 
protective effect against reductions in PA behaviour precipitated by a certain sense of social 
alienation experienced within regular community gyms.[191] 
3.2.4. Discussion 
Results from the thematic synthesis of qualitative studies indicate that men who have been 
diagnosed with prostate cancer can experience psychosocial facilitators and barriers to PA 
engagement, that are specific to the prostate cancer experience. Good co-ordination of PA 
messaging and support from multidisciplinary care teams may be one way to ensure that the 
maximum breadth of social cognitive factors is addressed. There is some evidence that PA 
behaviour in the context of prostate cancer may be influenced by the character of the relationship 
between the individual’s general sense of self-determination, and the diagnosis and treatment 
experience. There is also some evidence that social contact with other men with prostate cancer 
can function as a PA facilitator. Characteristics of different treatment pathways should be 
considered in PA intervention design, as barriers exist that are treatment-specific, with 
incontinence and fatigue being particularly obstructive. Finally, individual differences appear 
particularly important in this context, as there is some evidence that what motivates one individual 
could have a de-motivating effect on another. The present review demonstrates that it may be 
unwise to make overly general assumptions about what facilitates PA in this patient population (for 
example involvement in group PA, or involvement of the partner). 
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Due to the relatively small amount of quantitative studies to date, and the heterogeneous nature 
of these studies, the existing literature in this area does not present a particularly clear picture of 
what characteristics of a PA intervention would or would not be effective at increasing PA 
behaviour overall. There is some early suggestion that, in general terms, 12 weeks of twice weekly 
supervised PA may be effective at sustaining behaviour change to 6 months. However, the 
following caveats must be noted. First, I was unable to discern to what degree a differential sample 
selection bias could play a role in the relative effectiveness of these interventions (i.e. more 
burdensome, supervised intervention selecting out more motivated individuals). Although data on 
recruitment rates and reasons for non-recruitment were well-documented in most of these reports, 
there were not quite enough data available from different studies to discern whether such a 
differential selection bias might be present or not. Second, there appeared to be a tendency for 
effective interventions to have larger sample sizes. Given, therefore, that two of the interventions 
containing only behavioural components reported some effectiveness, it cannot be concluded that 
this style of intervention is not as effective. Aside from the specific barrier of incontinence, there is 
also little indication of which type of individuals would respond to what intervention components. 
Furthermore, within the literature reviewed it was not always possible to differentiate between 
factors influencing light PA (which has not been empirically linked to disease progression/survival), 
and factors influencing moderate or vigorous PA (which has been linked to disease 
progression/survival). 
Some observations can however be noted, and there are early indications of potentially useful 
avenues of inquiry in this area. Of the intervention studies reviewed here, there was a lack of 
systematic reporting of BCTs,[151] resulting in a lack of reliable replication, and difficulty in 
discerning what aspect(s) of these interventions are having a behavioural effect on participants. 
Of further note, there was some indication that barriers to PA engagement may vary as a function 
of treatment pathway; in particular, there was corroboration between qualitative and quantitative 
research supporting the notion that incontinence; hormonal symptoms; and treatment with a 
combination of therapies are barriers to PA. Consistent with this observation, research has shown 
that multimodality treatment is associated with worse quality of life outcomes, particularly in the 
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domain of urinary function.[192] Most quantitative reports reviewed here analysed mixed samples 
of men undergoing different treatments who, it seems, may possess differing barriers. Thus, it 
seems that the available literature is limited in terms of differentiation between treatment groups, 
offering only a generalised indication that supervised interventions tend to be effective at 
increasing PA behaviour over a 6-month period. Results from a further study involving a supervised 
PA intervention, and measuring PA as an outcome, have been published since this review was 
peer-reviewed and published (the ExPeCT trial[193,194]). In this study, intervention participants did 
not report a difference in PA compared with control participants at 3 months or 6 months follow up 
(n=61 participants in total), in contrast to the supervised exercise intervention studies reported 
above. However, it should be noted that in this study, all participants had metastatic prostate 
cancer.[194] 
My qualitative observation that individuals have differing preferences for various potential aspects 
of an intervention is unsurprising, given that this is what is observed in the general population of 
adults of this age group.[195] However, it is worth noting that programming preferences appear to 
differ between the healthy populace, and people with a cancer history, e.g. a higher proportion of 
cancer survivors have a preference for supervised PA.[196] Accounting for inter-individual 
heterogeneity, whilst simultaneously addressing PA barriers borne out of cancer therapy, may 
require a modular approach to PA programme design that addresses both clinical factors and 
patient preferences. However, such an approach has the potential to be resource-intensive, 
making implementation challenging. It is perhaps for this reason that I have not, to date, come 
across any reports describing such a programme design for men with prostate cancer. If one were 
to design a programme involving modular choices to accommodate preferences, the research 
reviewed here suggests that in terms of individual preferences, the following dichotomous 
alternatives could offer an initial basis for such programme modules: 1) supervised, or 
unsupervised; 2) in a group, or as an individual; 3) involving a partner, or not involving a partner. 
These recommendations would be congruent with previous research by Harrington et al. 
examining PA preferences in 135 men with prostate cancer undergoing ADT.[197] Harrington et al.  
found that 40% of their sample preferred exercising alone, whilst 24% preferred exercising in a 
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group, and 22% preferred exercising ‘with family of a friend’. Furthermore, whilst 58% of their 
sample preferred unsupervised exercise, 36% felt that they preferred expert supervision.[197] 
Co-ordination of the clinical care team emerged as an integral aspect of initiating and supporting 
prostate cancer patients with PA behaviour change. If PA promotion roles are assigned sensibly, 
this may help to accommodate certain barriers to PA promotion that have been reported by 
healthcare professionals working with cancer patients. In particular, clinicians have reported lack 
of consultation time, or not wanting to overwhelm the patient[198–200]; worry about undermining the 
relationship with the patient[199]; and lacking confidence in providing PA advice[199,201]. Reports also 
suggest that there may be a significant educational need amongst healthcare professionals in this 
regard,[201,202] which could be considered a secondary barrier for patients. 
There are some further noteworthy observations upon reviewing the quantitative and qualitative 
findings together. First, the notion that an individual’s sense of self-determination is intertwined 
with the experience of PA after a prostate cancer diagnosis appears related to one of the 
quantitative findings: that an individual’s perceived ‘role functioning’ can predict subsequent 
adherence to a PA programme. Existing research has suggested that self-perceived masculinity 
plays an integral role in coping and adjustment to the consequences of treatment for prostate 
cancer, and this style of coping can manifest as increased PA behaviour.[7,203,204] For instance, 
Alexis and Worsley conducted a meta-synthesis of qualitative studies examining prostate cancer 
patients’ sense of masculinity post-treatment.[7] Their analysis described in detail how, following 
treatment, a combination of a sense of infantilisation and physical impairments to sexual 
functioning can collide with hegemonic cultural ideals of masculinity to produce threats to a man’s 
self-identity. However, some of the studies reviewed by Alexis and Worsley had reported that this 
experience can make some individuals strive to do more PA, as a means of coping by trying to 
regain a sense of strength.[7] Although lower ‘role functioning’ score was associated with lower 
adherence to the PA programme in the study by Craike et al., it was also reported in the same 
study that urinary symptoms did not predict adherence,[170] when there is ample evidence that 
urinary symptoms are a PA barrier. Hence, it may be that adherence to PA programmes is not a 
good proxy for measuring PA itself. 
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Second, I observed that incontinence presents itself repeatedly across the qualitative and 
quantitative literature as a substantial barrier to PA, consistent with a 2008 review by Thorsen et 
al.[18]. Ideally this factor should be considered by exercise physiotherapists or physiologists when 
constructing individualised PA programmes for men with prostate cancer, avoiding the prescription 
of exercises that might exacerbate incontinence. Informing the patient that such a modification has 
been made may help to alleviate anxiety about incontinence whilst engaging with PA. 
Third, taking all the data together, there are data driven explanations as to what factors might make 
supervised group interventions effective. The reviewed research seems to primarily implicate: a) 
increases in task self-efficacy; and b) the creation of social relationships between both 
physiotherapist-patient, and patient-patient, that trigger social cognitive mechanisms that facilitate 
behaviour change (NB: this latter observation was drawn upon to conceptualise the behavioural 
intervention that has been piloted as part of this thesis, and is elaborated upon further below). 
These observations are consistent with the above referenced systematic review by Hallward et al. 
that examined BCTs in exercise interventions for men with prostate cancer.[152] Hallward et al. 
found that practical social support was one of the BCTs that was consistently present in 
interventions that had some success at changing behaviour, and consistently not present in 
unsuccessful interventions. Although these observations are probably limited to the segment of 
patients who prefer supervised activity, it seems that the social support aspect of this setting is an 
important one to these patients. 
A limitation of this review is that there was not enough homogeneity amongst included quantitative 
studies to be able to undertake a quantitative synthesis. A further limitation was that the qualitative 
studies were undertaken in several differing countries and contexts, which may have implications 
for the depth of understanding that was obtained from the thematic synthesis. Finally, a common 
caveat of qualitative syntheses is that re-analysis of primary data can present an epistemological 
issue, as the original data may have been collected with a slightly differing research question in 
mind. 
In summary, this review highlights a need to: 1) establish a framework for systematic reporting of 
PA intervention studies within this patient population, to include reports of BCTs and recruitment 
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data; 2) design flexible PA programmes that consider patient preferences in terms of supervision, 
social engagement, and the involvement of their partner, as well as clinical considerations such as 
incontinence and fatigue; 3) co-ordinate the clinical care team with appropriate PA promotion roles, 
to maximise the effectiveness of PA promotion to patients across the broader care pathway; and 
4) consider innovative ways in which social dynamics might be harnessed to bring about PA 




PART B Understanding the context 
In order to understand the context in which the intervention had to be applied, I conducted 
preliminary work that examined existing clinical data from the local NHS trust, relating to the 
existing PA pathway. The following section reports on these analyses, and then briefly describes 
an observation made in the local context that was consistent with findings from the systematic 
review already reported. 
3.3. Empirical insights from the local context 
To investigate the local context, two analyses were conducted using clinical data collected by Guy’s 
and St Thomas’ NHS Foundation Trust (GSTT). 
Local analysis 1 examined self-reported PA and quality of life data from men participating in 
GSTT’s existing PA pathway for men with prostate cancer. 
Local analysis 2 examined whether there were any differences between men with prostate cancer 
who have participated in on-site structured exercise classes provided by GSTT, compared with all 
other men diagnosed with prostate cancer at GSTT. 
3.3.1. Local analysis 1 
Local Analysis 1 aimed to descriptively analyse clinical data on men with prostate cancer collected 
by the Cancer Exercise Physiotherapy department at GSTT, to examine patient-reported outcomes 
and identify potential influences of treatment type on PA and quality of life outcomes. This data 
analysis was approved by GSTT as a service evaluation (project number: 5993). 
3.3.1.1. Methods 
3.3.1.1.1. Physical activity pathway at GSTT 
The current PA pathway already in place at GSTT utilises expert cancer exercise physiotherapist 
advice combined with a comprehensive approach to behaviour change that engages a patient for 
12 months (see Figure 7). Provided that they do not opt out, patients on the PA pathway are 
followed up via telephone and SMS for 12 months. Telephone calls take place at 4 months, 7 
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months and 12 months following the end of structured exercise classes/1:1 physiotherapy 
consultation, and are focused on feedback, goal setting, and motivational interviewing. This 
protocol is derived from the ‘Let’s Get Moving’ pathway, which was designed following 




Figure 7 Flow chart describing the physical activity pathway currently offered by Guy’s and St 
Thomas’ NHS Foundation Trust for men with prostate cancer, and methods to influence behaviour 




Participants were a cohort of 221 men diagnosed with prostate cancer who had participated in the 
GSTT PA pathway delivered by the Cancer Exercise Physiotherapy department, between January 
2015 and September 2017 (see Table 8). No cases were excluded from the original clinical data. 
The proportion of patients who remained on the PA pathway at each follow up time point are shown 
in Table 6. 
    n remaining on physical activity pathway 
     
Baseline 4 months 7 months 12 months 
 
  






Active surveillance 25 19 15 15 
   
Curative 120 105 87 81 
   
Systemic 76 69 60 54 
 
Table 6 Number of men remaining on the physical activity pathway at each follow up time point. 
 
3.3.1.1.3. Physical activity pathway outcomes 
Data on self-reported PA was routinely collected by the Cancer Exercise Physiotherapy team using 
the Scottish Physical Activity Questionnaire (SPAQ).[206] Data on quality of life was collected using 
the EQ-5D-3L quality of life scale.[207] The analysis aimed to answer the following research 
questions: 
▪ Do men on the PA pathway improve on self-reported physical activity levels over time? 
▪ Do men on the PA pathway improve on self-reported quality of life over time? 
▪ Are there observable differences between individuals receiving active surveillance, 
curative treatment, or systemic treatment in the results of the above analyses? 
3.3.1.1.4. Analysis 
To address the above questions, patients in the dataset were categorised as undergoing active 
surveillance (n=25); curative treatment (n=120); or systemic treatment (n=76); and analysed 
separately, in addition to being analysed as one. Due to the opportunistic nature of the dataset, 
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there were substantial amounts of missing data on patient-reported outcomes, across the various 
time points (see Table 7). 
 Physical activity outcomes 
missing data, % 
Quality of life outcomes 
missing data, % 
Baseline (first appointment) 29.0 24.9 
4 months follow up 35.2 29.6 
7 months follow up 64.0 58.7 
12 months follow up 64.0 60.7 
 
Table 7 Quantity and proportion of missing data at each time point in the dataset (not including 
individuals who had been recorded as ‘off pathway’ at each time point). 
 
Hence, a pragmatic approach to analysis was taken. For each statistical test, individual 
subsamples were separately examined, which comprised all patients who reported data at both 
baseline and one of the other time points (T1), enabling a binary comparison. i.e.: 
▪ one subsample for all men who reported data at both baseline and 4 months (T1); 
▪ another subsample for all men who reported data at both baseline and 7 months (T1); 
▪ another subsample for all men who reported data at both baseline and 12 months (T1). 
Preliminary analysis found that most data were non-normal. Therefore, non-parametric analyses 
were undertaken using Wilcoxon sign-rank tests, to compare patient-reported outcomes across 
each of the above binary pairs of time points. 
3.3.1.2. Results 
Self-reported PA and self-reported quality of life outcomes for each subsample are reported in 
Table 9 and Table 10, respectively. The number and proportion of patients reporting data in each 
subsample is also reported (accounting for those recorded as having exited the pathway). There 
were no statistically significant relationships between time spent on the pathway and age, ethnicity, 













Age M (SD) 61.8 (9.1) 67.8 (8.3) 69.81 (9.7) 67.8 (9.1) 
Ethnicity    n (%)    
 
 
 White 13 (68.4) 63 (65.6) 46 (66.7) 122 (66.3) 
 Black 6 (31.6) 25 (26.0) 17 (24.6) 48 (26.1) 
 Asian 0 7 (7.3) 2 (2.9) 9 (4.9) 
 Other 0 1 (1.0) 4 (5.8) 5 (2.7) 
 [Not specified/missing] [6] [24] [7] [37] 
Education 
     
 No further education 4 (50.0) 33 (52.5) 21 (43.9) 58 (48.7) 
 Further education 4 (50.0) 30 (47.5) 27 (56.1) 61 (51.3) 
 [Not specified/missing] [17] [57] [28] [102] 
Source of referral 
     
 Health and wellbeing event 14 (58.3) 36 (30.0) 8 (10.8) 58 (26.2) 
 Cancer nurse specialist 8 (33.3) 42 (35.0) 37 (50.0) 87 (39.4) 
 Self-referral 2 (8.4) 20 (16.7) 12 (16.2) 34 (15.4) 
 Consultant 0 4 (3.3) 8 (10.8) 12 (5.4) 
 Radiographer 0 14 (11.7) 8 (10.8) 22 (10.0) 
 Dietician 0 4 (3.3) 1 (1.4) 5 (2.3) 
 [Not specified/missing] [1] [0] [2] [3] 
            
 
Table 8 Descriptive characteristics of men who engaged with the physical activity pathway at Guy’s 




 n reporting (% of 
total still on 
pathway) 
Baseline T1  
All treatment types (n=221) 
M (SD) M (SD) p 
       
Baseline to 4 months 95 (49.2) 461 (388) 651 (592) <0.01** 
Baseline to 7 months 53 (32.7) 580 (482) 800 (752) 0.01* 
Baseline to 12 months 46 (30.7) 499 (416) 589 (615) 0.15 
     
Active surveillance (n=25)       
       
Baseline to 4 months 8 (42.1) 496 (365) 480 (310) 0.79 
Baseline to 7 months 6 (40.0) 502 (307) 1012 (1184) 0.33 
Baseline to 12 months 3 (20.0) 478 (367) 365 (161) 0.72 
     
Curative treatment (n=120)       
       
Baseline to 4 months 50 (47.6) 444 (347) 659 (554) 0.002** 
Baseline to 7 months 26 (29.9) 578 (411) 689 (546) 0.25 
Baseline to 12 months 25 (30.8) 514 (404) 573 (609) 0.53 
     
Systemic treatment (n=76)       
       
Baseline to 4 months 37 (53.7) 476 (451) 676 (685) 0.06 
Baseline to 7 months 21 (35.1) 603 (607) 876 (844) 0.05* 
Baseline to 12 months 18 (33.3) 482 (460) 650 (679) 0.04* 
 
Table 9 Results from descriptive analysis of self-reported physical activity data amongst men on the 




  n reporting (% of 
total still on 
pathway) 
Baseline T1  
All treatment types (n=221) 
M (SD) Mean (SD) p 
       
Baseline to 4 months 105 (54.4) 72.0 (17.1) 75.9 (17.0) <0.01** 
Baseline to 7 months 60 (37.0) 74.5 (16.1) 76.4 (16.5) 0.35 
Baseline to 12 months 51 (34.0) 73.7 (17.9) 77.0 (16.6) 0.06 
     
Active surveillance (n=25)       
       
Baseline to 4 months 9 (47.3) 71.2 (16.5) 82.8 (13.5) 0.09 
Baseline to 7 months 7 (46.7) 76.6 (14.5) 82.3 (13.3) 0.24 
Baseline to 12 months 5 (33.3) 80.2 (16.0) 84.0 (12.5) 0.43 
     
Curative treatment (n=120)       
       
Baseline to 4 months 58 (55.2) 72.8 (15.3) 77.5 (14.0) <0.01 
Baseline to 7 months 30 (34.5) 77.6 (14.3) 78.8 (17.4) 0.66 
Baseline to 12 months 27 (33.2) 76.7 (14.0) 80.0 (13.2) 0.11 
     
Systemic treatment (n=76)       
       
Baseline to 4 months 38 (55.1) 71.0 (20.0) 71.8 (20.9) 0.66 
Baseline to 7 months 23 (38.4) 69.8 (18.2) 71.4 (15.4) 0.66 
Baseline to 12 months 19 (35.2) 67.8 (21.2) 69.6 (19.6) 0.49 
 
Table 10 Results from descriptive analysis of self-reported quality of life data amongst men on the 





3.3.1.3. Discussion and conclusions 
Findings indicated that some men on the PA pathway demonstrated increased self-reported PA 
whilst on the pathway. The analysis indicated that overall, men on the PA pathway tended to 
increase their self-reported PA at 4 months and 7 months, compared with baseline. 
Although the extent of missing data points prohibited a robust between-group analysis of treatment 
types, there were some observable discrepancies between treatment types in terms of PA 
adoption. Notable was that the only group of men that demonstrated significant increases in self-
reported PA from baseline to 12 months were those that were undergoing (or had undergone) 
systemic treatment. This finding is consistent with the exercise intervention studies reported in Part 
A, in that the only RCT to report PA outcomes to 12 months did not find PA to be maintained; and 
that this study mainly included men who had received curative treatment.[125] It is also consistent 
in the sense that some of the barriers that were reported above were associated with treatment. 
One candidate hypothesis would be that men on systemic treatment place a greater importance 
on staying physically active. Previous studies using survey data have indicated that men on 
systemic treatment are more likely to report unmet physical needs,[208,209] which could help explain 
the difference observed in the present analysis. 
Findings also indicated that, generally, there was a trend towards increased quality of life over time 
amongst men on the PA pathway. The overall trend appeared to be driven by men who had 
received curative treatment; it was not observed amongst those men who were on systemic 
treatment at baseline. Given that men treated curatively would be likely to recover their health over 
time, this is perhaps unsurprising. 
In conclusion, ‘real-world’ data at the local level indicates that the existing PA pathway at GSTT 
seems to be capable of changing (self-reported) PA behaviour. The data suggest that challenges 
remain with regards to maintenance of behaviour change over the longer term. Patients receiving 
curative treatment and systemic treatment may potentially differ in their behavioural needs with 
regards to PA. 
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3.3.2. Local analysis 2 
Local analysis 2 aimed to use local clinical data from GSTT to compare the attributes of men with 
prostate cancer who have participated in structured exercise classes at GSTT as part of the PA 
pathway, with those of men with prostate cancer generally. The analysis aimed to identify potential 
systemic barriers to engagement with supervised exercise that is provided on-site. The data 
analysis was approved by GSTT as a clinical audit. 
3.3.2.1. Methods 
3.3.2.1.1. Study design 
The study was a retrospective cohort design. Due to the exploratory aims, there were numerous 
exposure variables (see below). The outcome was whether an individual had participated in 
structured exercise classes provided on-site by GSTT. 
3.3.2.1.2. Study sample 
The analysis used a clinical dataset obtained from GSTT. The sample cohort was all men treated 
at GSTT who had had a diagnosis of prostate cancer recorded between 1st April 2009 and 31st 
September, as per Cancer Outcomes and Services Dataset (COSD) procedures (ICD code: C61, 
‘Malignant neoplasm of prostate’) (n=8,493). Data were provided from the Cancer Exercise 
Therapy department that enabled the identification of all individuals that had engaged with the PA 
pathway, at any time up to 31st September 2018 (n=381). 
Several steps were taken to prepare the sample for analysis (see Figure 9): 
• First, n=28 men from the Cancer Exercise Physiotherapy database were not identifiable 
within the wider GSTT cohort. It is possible this was due to COSD data entry lag, as these 
men were mostly recent additions. These cases were omitted from the analysis. 
• Second, during initial data verification processes, n=1 case was found to have been 
misclassified, as he did not have prostate cancer. Hence, in order to recover confidence in 
the integrity of the dataset, n=50 cases were randomly selected and medical notes for all 
81 
 
50 were manually checked to identify any further contamination. No further contamination 
was found. The misclassified case was hence omitted from the dataset. 
• Third, n=95 cases that were found to be resident in Jersey, Gibraltar, or UK devolved 
nations were omitted. 
• Fourth, n=376 cases that did not have a decision-to-treat date were omitted, as the age of 
these men when they presented at/were referred to GSTT could not be determined. 
• Fifth, n=630 cases who had a recorded date of death that preceded the establishment of 
the PA pathway were omitted. 
• Sixth, postcodes were converted into the radial distance of the patient’s residence from 
GSTT in miles (to two decimal places), using an open source online tool. Upon examination 
of frequency tables of these distances, it was apparent that at roughly 13 miles, there was 
a steep drop in patients presenting at/being referred to GSTT (see Figure 8). I interpreted 
this as the threshold at which travel to GSTT becomes prohibitively far. Hence, n=1,107 
patients who resided >13 miles from GSTT were omitted. 
Figure 8 Histogram showing the frequency distribution of distances lived from the hospital 
site where the structured exercise classes take place (derived from first half of postcode). 
At a radius of 13 miles, there is an abrupt drop in the number of patients presenting or being 
referred to Guy’s and St Thomas’ NHS Foundation Trust. It can hence be interpreted that 




Figure 9 Flow diagram showing excluded cases from the original cohort with reasons. 




Data were available for the following variables: 
• Age was calculated as the patient’s age at decision-to-treat date (i.e. not current age). 
• Radial distance from hospital site was approximated using the first half of postcode (in 
miles, to two decimal places). 
• Socioeconomic status was quantified as Index of Multiple Deprivation (IMD) rank. This 
was calculated from postcode using open source online data and tools from UK 
Government.[210,211] 
• Ethnicity was as documented in the patient’s NHS record. For analysis purposes, ethnicity 
was collapsed into ‘White’, ‘Black’, ‘Asian’, ‘Other’, or ‘Not stated’. 
• Initial treatment/care plan was as documented in COSD data collected by GSTT. 
• Histological Gleason score was as documented in COSD data collected by GSTT. 
• Whether receiving first treatment/subsequent treatment was as documented in COSD 
data collected by GSTT. 
• Whether treated before/after 1st January 2015 was determined by decision-to-treat date 
(January 2015 was when the PA pathway was established). 
Sociodemographic and clinical characteristics of the sample (and subgroups by outcome) can be 






Engaged with PA pathway? 
 
 
Yes                       
(n=255) 
No                            
(n=6,029) 
Total           
(n=6,284) 
M (SD)    
Age at treatment 65.7 (8.5) 67.9 (9.5) 67.8 (9.5) 
Distance from hospital site, miles 5.46 (3.24) 5.97 (3.37) 5.95 (3.36) 
       
n (%)    
Ethnicity    
White 133 (56.1) 3,117 (59.5) 3250 (59.4) 
Black 67 (28.3) 1,367 (26.1) 1434 (26.2) 
Asian 13 (5.5) 162 (3.1) 175 (3.2) 
Other 5 (2.1) 113 (2.2) 118 (2.2) 
Not stated 19 (8.0) 479 (9.1) 498 (9.0) 
[Missing] [18] [791] [809] 
    
Indices of multiple deprivation rank    
First decile (highest deprivation) 8 (3.1) 229 (3.8) 237 (3.8) 
 48 (18.9) 1,227 (20.4) 1,275 (20.3) 
  33 (13.0) 945 (15.7) 978 (15.6) 
 39 (15.4) 794 (13.2) 833 (13.3) 
Fifth decile 33 (13.0) 588 (9.8) 621 (9.9) 
 19 (7.5) 417 (6.9) 436 (6.9) 
  22 (8.7) 476 (7.9) 498 (7.9) 
 10 (3.9) 373 (6.2) 383 (6.1) 
  23 (9.1) 573 (9.5) 596 (9.5) 
Tenth decile (lowest deprivation) 19 (7.4) 400 (6.6) 419 (6.7) 
[Missing] [1] [7] [8] 
    
First treatment type    
Radical prostatectomy 71 (27.8) 1,543 (25.6) 1,614 (25.7) 
Radiotherapy 20 (7.9) 1,282 (21.2) 1,302 (20.7) 
Chemotherapy 102 (40.0) 1,529 (25.4) 1,631 (26.0) 
Hormone therapy 20 (7.9) 173 (2.9) 193 (3.1) 
Active surveillance 34 (13.3) 1,250 (20.7) 1,284 (20.4) 
Other 8 (3.1) 251 (4.2) 259 (4.1) 
[Missing] [0] [1] [1] 
    
Gleason score    
6 25 (17.9) 514 (23.5) 539 (23.2) 
7 77 (55.0) 1,261 (57.8) 1,338 (57.6) 
8 9 (6.4) 132 (6.0) 141 (6.1) 
9 27 (19.3) 255 (11.7) 282 (12.1) 
10 2 (1.4) 21 (1.0) 23 (1.0) 
[Missing] [115] [3846] [3961] 
        




The analysis aimed to answer the following research question: 
▪ Do men with prostate cancer who have participated in hospital-based structured exercise 
classes differ to the average man who is diagnosed with prostate cancer at GSTT, on 
sociodemographic and clinical characteristics for which data is available? 
To address this question, the above variables were entered into a multivariate logistic regression 
model, to estimate adjusted odds ratios (ORs) with 95% confidence intervals. Hence, it was 
determined whether each variable (exposure) could independently predict the likelihood of 
structured exercise class participation (outcome). Age, radial distance from hospital site, and 
socioeconomic status were entered into the model as continuous variables. All other variables 
were defined as categorical. For ethnicity, White ethnicity was used as a reference category, as 
most of the sample were of White ethnicity. For initial treatment/care plan, treatment with radical 
prostatectomy was used as a reference category, as a crosstabulation indicated that unlike other 
treatments, patients who had received radical prostatectomy were similarly represented amongst 
both exercise class participants (27.8%) and non-participants (25.6%). Variables that did not 
independently predict structured exercise class participation in the first model were omitted from 
the final model. 
3.3.2.2. Results 
The initial regression model showed that histological Gleason score and whether receiving 
first/subsequent treatment were not independent predictors of the likelihood of exercise class 
participation, so these variables were removed from the model. Variables that independently 
predicted exercise class participation are shown in a forest plot in Figure 10 (apart from whether 
treated before/after January 2015 which, as expected, independently predicted the outcome and 
was thus controlled for).  Radial distance from hospital site, age, socioeconomic status, ethnicity, 
and initial treatment/care plan all independently predicted an individual’s likelihood of structured 
exercise class participation. 
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Radial distance from hospital site. The model showed that for every mile increase in distance 
from the hospital site, patients were 6% less likely to participate [adjusted OR: 0.94; 95% CI: 0.90–
0.99]. 
Age. The model showed that for every year increase in age, patients were 3% less likely to 
participate [adjusted OR: 0.97; 95% CI: 0.95–0.98]. 
Socioeconomic status. The model showed that for every decile increase in IMD rank (i.e. 
lessening deprivation) patients were 9% more likely to participate [adjusted OR: 1.09; 95% CI: 
1.03–1.16]. 
Ethnicity. The model showed that, compared with being of White ethnicity, being of Asian ethnicity 
(n=175) was associated with an 87% increased relative likelihood of participation [adjusted OR: 
1.87; 95% CI: 1.03–3.41]. Being of Black or Other ethnicity did not affect likelihood of participation, 
compared with being White. 
Initial treatment/care plan. The model showed that, compared with having received radical 
prostatectomy, receipt of radiotherapy (n=1,302) was associated with a 54% lower relative 
likelihood of participation [adjusted OR: 0.46; 95% CI: 0.27–0.79]. Receipt of chemotherapy 
(n=1,631) was associated with a 73% higher relative likelihood of participation [adjusted OR: 1.73; 
95% CI: 1.22–2.44]. Receipt of hormone therapy (n=193) was associated with 227% higher relative 
likelihood of participation [adjusted OR: 3.27; 95% CI: 1.90–5.61].  Receipt of active surveillance 
(n=1,284) was associated with a 36% lower relative likelihood of participation [adjusted OR: 0.64; 




Figure 10 Forest plot displaying adjusted odd ratios (ORs) and 95% confidence intervals taken from the multivariate logistic regression model, describing 
the relative likelihood of structured exercise class participation at Guy’s and St Thomas’ NHS Foundation Trust under each condition. DTT, decision to 
treat date; RP, radical prostatectomy. 
Covariates not displayed: whether treated before/after January 2015. 
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3.3.2.3. Discussion and conclusions 
Analysis of this clinical dataset suggests that the likelihood of prostate cancer patients participating 
in the structured exercise classes provided by GSTT is lower if patients live further away; are older; 
are of a lower socioeconomic status; or have received treatment with radiotherapy or active 
surveillance monitoring as an initial care plan. The analysis suggests that the likelihood of 
participation was higher if patients were of Asian ethnicity; or had received treatment with 
chemotherapy or hormone therapy as an initial care plan. 
The ‘real-world’ data analysed here suggest that formalised exercise programmes that require 
patients to attend do not provide equal access opportunities to all patients. There appears to be 
some inequality in the sense that currently, the benefits of supervised exercise offered at GSTT 
appear less likely to be reaped by patients who live further from the hospital, or who are of a lower 
socioeconomic status, or who are older. 
The finding that distance was associated with likelihood of exercise class participation would be 
consistent with previous findings in the literature that many men with prostate cancer (but not all) 
express preference for independent exercising (e.g. [197,212]; also see findings of my systematic 
review, Section 3.2.3.2.4). However, it does also raise a concern that geographical distance may 
be acting as a barrier to those who prefer, or feel they need, supervision. Reliance on public 
transport to access exercise facilities has been reported as a potential barrier to PA amongst older 
adults[213]; and attending an exercise facility that is not local requires more time and energy.[214] 
These factors could discourage those living further away from seeking the supervision that they 
would benefit from. Although Cancer Exercise Physiotherapy at GSTT do offer signposting to local 
facilities for patients, this is not particularly well-advertised to patients that are not already on the 
PA pathway. Addressing this need is worthwhile, given the findings reported here. The TrueNTH 
Lifestyle Management programme, developed by researchers in Canada, has begun to address 
this need by developing a community-based, 12 week intervention, that includes physical activity, 
yoga, and nutritional information for men with prostate cancer.[215] The programme involves 
equipping community fitness professionals with adequate training to conduct supervised exercise 
with people with prostate cancer. Consistent with the findings reported here, qualitative data 
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analysed by the TrueNTH researchers has described how some participants felt that the 
geographical proximity provided by the community-based approach was vital to their participation 
in the programme.[189] 
The observation that socioeconomic status predicted exercise class participation independently of 
geographical distance is notable. Research shows that the way in which individuals from different 
socioeconomic cohorts engage in PA is different.[216–219] There is evidence that those of a lower 
socioeconomic status are less likely to engage in effective self-regulation of exercise 
behaviour.[217,218] However, it has recently emerged that the nature of the relationship between 
socioeconomic status and PA is dependent upon the type of PA being measured, with evidence 
beginning to suggest that lower socioeconomic status is associated with lower PA only when 
measuring leisure-time PA.[216,219,220] In fact, a systematic review by Stalsberg and Pedersen found 
that studies examining occupational, transport, and household PA have tended to report an inverse 
relationship between socioeconomic status and PA.[219] These findings offer an insight into the 
current analysis, given that participation in the PA pathway would not be classified under any of 
these three PA categories. Furthermore, qualitative research has indicated that older adults of a 
lower socioeconomic status can conflate time and energy when it comes to barriers to PA,[214] 
leading to a perception of a lack of time for PA amongst individuals whose wider cognitive capacity 
is being strained by other factors. Given the above findings, and that having to use public transport 
to access a PA facility can be a barrier,[213,214] it may be that some individuals of a lower 
socioeconomic status simply see participation in hospital-based structured exercise classes as 
unsuitable for them, in the wider context of their lives. It is noteworthy that preliminary data from 
the TrueNTH Lifestyle Programme described above has shown that amongst participants for which 
data were available, 60% had a household income of >$90,000; while just 18% had a household 
income of <$60,000.[215] These data are somewhat consistent with the findings reported here and 
illustrate an ongoing challenge in engaging prostate cancer survivors of a lower socioeconomic 
status with physical activity initiatives. 
Discussion of these findings with the Cancer Exercise Physiotherapy team indicated that the 
discrepancies between initial treatment/care plan types are likely due to differences in practice 
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between clinical care teams. Hence, there may be a local need for improved organisational 
integration, or perhaps clinician education (as discussed in Section 653.2.4 above). The present 
analysis also found that older age was associated with a lower likelihood of participation. Existing 
studies examining the associations between age and PA programme adherence have yielded 
inconsistent findings, with some reporting that older men are less likely to adhere (e.g. [169]) and 
others reporting no association (e.g. [170]). The fact that each study is conducted in a different 
setting – each involving its own contextual factors – makes it difficult to draw general conclusions 
about such relationships. For example, in my discussion of these findings with the Cancer Exercise 
Physiotherapy team, we considered the potential that older patients may be less likely to be 
referred to the exercise classes due to a perception of patient frailty by the clinician seeing them. 
A post hoc cursory examination of the PA pathway data examined in Local analysis 1 did, in fact, 
show an age discrepancy related to the source of the patient referral (specifically, between referrals 
from nurses, and referrals from consultants) that was statistically significant. Although data 
limitations precluded any solid conclusions in this regard, this could be a hypothesis worthy of 
further study. 
In conclusion, being of older age, lower socioeconomic status, and living further from the hospital 
site are all associated with a decreased likelihood of participation in on-site, structured exercise 
classes at GSTT. Being an ethnic minority does not appear to be a barrier to participation in these 
classes. The likelihood of participation varies substantially depending on which treatment/care plan 
a patient has received, with patients receiving radiotherapy or active surveillance monitoring 
particularly underrepresented. 
3.3.3. Peer support and physical activity motivation 
The following section briefly expands on an observation that was reported in the systematic review: 
that peer support between prostate cancer patients can act as a PA motivator. It is highlighted here 




Qualitative studies that were examined in the systematic review suggested that the shared 
experience of prostate cancer can, amongst certain individuals and in appropriate contexts, result 
in some contagion of motivation to exercise.[179,186,187,189,191] Below are three example quotations 
from these reports: 
“Several men commented on the importance of social support to stay physically active. 
They were very positive about group exercise citing shared purpose and motivation as an 
attraction to them.” [179][p.5] 
 “For some men … peer support was the main factor that motivated ongoing participation 
[in a PA programme].” [187][p.28] 
   “‘…psychologically a lot of it is left to your own mindset and if you’re not relating it to other 
people or recognising it in other people and saying “Hey that person’s okay, I’m okay too” 
… If you feel socially part of the group, we’ll all get there together. You don’t worry about 
it, you focus on life and the positive’” [181][p.44] 
The theme of peer support providing motivation for PA is consistent with survey data from men with 
prostate cancer participating in the local PA pathway. I described this in a report that I authored on 
patient’s experiences of the PA pathway, which was published in BioMed International.[212] The 
report describes a content analysis of 41 structured telephone interviews, that were conducted with 
men participating in the structured exercise classes locally. The following quote is taken from this 
report and describes how one participant reported this peer support effect: 
“[The patient] had been told by his doctor that he needed to engage with exercise but had 
been too depressed to adhere to this advice alone; he went on to say that the class enabled 
him to talk with another patient who had been through the classes already and had lost 
weight and got fit. The interviewee described this encounter as a strong antidote to the 
inertia he was experiencing as a result of his depression.” [212][p.4] 
It should be noted that the above passage is anecdotal, as it describes the account of only one 
individual. However, what it demonstrates is that the peer support effect is not localised to the 
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settings of the other studies above. It appears to also take place in the local context. Hence, such 
an effect could potentially be utilised to promote PA motivation in the local patient population. 
3.3.4. Overall conclusions and implications for intervention 
The observations reported in this section illustrate the importance of doing empirical groundwork 
in the local context before embarking on intervention design and implementation. Three key 
observations have been made that are relevant to the design of a local PA intervention for men 
with prostate cancer. 
The first point relates to intervention reach: 
▲ Systemic sociodemographic biases may exist with regards to prostate cancer 
patients’ likelihood of engaging with a formalised PA pathway. In other words, there 
is currently some inequity in the system. 
The second point relates to treatment settings: 
▲ Notwithstanding that all prostate cancer patients should be provided with adequate 
PA support; it could be that patients receiving curative treatment need additional 
forms of behavioural support in order to increase (and maintain) PA behaviour. 
The third point relates to intervention mechanism: 
▲ Peer support from other men with prostate cancer can act as a PA motivator for men 
with prostate cancer. 
The above three key observations were drawn upon during the intervention design process to 




PART C Drawing upon existing theories 
3.4. Use of an existing framework: The Behaviour Change 
Wheel 
This section will describe how the intervention was designed. It will first provide an overview of the 
Behaviour Change Wheel (BCW) framework.[143] Next, the process of specifying the intervention 
approach, using the BCW, is described. 
3.4.1. The Behaviour Change Wheel 
I decided to use the BCW to design the intervention because the aim of this intervention was to 
change behaviour, using a theory-based approach.[145] The BCW framework was proposed by 
Michie et al. as a method of systematically designing interventions aiming to change behaviour.[143] 
The framework uses the concept of a wheel with three concentric circles, each representing 
different stages of the intervention design process (see Figure 11).[143] 
Figure 11 The Behaviour Change Wheel. Reproduced from Michie, Van Stralen, & West.[143] 
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The innermost circle of the BCW contains sources of behaviour. It incorporates a model of 
behaviour proposed by Michie et al.,[143] called the COM-B system, that was formulated by drawing 
upon two sources: 1) a consensus meeting of behavioural theorists in 1991; and 2) a centuries-old 
principle of US criminal law used to determine the likelihood of guilt. Both sources indicate that 
behaviour (or, the likelihood of guilt) is predicated on the fulfilment of three conditions: 
1) Capability to perform the behaviour 
2) Opportunity to perform the behaviour 
3) Motivation to carry out the behaviour 
 
Figure 12 The COM-B system. Reproduced from Michie, Van Stralen, & West.[143] 
 
Michie and colleagues proposed a parsimonious model that can be used to influence behaviour, 
by stating that capability and opportunity will both influence motivation; and that capability, 
opportunity, and motivation will each interact reciprocally with behaviour (see Figure 12). 
They enhanced this model to incorporate a more modernised understanding of behaviour, by 
subdividing each of these three sources of behaviour into two further sub-categories, creating six 




Source of behaviour Description 
Physical capability The physical ability to perform the behaviour. 
Psychological capability The psychological knowledge or skills to perform the behaviour. 
Physical opportunity A physical environment that allows for, or facilitates the behaviour. 
Social opportunity A social environment that encourages the behaviour. 
Automatic motivation Motivation driven by automatic, non-conscious psychological processes. 
Reflective motivation Motivation driven by reflective, propositional cognitive processes. 
 
Table 12 COM-B categories and their respective sub-categories. Modified from Michie, Van Stralen, & 
West.[143] 
 
The middle circle contains intervention functions, which are methods that can be used to change 
behaviour (see Figure 11).  These were identified by Michie and colleagues after conducting a 
systematic review of interventions, then identifying all frameworks with individual utility, and 
demarcating their relationships to components of the COM-B model. The intervention functions in 
the BCW are education; persuasion; incentivisation; coercion; training; enablement; modelling; 
environmental restructuring; and restrictions. Each of these methods are thought to target 
particular sources of behaviour.[143] 
The outermost circle contains policy categories. These are strategies that can be used to 
implement the intervention functions, consisting of environmental/social planning; 
communication/marketing; legislation; service provision; regulation; fiscal measures; and 
guidelines (see Figure 11). 
Michie et al. have constructed a systematic process that aims to facilitate the design of 
interventions that are workable and more likely to be effective.[221] The process begins by 
identifying potential target behaviours (see Appendix 4). The potential target behaviours are then 
narrowed down, using a combination of: 1) a ‘behavioural analysis’, in which judgements are made 
about the relationships between different behaviours (see Figure 13); and 2) a process whereby 
behaviours are classified as ‘very promising’, ‘promising’, ‘unpromising but worth considering’, or 
‘unacceptable’, in terms of the behavioural analysis and a set of criteria, called the ‘APEASE’ 
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• likely to be effective/cost effective 
• likely to have side-effects (is it safe?) 
• egalitarian 
The BCW process then involves moving through each of the ‘circles’ described above, selecting 
the options that are most appropriate for the context in question. It concludes with the selection of 
behaviour change techniques (BCTs)[151] to be used to influence the sources of behaviour. 
3.4.2. Intervention design process 
The full intervention design process, described in terms of the BCW framework, is documented in 
Appendix 4. Decisions about the potential of each target behaviour were informed by preliminary 
meetings with three prostate cancer nurse specialists, two consultants, and two cancer exercise 
physiotherapists; all of whom worked at one of the two NHS trusts in which the intervention was to 
be piloted. These meetings aimed to involve key stakeholders in the design process, as is advised 
by O’Cathain et al. in their guidance on intervention development.[145] In these meetings, issues 
were discussed relating to local capacity; organisational structure; existing provisions; and the 
clinical experiences of these practitioners. These stakeholders were presented with the findings 
from my systematic review and the analyses of local data outlined earlier in the chapter, to prompt 
discussion of ideas and key issues. I collated and used the insights gained from these meetings, 
alongside the ‘behavioural analysis’ (see Figure 13) to make decisions about the format and 
content of the intervention; and then presented my initial ideas to these stakeholders for feedback 
and took suggestions for adjustments. Decision making was informed by key observations, which 
are denoted throughout this chapter with ▲. 
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3.4.2.1. Intervention design issues 
A central problem that had to be considered throughout this process was one of behavioural 
complexity. There are a wide variety of different forms that increased PA can take and there is 
much evidence that individual preferences in PA engagement styles vary 
substantially.[196,197,212,222–224] Such an interplay creates considerable complexity in terms of 
potential target behaviours, if one intends to increase PA behaviour across the whole prostate 
cancer cohort as part of standard care (given that their only unifying factors are being male, having 
a prostate cancer diagnosis, and being mostly over 50 years old). It can be reasonably assumed 
that as a target group, they possess broad variability in terms of psychosocial and physical 
circumstances that affect capability, opportunity and motivation to engage with PA behaviour 
(which is likely to affect preferences). Appendix 4 illustrates this, showing the many target 
behaviours that were assessed with the APEASE criteria as ‘promising’ or ‘very promising’ in terms 
of having a behavioural effect in an individual; but ‘unpromising’ or ‘unacceptable’ in terms of the 
likelihood of changing this behaviour across the cohort. 
▲  Options for PA behaviour vary hugely. Individual preferences for PA behaviour also 
vary, probably for a multitude of biopsychosocial reasons. 
Hence, instead of selecting a very specific target behaviour, as advocated by Michie et al., I defined 
the primary target behaviour broadly, as ‘an individual taking a decisive action of their preference 
to increase their PA levels’. Such a definition enabled the consideration of a wide range of 
behavioural antecedents (see Figure 13), whilst also acknowledging patients’ preferences. I 
thought that this would increase the potential for behavioural ‘overspill’ to take place (i.e. promoted 
behaviours triggering other PA-related behaviours), and therefore broaden the likelihood of 
engagement with the primary target behaviour across the cohort. My approach aligns with the 
concept of ‘minimally disruptive medicine’, which advocates for healthcare provision to take into 
account the complex interplay of biopsychosocial factors that can affect an individual’s capacity to 
self-manage a chronic health condition.[225] Although this contravenes Michie et al.’s advice to aim 
for incremental change by targeting one or two specific behaviours at a time,[221] in the present 
setting it is arguable that both types of approaches should be considered. 
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A second issue that arose in my meetings with clinical stakeholders was that it was apparent that 
to some extent, the efficacy of a given PA behavioural intervention may be inversely associated 
with its reach (see Appendix 4). In other words, interventions that require high engagement from 
participants (e.g. structured exercise classes) may be behaviourally potent; but may also possess 
barriers for some, and thus have limited (and potentially socially unequal) uptake. On the other 
hand, interventions that require very little engagement (e.g. informational leaflet) can be easily 
disseminated but may have little behavioural impact. 
▲  To some extent, the behavioural potency of a given PA intervention may be inversely 
associated with the proportion of the patient population who engage with it. 
Consideration of how to best reconcile this problem led to the idea of using existing educational 
patient seminars, as a means via which to access the broadest possible audience with a brief, but 
substantive, intervention. 
▲  Existing educational seminars provide a medium via which almost all patients can be 
systematically engaged. 
I reasoned that if this brief intervention was adequately underpinned by psychological theory, it 
could conceivably still have some behavioural potency. A theoretical basis to this reasoning is 
outlined toward the conclusion of this chapter (Part D), in which an initial intervention mechanism 










Primary target behaviour 
Take one’s preferred decisive action to increase 
physical activity to recommended levels for people with 
cancer (behaviour of patient) 
Change(s) needed that are targeted 
by intervention 
 
To broaden engagement with NHS physical activity 
pathway across the patient cohort 
 
To make associated health consequences of behaviour 
more salient 
 
To convincingly persuade of the positive case for 
physical activity as a force for feeling fit, strong, and 
positively self-determined 
 
To provide exposure to behavioural role models that 
patients respect 
 
Target behaviours selected 
Generalised behaviour as described in the primary 
target behaviour, enabling various manifestations of 
physical activity behaviour to be targeted 
Intervention function Persuasion, Modelling 
Policy categories Service provision 
BCTs applied 
• Information about health consequences 
• Information about emotional consequences 
• Salience of consequences 
• Credible source 
Mode of delivery Face-to-face, group 
 
Table 13 Characteristics of the intervention, described as per the Behaviour Change Wheel 






3.4.3. The intervention 
Here I will briefly summarise how key factors (denoted above with ▲) influenced the intervention 
design. A description of the intervention is then provided. 
3.4.3.1. Key factors influencing intervention design 
To summarise, the following observations were influential in the intervention design process (see 
Figure 14). 
▲ Systemic sociodemographic biases may exist with regards to prostate cancer patients’ 
likelihood of engaging with a formalised PA pathway. In other words, there is currently 
inequity in the system. 
➢ The above observation led the clinical stakeholders and I to conclude that in addition to a 
comprehensive PA pathway (which tend to be accessed more by either younger patients, 
those of a higher socioeconomic status, or those who live closer to the hospital), further 
behaviour change methods are needed that maximise PA support for the wider patient 
population. Existing educational seminars, that are delivered as part of the standard care 
pathway, were deemed to be a useful medium for delivering a behavioural intervention. 
▲ Notwithstanding that all prostate cancer patients should be provided with adequate PA 
support; it could be that patients receiving curative treatment need additional forms of 
behavioural support in order to increase (and maintain) PA behaviour. 
➢ Consideration of the above led to the decision to focus the pilot testing on curatively 
treated patients. Specifically, I decided to study patients who had were receiving radical 
prostatectomy for localised prostate cancer.  
▲ Peer support from other men with prostate cancer can act as a PA motivator for men with 
prostate cancer. 
➢ The above empirical observation was the basis for the central idea for the intervention. I 
was interested in whether this empirical phenomenon could be produced via a behavioural 
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intervention that could provide benefits to all patients, not just those who engage with a 
comprehensive PA pathway. 
▲  Options for PA behaviour vary hugely. Individual preferences for PA behaviour also vary, 
probably for a multitude of biopsychosocial reasons. 
➢ The above observation led me to take the approach of aiming to modify patients’ 
underlying attitude toward PA, which they could then act upon in a way that was preferable 
and manageable for them personally, in line with the principles of minimally disruptive 
medicine.[225] An intervention using a combination of peer support and narrative 
storytelling was thought to have the potential to achieve this. A theoretical mechanism for 
this process is outlined below, in Section 3.5. 
▲  To some extent, the behavioural potency of a given PA intervention may be inversely 
associated with the proportion of the patient population who engage with it. 
➢ Consideration of the above problem led me to consider how a minimally ‘invasive’ PA 
intervention could also be effective. Psychological theories suggested that a combination 
of peer support and narrative storytelling might be effective at promoting PA, whilst being 
deliverable as a brief intervention within an educational seminar. 
▲  Existing educational seminars provide a medium via which almost all patients can be 
systematically engaged. 
➢ For reasons outlined above, this fact led to the adoption of existing educational seminars 
as a medium for delivering the behavioural intervention. 
103 
 
Figure 14 Key observations made during literature review and during the collaborative design process, with arrows displaying at 
which stages they contributed to the intervention design process. 
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3.4.3.2. Intervention description 
The intervention that was ultimately decided upon was a brief, PA-themed peer support 
intervention, to be delivered in existing educational seminars. The intervention consisted of 
a 10-minute presentation about PA, delivered once to each patient via seminars, by a non-
clinician with a history of treatment for locally advanced prostate cancer. 
The presentation contained a story about the presenter’s experience with PA in the context 
of their prostate cancer diagnosis and treatment. The patient presenter was an advocate for 
PA and was generally given creative free reign over the presentation content, but he was 
instructed to avoid making scientific claims. The intervention presentation was to take place 
immediately following an already established routine 20-minute presentation by a cancer 
exercise specialist, which covers the evidence that PA is beneficial to people with cancer; 
official PA recommendations; what constitutes moderate and vigorous PA; assurance that 
PA is safe for them; and advice on how to integrate PA into everyday life. 
These two presentations were delivered at two NHS trusts, in two different types of 
educational seminar (differing by trust). At one trust, the intervention was delivered in pre-
treatment seminars that equip patients with the information they need about their upcoming 
surgical procedure. At the other trust, it was delivered in post-treatment seminars, which are 
provided for all patients who have undergone a radical prostatectomy and aim to equip 
patients with information to help them with self-management, following their treatment for 
prostate cancer. 
This chapter will now conclude by outlining a psychological mechanism via which it was 




PART D Articulating a programme theory 
3.5. A working theoretical mechanism of the intervention 
The following section describes the theories and existing findings that were drawn upon to postulate 
an initial theoretical mechanism of action for the intervention. It begins by outlining on overall 
framework of PA behaviour using the theory of planned behaviour (TPB). It then introduces the 
dual process framework, and briefly describes how implicit processes are likely to be integral to the 
TPB. Next, a dual process model, the associative–propositional evaluations (APE) model, is used 
to explain how narrative storytelling could exert influences on behaviour. 
3.5.1. The theory of planned behaviour 
The theory of planned behaviour (TPB) has played a prominent role in the area of social 
cognition.[130] In the 1960’s, the behaviourist model of psychology advocated by Skinner[226] was 
strongly undermined by the critique that it did not account for language.[227] Subsequently, there 
was a surge of interest in examining cognitive processing, which coincided with a rejection of the 
examinations of mere outward behavioural responses that had been developed by Skinner. Social 
psychology – which had long relied on the idea of cognitive processing to explain people’s 
responses to their social environment – was a beneficiary of this surge of interest.  An 
understanding that social psychology and cognitive psychology were intertwined was articulated in 
Bandura’s social cognitive theory.[127,228] The emergence of the social cognitive framework, 
combined with sustained interest by experimental psychologists in gathering empirical data on 




Current social cognitive understanding of health behaviour is highly influenced by the TPB,[128] 
which was developed from the theory of reasoned action.[230] The TPB states that human behaviour 
can be predicted primarily by behavioural intention, alongside perceived behavioural control – the 
degree to which the individual believes they have control over a given behaviour. Intention is, in 
turn, predicted by the interplaying factors of attitude toward the behaviour, subjective norm (the 
individual’s perception of what constitutes socially normative behaviour), and perceived 
behavioural control (see Figure 15). 
Figure 15 The theory of planned behaviour. Reproduced from Ajzen.[130] 
 
The TPB has been extensively applied to research on PA behaviour, and there exists a strong 
empirical basis for its ability to predict PA behaviour, making it a useful, parsimonious framework 
for intervention design.[231] However, whilst its description of the relationships between certain 
cognitions and behaviour has strong empirical support, the theory does not attempt to postulate 
any antecedents to attitude, subjective norm, and perceived behavioural control. The model places 
emphasis on reflective, propositional processes, which may only provide one part of the overall 
picture, as will be explained below.[232] A meta-analysis by Hagger et al. has underlined this 
limitation.[231] Hagger and colleagues used a meta-analytic review to examine the relationships 
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between constructs in the TPB and past behaviour, in the context of PA. They showed that when 
previous PA behaviour is controlled for, the strength of the relationships between TPB constructs 
and actual behaviour is substantially attenuated.[231] The findings of Hagger and colleagues 
highlight the challenging nature of changing existing behavioural habits, that tend to result from 
more automatic, rather than deliberative, cognitive processes. Such pre-existing habits have been 
shown to be a strong influence on PA behaviour, moderating the effect of intention on behaviour.[233] 
These more automatic processes are accounted for in dual process-style theories. 
3.5.2. The role of implicit and explicit processes 
The idea of two dynamically interacting systems in the human mind has, in the last few decades, 
seen extensive empirical testing that has provided strong support for the central tenets of such a 
framework.[232] Numerous dual process-style theories have been produced. Some examples of 
these are the reflective-impulsive model,[232] the associative-propositional evaluative model,[234,235] 
and cognitive-experiential self-theory.[236] 
Although these models each have their own focus, they broadly share a common proposition, which 
is sometimes referred to as dual process theory (DPT). The proposition is that cognitive processing 
is driven by the interplay of two groupings of cognitive functions, and that these two groupings of 
functions are qualitatively distinct from one another. One grouping is characterised by slow, 
reflective processes that consist of deliberative and syllogistic reasoning, which tend to be 
demanding on cognitive resources. The other is characterised by instant responses to 
environmental stimuli that emerge from the reaction of a vastly complex, non-conscious, learnt 
network of associated schema. This associative network is thought to function through a process 
that has been termed spreading activation, in which activated schemas in turn activate associated, 
‘proximal’ schemas. Aggregation of activated schemas, via automatic spreading activation, is 
thought to produce implicitly constructed, largely affective responses to external stimuli, that can 
influence behaviour toward the object. It is thought that this structure is evolutionarily adaptive, by 
allowing for the human mind to process environmental stimuli heuristically with minimal cognitive 
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depletion (but perhaps more error prone), whilst only deploying energy-intensive cognitive 
reflection where necessary, thus preserving precious energy needed for survival.[133] 
3.5.3. The role of implicit processes in the theory of planned 
behaviour 
Dimmock and Banting[237] have argued that implicit processes play a key role in the TPB in the 
context of PA. Their argument builds upon work done by Ferguson, which showed that implicit 
attitudes toward goals can predict goal pursuit[238]; and the work of Kehr, who showed that large 
discrepancies between implicit and explicit motives require stronger self-regulation of 
behaviour.[239] Regarding the TPB, Dimmock and Banting present arguments from the literature 
that implicit cognition is implicated as a moderator of the relationships between beliefs, and the 
core variables in the TPB. Hence, it could be an antecedent to these variables (e.g., implicit 
cognition moderates the importance of behavioural beliefs in influencing attitude). Further 
arguments are presented by Dimmock and Banting that implicit cognitions can be situated within 
the TPB as a moderator of the importance of attitude, subjective norm, and perceived behavioural 
control in predicting behavioural intention; and also as a moderator of the importance of intention 
in predicting actual behaviour.[237] For example, they present evidence that implicit ‘exerciser’ self-
schemas can predict actual behaviour, unmoderated by explicit behavioural intention.[240] 
More broadly, the proposition that implicit processes may play an integral role in theories of 
behaviour has recently been given support by a meta-analysis of 26 studies by Chevance et al., 
who aimed to summarise the relationship between implicit PA attitude and PA behaviour.[131] These 
investigators found that implicit attitudes towards PA show a small, but robust, correlational 
relationship with PA behaviour.[131] Given that positive implicit attitudes toward PA are, in theory, 
unlikely to be strongly moderated by more conscious, deliberative processes due to a lack of 
motivation to do so,[241] PA behaviour may indeed be amenable to influence via the manipulation 
of implicit processes. This idea has been demonstrated experimentally by Antoniewicz and Brand, 
who observed that manipulation of automatic evaluations of exercise resulted in subsequent 
increased exercise behaviour.[242] The next section invokes a specific model of implicit and explicit 
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evaluations, the associative-propositional evaluation model,[234,235] to outline a mechanism of how 
this would occur. 
3.5.4. The associative-propositional evaluation model 
The associative–propositional evaluation (APE) model offers a description of individuals’ 
evaluations of objects, by describing a dual system process comprising of implicit evaluations, and 
explicit evaluations. It is thought to describe processes that are instrumental in the formation and 
articulation of attitudes.[235] 
The APE model proposes that automatic, affective experiences in response to environmental 
stimuli are cognitively ‘translated’ into a propositional format (e.g. ‘I like/dislike the object’), and then 
judged on their subjective validity by other momentary propositions that take place within conscious 
thought, in a process termed propositional validation. These other propositions might consist of 
perceived states of affairs (e.g. ‘exercise is a boring and hard activity’), or other attitude objects 
(e.g. ‘I want to be in control of my health’). It is assumed that any resulting inconsistency between 
competing propositions produced by the stimulus (including the proposition translated from the 
initial automatic affective reaction) represents the presence of an erroneous belief that must be 
corrected. These circumstances will produce cognitive dissonance[243] that will cause psychological 
discomfort until the inconsistency is resolved. An example of this process is shown in Figure 16.[235]  
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Figure 16 The process of propositional validation, according to the associative–propositional evaluation 
(APE) model. (A) represents a situation of cognitive inconsistency, produced by an automatic affective 
reaction, that must be resolved in order to maintain a coherent set of beliefs. The situation is resolved 
into either (B) (rejection of the affective response), (C) (modification of another attitude object), or (D) 




In a similar way to other dual process theories, the APE model posits that propositional processes 
can influence associative networks (i.e. a ‘top-down’ process). The way in which this top-down 
process is proposed to work is via inclusion in the system of novel propositions, which can either 
be externally provided, or self-generated. If an individual is motivated to believe a certain 
proposition, they may selectively search for information that supports that proposition.[241] Such 
biased retrieval, if repeated, will activate related schemas in the associative system, resulting in 
the formation of associative networks that may be more likely to be activated in the future.[235] If a 
memory relating to a proposition is particularly accessible to cognition, we can logically assume 
that this process will be enhanced – the schemas associated with that proposition will be more 
frequently activated, causing long term potentiation and strengthening the schematic associations. 
This assumption underlies the intervention mechanism proposed here. 
One final theoretical point to be considered here is that this ‘top-down’ process, in which novel 
propositions influence related associative networks, is thought to only work through the positive 
affirmation of a proposition, as opposed to a negation of a proposition. This is because the 
associative network only seems to be concerned with whether concepts are related; it does not 
concern itself with how they are related. Therefore, attempting to influence the associative network 
using negation of a proposition (e.g. ‘scrapyard-dwelling rottweilers are not to be feared’) can in 
fact have the reverse effect, by potentiating the associative connection between the presented 
concepts (e.g. ‘rottweiler’, ‘scrapyard’, and ‘fear’).[235,244] Hence, according to the APE model, an 
intervention aiming to modify implicit attitude toward PA using propositional reasoning would need 
to reinforce the positive aspects of PA, rather than the negative aspects of physical inactivity. 
To recap, a brief intervention to influence PA attitude and/or motivation could theoretically do so 
via implicit processes by: a) using positive message framing; b) presenting a PA message in a way 
that activates broad subsets of associative schemas; and c) being memorable and therefore 
accessible, facilitating repetitive recall beyond the intervention itself. The next section describes 




3.5.5. Narrative and authenticity in cancer communication 
Narrative storytelling is often used by public health campaigns to deliver persuasive messages 
designed to influence health behaviour.[245] Public heath interventions using narratives “naturally 
lend themselves to creating the psychological space individuals need to integrate new information 
about new behaviour into an existing web of associations, cause–effect relationships, and 
experiences”[246][p.180]. A meta-analysis of the effects of persuasive approaches utilising narrative 
storytelling reported that this approach can influence beliefs, attitudes, intentions and behaviour.[247] 
Petraglia[246] argues that narratives can be used to provide health communication with ‘authenticity’. 
Petraglia defines authenticity as “a judgement, a decision made on the part of the learner based 
on prior experience and sociocultural context”[246][p.179]. They argue, from a rhetorician’s 
perspective, that recommendations to change health behaviours are not automatically seen as 
authentic by the receiver. Authenticity, according to Petragia, is a judgement projected onto the 
message by the receiver both cognitively and emotionally, embodying “not just a perceived 
relevance but a felt relevance that pulls information out of the background and into the fore”[p.176]. 
Petraglia contests that authenticity “enables individuals to understand, emotionally as well as 
cognitively, how information can relate to their everyday existence”[246][p.176]. Invoking a geometric 
metaphor, they suggest that many health behaviours are experienced as ‘three-dimensional’ 
objects, in that they have “history, emotional resonance, links to social identity, and extensive 
connections within memory”[p.180]. Petraglia implies that persuasive approaches using similarly 
‘three dimensional’ narratives are useful for influencing such behaviours.[246] 
The use of narrative storytelling and imagery to influence implicit processing has also been 
suggested by Epstein, in their articulation of one of the dual process models cited above, the 
cognitive–experiential self-theory of personality.[248] Associative, implicit processing is 
conceptualised by Epstein as an experiential self, that adaptively learns through an individual’s life 
experiences and is intimately related with affect. According to Epstein, the abstract way in which 
objects are represented by the complexity of the experiential system means that “communicating 
with the experiential system in its own medium refers to the use of association, metaphor, imagery, 
fantasy, and narrative”[248][p.177]. Epstein’s proposition seems to be broadly consistent with 
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Petraglia’s ‘three dimensional’ metaphor.[246] Both are suggesting that this approach appeals to 
more deeply integrated schematic networks in the associative system (see Figure 18). It is this 
system that tends less toward with externally validated truths; and more toward subjective 





The potential uses of narrative storytelling as a practical tool for addressing cancer prevention and 
control have been outlined by Kreuter et al.[249]. Their literature review identifies three principle ways 
in which narrative can be useful for delivering health messages in the context of cancer diagnosis, 
treatment, and survivorship. These are: 
1) Facilitating processing of cancer control information. 
2) Providing surrogate social connections to support cancer control. 
3) Representing emotional and existential issues related to cancer control. 
First, they propose that narrative facilitates processing of information in the cancer context by 
contextualising a complex situation in a psychologically manageable way – one that is accessible 
to those who may have lower health literacy, mistrust of health professionals, or certain culturally-
influenced personal values related to health. Narrative storytelling, they propose, also provides 
Figure 17 Conceptual illustration depicting the way in which narrative storytelling may lead to broader 
subsets of associative schemas being activated within the associative system. The circles represent 
learned schemas residing in the associative system, which are activated via a ‘spreading activation’ 
process, in which activated schemas trigger the activation of other associated schemas. This broader 
activation would be a result of the incoming information being contextualised by the recipient, due to its 
appeal to more deeply ingrained aspects of the self, such as life experiences and cultural archetypes. 
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coherent ‘social information’ that is fundamental to how human beings understand their 
environment.[249] 
Second, they propose that narrative storytelling can create ‘para-social’ relationships, in which the 
audience can form a ‘surrogate’ social connection to characters within the story, and even extract 
‘surrogate’ social support to help them psychologically cope with their health situation. They cite 
research showing that such identification with characters engaging in health behaviours can 
influence the health behaviours of the audience (e.g. [250]).[249] 
Third, they propose that narrative storytelling is better suited than propositional information to 
represent emotional and existential issues to cancer, by acknowledging the complex psychological 
processes that underpin an individual’s sense of self in such a disruptive and complicated 
psychological situation.[249] 
To my knowledge, there is no published research on the application of narrative storytelling in the 
context of prostate cancer survivorship. However, a study of breast cancer patients, which 
examined perceptions of PA, found that written testimonials about PA by former patients were more 
effective at increasing PA self-efficacy and intention, than were written recommendations by an 
expert.[251] 
In summary, the contribution of narrative storytelling to the intervention mechanism lies in the 
proposition that narratives are persuasive because they help individuals to contextualise health 
information, by appealing to abstract systems of representation that reside in the associative 
system. Therefore, it can be theorised that an intervention utilising narrative storytelling, delivered 
by a source deemed to be ‘authentic’, may be useful for increasing PA behaviour in men with 
prostate cancer. A theoretical framework, using the TPB and incorporating the role of implicit 
processes in influencing behaviour, can provide a theoretical backdrop for understanding the 
intervention mechanism. This theoretical framework is briefly outlined in the following section. 
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3.5.6. Cognitive mechanism of the intervention in terms of 
the APE model 
Given that PA has aspects that can simultaneously be perceived as positive (e.g. feeling healthier) 
and negative (e.g. unappealing physical effort), it can be reasonably assumed that the affective 
response produced by thoughts of PA may be a mixture of positive and negative affect, the 
composition of which varies from individual to individual. In terms of the APE model, the resulting 
cognitive proposition could thus be characterised somewhere along a continuum, i.e. as ‘I mostly 
like physical activity’; ‘I mostly dislike physical activity’; or ‘I am ambivalent about physical activity’ 
(see Figure 18). 
 
Figure 18 Affective responses to physical activity are likely to be a mixture of positive and negative 
affect; the composition of this mixture will vary between individuals. The resulting mental propositions 
will differ in their evaluation of physical activity. 
 
In terms of Figure 19, the intervention aims to influence patients to be more akin to ‘Individual (x)’ 
than ‘Individual (y)’. It aims to achieve this by using a former prostate cancer patient as a storyteller 
to create affirmative novel propositions. Following this intervention, these propositions might 
continue to exert ‘top-down’ effects on related, newly formed associative networks that are 
interlinked with aspects of an individual’s experiential self. We might expect this because these 
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propositions will also be very accessible to cognition, as they have been learned as part of an 
affect-laden experience and thus are likely to be more strongly consolidated in memory. The 
process described is shown in Figure 20 and Figure 21. An overview of the intervention mechanism, 
incorporating all the processes hitherto described, is shown in Figure 22, which will conclude this 
chapter. The next chapter will report on a pilot study I conducted to test the intervention.[252] 
 
  
Figure 19 Conceptual diagram, using the framework of the associative–propositional 
evaluations (APE) model, showing an example cognitive evaluation of physical activity 
prior to intervention. 
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Figure 20 Conceptual diagram, using the framework of the associative–propositional evaluations (APE) 
model, to show how the intervention may influence attitude toward physical activity. Novel, affirmative 
propositions (examples in yellow) are used to influence implicit processing, by being linked with well-
consolidated, accessible memories of the intervention. Individuals are motivated to believe that physical 
activity can help them manage their cancer, and so are likely to engage in biased retrieval of these 
memories, resulting in repeated activation of associative networks that are well-integrated into the 
associative system. This modification to implicit processing may alter the quality of the individual’s 
affective reaction to thoughts of physical activity, towards a more positive affective reaction. The 
resulting attempts to maintain cognitive consistency (examples in blue) may precipitate a change in the 
individual’s explicit attitude toward physical activity over the longer term. 
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Figure 21 An integrated model showing the proposed psychological effects of the intervention, in the context of the frameworks of the theory of planned 
behaviour. Effects on implicit processing may influence behaviour through moderative effects on construct relationships in the theory of planned behaviour. 




3.6. Chapter summary 
This chapter described the design of an intervention to promote PA in men with prostate cancer 
as part of standard care. The process described followed established guidelines for the 
development of intervention, which suggest reviewing the evidence; understanding the context; 
drawing upon existing theories; and articulating a programme theory. 
Evidence was reviewed via means of a systematic review of barriers and facilitators to PA in men 
with prostate cancer. Amongst other things, this review identified that peer support between men 
who share the experience of prostate cancer can be a PA motivator. Understanding of the context 
was facilitated via analysis of clinical data taken from the locality. Local analysis 1 indicated that 
men on the existing PA pathway who have undergone curative treatment appear to be less likely 
to increase and maintain PA behaviour than men on systemic treatment. Local analysis 2 indicated 
that the existing local PA pathway is underutilised by those who are older, live further away, or are 
of a lower socioeconomic status. 
Existing theories for intervention design were drawn upon by using an established framework for 
the design of interventions, the Behaviour Change Wheel.[143] The intervention design process 
involved key clinical stakeholders and incorporated findings from the systematic review and the 
analyses of local clinical data. The final intervention was a short PA presentation, to be delivered 
by a former patient in existing educational seminars and thus engage large amounts of patients. 
An initial programme theory was articulated, that drew upon theories of social cognition to postulate 
a working theory as to how this intervention could positively affect patients’ attitudes toward PA. 





Chapter 4: Pilot study 
The following chapter reports on the mixed methods pilot study that I conducted to determine 
whether the intervention was beneficial to patients. The findings of this study are in press at the 
time of writing and will be published in Supportive Care in Cancer.[252] The chapter begins with a 
brief introduction and a description of the methodological background for the pilot study. Next, the 
methods and results for both the quantitative and qualitative aspects of the study are reported. 
Finally, conclusions are drawn about the intervention and are discussed, based on all aspects of 
the pilot study findings and reference to wider literature. 
This chapter addresses research objective 3: 
3) Collect and analyse original data to examine whether the PA intervention is effective; 
and/or identify issues relating to its effectiveness. 
 
4.1. Introduction 
Peer-support interventions for people with cancer have been widely studied.[253–255] Most of this 
research has examined community peer-support initiatives, designed to provide psychosocial 
support.[253] To my knowledge, there are no published studies of peer-support interventions for 
cancer patients that both: 1) had a specific aim of promoting PA; and 2) are hospital-based, and 
hence are accessed by patients during routine cancer care appointments. Two studies have 
examined the effect of a peer-support intervention on PA adoption in cancer patients, but were not 
hospital-based (one study on breast cancer; one on prostate cancer).[163,256] 
Galvão et al.[163] examined a peer-led telephone-based intervention to promote PA in men with 
prostate cancer (the study was included in the systematic review reported in Section 3.2).[142] The 
intervention consisted of a monthly teleconference for six months, led by two peer-support 
volunteers who did not have a history of cancer, and a specialist nurse. The teleconference peer-
support groups covered various topics relating to self-management. One session was dedicated 




where participants could discuss their progress with PA goals. Participants in the intervention arm 
also received some basic exercise equipment. The investigators conducted a randomised 
controlled trial on 463 men with prostate cancer, to examine whether this intervention was better 
than usual care at promoting PA. Results from this study showed that the intervention resulted in 
more self-reported resistance exercise at 6 months follow up (i.e. at the conclusion of the 
intervention), but not at 12 months. The investigators found no difference in self-reported aerobic 
exercise between the groups at any of the follow up time points.[163] 
Pinto et al.[256] examined a peer-support based PA intervention in people with breast cancer, 
consisting of 12 weeks of weekly telephone counselling from trained volunteers with no history of 
cancer. The telephone counselling aimed to support patients to increase their PA levels, using a 
behaviour change programme based on social cognitive theory.[127] The investigators conducted a 
randomised controlled trial on 76 people with breast cancer, to examine whether this intervention 
could increase PA compared to a control group in which participants received an information 
booklet and had general questions (unrelated to PA) answered by the coaches. PA was measured 
by corroborating self-reported PA with data from accelerometers. Results showed that this 
intervention was effective at increasing PA compared with the control group after 12 weeks. The 
effect was also maintained – albeit attenuated – after 24 weeks.[256] 
The intervention reported on here differed procedurally from these previous PA interventions in 
three ways. First, the present intervention was a single-contact intervention, as opposed to 
involving regular contact for an extended period. Second, the intervention was hospital-based and 
was integrated into the standard cancer care pathway. Therefore, almost every patient receiving 
radical prostatectomy for prostate cancer at the hospital could theoretically benefit, should the 
intervention turn out to be beneficial to patients. Third, in the present study the peer-supporter had 
a history of prostate cancer. Prior studies on hospital-based peer support interventions (that did 
not aim to promote PA) have indicated that some cancer patients see this prior experience as an 
asset in a peer-supporter, as it equips the peer-supporter with an enhanced sense of 




themselves has not yet been studied in the context of a PA intervention for the self-management 
of cancer. 
The present study therefore aimed to: 
1) Examine whether the proposed intervention can result in increases of physical activity 
behaviour in men receiving curative treatment for prostate cancer, when applied in an 
ecologically valid setting (i.e. during a routine clinic appointment). 
2) Examine whether the intervention can affect established theoretical constructs from a 
behavioural theory that was used to postulate the intervention mechanism. 
3) Explore any other effects of the intervention on patient wellbeing. 
4.2. Methodology 
4.2.1. A mixed methods approach 
The pilot study used a mixed methods approach. Mixed methods research (MMR) “combines 
elements of qualitative and quantitative research approaches … for the broad purposes of breadth 
and depth of understanding and corroboration”[260][p.123]. Over the last three decades, MMR has 
matured from being used as a simple descriptor for the use of both qualitative and quantitative 
methods in research, into its own methodological discipline, complete with its own textbooks, 
journals, conferences, and scientific philosophy.[261] MMR is being increasingly used in the health 
sciences, following calls from major medical journals for the integration of qualitative methods into 
prospective health research.[262] As noted by Creswell and Plano Clark, “MMR provides strengths 
that offset the weaknesses of both quantitative and qualitative research”[261][p.12]. 
An MMR approach was used for the present study for several reasons: 
1. A quantitative analysis was necessary to provide variable-level information – i.e. 
generalised, statistical effects between groups – in order to establish the degree to which 
the intervention was broadly effective (not just efficacious) across the population (this 




2. Quantitative data were required to determine whether intervention effects could be 
categorised as clinically meaningful, based on established numerical thresholds for the 
measures used. 
3. There was a need to obtain qualitative, individual-level information about complexity. This 
is because it is not known what variables that could affect the quantitative outcomes. 
Individual-level variation – i.e. differential effects between individuals – could theoretically 
influence the outcomes of interest. Qualitative data could therefore mitigate the risk of a 
Type II error (i.e. a falsely negative finding). 
4. Qualitative data was likely to assist in the interpretation the quantitative results. 
5. Qualitative data would help to determine which (if any) aspects of the theoretical framework 
used might be empirically substantiated, or empirically refuted. 
6. Qualitative data was likely to provide useful feedback from patients about the intervention 
that could be used for refinement in future iterations. 
 
In the present study, qualitative data were collected after all quantitative measures had been 
obtained. It has been suggested that this sequential design is the appropriate one for intervention 
studies that seek to obtain participant feedback; explain quantitative outcomes; and understand in 
further depth how mechanisms in a theoretical model may (or may not) have worked.[262] The 









4.2.2. Quantitative methods  
As stated in Chapter 1, this project aimed to develop an intervention for use as standard care. To 
date, many of the published exercise intervention studies for men with prostate cancer have used 
trial designs and procedures that I would argue are prone to selection or self-selection biases (see 
Section 3.2.4). When examining behaviour, this is particularly problematic. If a physical activity 
intervention is highly demanding, the likelihood is increased that individual differences in cognitions 
and personality will act as confounding variables – i.e. associated with both the likelihood of 
participation and the likelihood of behavioural responsiveness to the intervention. Low ecological 
validity could therefore undermine the overall clinical value of a behavioural intervention. 
Aiming to address this problem, the present study used a ‘pragmatic trial’ approach.[263] Pragmatic 
trials have been proposed as a way to alleviate issues of ecological validity and clinical 
effectiveness of interventions, by taking steps to minimise the artificiality of procedures and data 
collection burden on patients.[263] Table 14 shows the ways in which the present study adopted this 
style of approach, detailing nine dimensions for assessing the level of pragmatism in a trial as 





Dimension Assessment of pragmatism To what extent is the present study pragmatic? 
Recruitment of investigators and participants 
Eligibility To what extent are the participants in the trial 
similar to patients who would receive this 
intervention if it was part of usual care? 
Very pragmatic – they are the same. 
Recruitment How much extra effort is made to recruit 
participants over and above what would be 
used in the usual care setting to engage with 
patients? 
Moderately pragmatic – a system for inviting all radical 
prostatectomy patients to the seminar has been put in 
place for the study. This system is simple and certainly 
implementable as usual care. 
Setting How different are the settings of the trial from 
the usual care setting? 
Very pragmatic – they are the same. 
The intervention and its delivery within the trial 
Organisation How different are the resources, provider 
expertise, and organisation of care delivery in 
the intervention group of the trial from those 
in usual care? 
Mildly pragmatic – the intervention requires a former 
patient that is 1) willing to regularly volunteer time, 2) 
has a positive history of exercise behaviour, and 3) is 
adept at speaking to an audience. 
Flexibility in 
delivery 
How different is the flexibility in how the 
intervention is delivered from the flexibility 
anticipated in usual care? 
Very pragmatic – the patient speaker was permitted 
creative flexibility in the delivery of the intervention; he 




How different is the flexibility in how 
participants are monitored and encouraged 
to adhere to the intervention from the 
flexibility anticipated in usual care? 
Moderately pragmatic – this depends on how well 
systems for facilitating attendance at patient seminars 
can be established and maintained (see above). 
The nature of follow-up 
Follow-up How different is the intensity of measurement 
and the follow-up of participants in the trial 
from the typical follow-up in usual care? 
Very pragmatic – low intensity: four short questionnaires 
(5-15 mins to complete in total), delivered at two time 
points (one at patient’s existing clinic appointment; one 
administered via post, with return envelope). Questions 
are not invasive or cognitively demanding. 
The nature, determination, and analysis of outcomes 
Primary 
outcome 
To what extent is the primary outcome of the 
trial directly relevant to participants? 
Very pragmatic – primary outcome of physical activity, 
which provides numerous benefits and is therefore 
relevant to patients. 
Primary 
analysis 
To what extent are all data included in the 
analysis of the primary outcome? 
Moderately pragmatic – a substantial portion of 
participants did not provide T1 data; a few more 
participants completed questionnaires incorrectly, 
rendering them invalid (see Figure 2). 
 
Table 14 Assessment of the pragmatism of the present study, in accordance with the nine dimensions 
for assessing trial pragmatism proposed by the Pragmatic–Explanatory Continuum Indicator Summary 





Practical constraints required me to target a subgroup of prostate cancer patients, as targeting all 
patients would not have been deliverable within the scope of a doctoral project. Moreover, the 
additional complexity may have made interpretation difficult. Following the conclusions of Local 
Analysis 1 (see Section 3.3.1), it was decided that the pilot study would examine the intervention 
in men receiving radical prostatectomy (i.e. curative treatment). An exploratory approach was 
adopted because this style of intervention had not been attempted to date. A null finding could 
therefore be erroneously interpreted as the intervention being universally ineffective, when in fact 
it could really be the case that an effect is only demonstrable under certain conditions (i.e. Type II 
error). To minimise the likelihood of Type II error, I piloted the intervention at two different NHS 
trusts (which serve differing sociodemographic populations) and at two different points in the 
treatment pathway (prior to surgical treatment at one site; after surgical treatment at the other site). 
The educational seminars were allocated on an alternate basis (i.e. control, intervention, control, 
intervention). 
The primary outcome was self-reported PA (see Section 4.3.4.2.1 below). Given the inherent 
difficulties in reliably measuring PA through self-report measures,[265] it was decided that a self-
reported primary outcome measure would be supplemented with a second primary outcome 
measure, examining whether or not patients subsequently engaged with the local PA pathway at 
each site.  
Exercise motivation, quality of life, and fatigue were secondary outcomes (see Section 4.3.4.2.2 
below). Exercise motivation was measured using a tool incorporating the theoretical constructs 
from self-determination theory. Such information was deemed to be useful in examining the validity 
the proposed psychological mechanism, were any primary effect to be observed. Quality of life and 
fatigue were chosen because it is well-established in the literature that PA is generally beneficial 
to these outcomes in men with prostate cancer (see Section 2.3.3.2.2). Furthermore, it was 
important to establish baseline levels of these outcomes to ensure that these did not differ between 
experimental groups. Finally, data on key clinical and demographic characteristics were solicited 
from participants to ensure parity between experimental groups on further variables that could 




The following null hypotheses were proposed for the quantitative aspect of the study: 
H1: There will be no significant difference between the intervention and control groups in 
changes to self-reported PA between baseline and T1. 
H2: There will be no significant difference between the intervention and control groups in the 
number of patients who received a consultation with an in-house cancer exercise specialist 
between baseline and T1. 
H3: There will be no significant difference between the intervention and control groups in 
changes to exercise behavioural regulations between baseline and T1. 
H4: There will be no significant difference between the intervention and control groups in 
changes to fatigue between baseline and T1. 
H5: There will be no significant difference between the intervention and control groups in 
changes to quality of life between baseline and T1. 
 
4.2.3. Qualitative methodology 
The qualitative methods used were based on a constructivist perspective. An epistemology based 
on constructivism assumes that the reality in which one is interested is socially constructed 
between individuals, including the researcher.[266,267] Such an analytical framework was thought to 
be appropriate, given that the intervention aimed to influence participants by producing 
psychological propositions that are socially constructed (see Section 3.5). In MMR, the pluralistic, 
‘pragmatist’ worldview is now commonly accepted,[261] which allows for the rejection of a ‘forced-
choice dichotomy’ between post-positivism (e.g. using statistical inference) and constructivism. 
The pragmatist worldview puts a focus on answering the research question.[261]  
One-to-one interviews were thought to be the strongest approach to answering the question ‘How 
is the intervention experienced?’ Although focus groups were considered, the focus group format 




intervention for themselves. Moreover, the focus group dynamic would produce conversations that 
centred upon the practical aspects of physical activity and treatment, rather than focusing on the 
psychological effects of the intervention. Hence, one-to-one interviews were thought to have the 
strongest potential to provide insight into the intervention experience, i.e. creating space to allow 
for participants to construct (or reconstruct) their own thought processes related to the intervention. 
The analysis aimed to identify patterns in the data, organically constructed from first-hand accounts 
of participants, that could be used to broadly characterise the intervention experience. Hence, an 
inductive thematic analysis was used.[268] To assess the potential constructing of sequential 
processes that may have taken place as a result of the intervention,  it also seemed practical to 
implement elements of a grounded theory approach, which aims to produce a ‘mid-range’ theory 
to explain phenomena of interest.[266,269] 
A pragmatic approach was taken to the qualitative data sampling. All men who had been exposed 
to the intervention and indicated that they would be happy to be interviewed were contacted. All 
men who were contactable and agreed to an interview were interviewed. 
4.3. Methods 
4.3.1. Study design 
The study design was a mixed methods study, comprising a pragmatic trial[263] and qualitative 
interviews, in a fully mixed, sequential (quantitative → qualitative), equal status design, according 
to Leech and Onwuegbuzie’s typology of mixed methods studies.[270] The mode of delivery for the 
intervention was educational seminars, covering various topics including diet, fluid intake, 
psychological advice and PA, that are delivered in a urology clinic as part of the standard NHS 
care pathway for men undergoing radical prostatectomy. The pragmatic trial design alternately 
allocated educational seminars to either a control condition, consisting of the existing seminar 
format; or an intervention condition, existing of the new seminar format containing the intervention. 




questionnaires to complete; and the final sample was opportunistic, comprising all patients who 
opted to return data at both study timepoints (pre- and post-test). 
4.3.2. Intervention 
Data were obtained from two study sites, at which the intervention was applied in differing contexts. 
At Site A, the intervention was delivered via a post-treatment seminar, which all men undergoing 
radical prostatectomy were invited to, but at which attendance was optional. At Site B, the 
intervention was delivered in a pre-treatment seminar, which is generally mandatory before 
undergoing radical prostatectomy. At each site, individual seminars were allocated into one of the 
two formats: 
1) Control seminar. Amongst other content, patients heard a 20-minute PA presentation 
by a cancer exercise specialist. The presentation covered: the evidence that PA is 
beneficial to people with cancer; official PA recommendations; what constitutes moderate 
and vigorous PA; assurance that PA is safe for them; and advice on how to integrate PA 
into everyday life (see Table 15). 
2) Intervention seminar. Amongst other content, patients heard the above presentation, 
immediately followed by a 10-minute PA presentation by a non-clinician previously treated 
for locally advanced prostate cancer. The presentation was delivered in a narrative style, 
focusing on his personal story, describing his positive experience of PA within the context 
of his medical history of treatment for prostate cancer with radical prostatectomy and 
hormone therapy (see Table 15). 
4.3.3. Ethics 
Approval was granted for all activities to take place as two quality improvement projects (QIPs) 
(Quality improvement project number 8190 at Guy’s and St Thomas’ NHS Foundation Trust; quality 





4.3.4. Quantitative methods 
A protocol for the quantitative aspects of this study has been peer-reviewed and is published in 
BMJ Open Sports and Exercise Medicine.[271] 
4.3.4.1. Participants 
Participants were men who had either received (Site A) or were receiving (Site B) radical 
prostatectomy for a diagnosis of prostate cancer at two Central London hospitals. All patients 
attending the educational seminars under study were approached (patients who are unable to 
speak English do not attend these seminars, instead receiving 1:1 consultation). One individual 
required sign language interpretation and was not approached. The final sample consisted of 148 
men who opted to complete all questionnaires at both time points (see Figure 23). 
4.3.4.2. Measures 
Patient-reported outcome measures were administered in the clinic immediately prior to each 
seminar (baseline), and via post either 90 days after the seminar (Site A), or 90 days after the 





Table 15 How behaviour change techniques (BCTs)[151] were applied in the two types of seminars 
being compared. 
 
4.3.4.2.1. Primary outcomes: self-reported physical activity 
The first primary outcome was self-reported PA, which was measured at both baseline and T1. Self-
reported PA was measured using the Short Questionnaire to Assess Health-Enhancing Physical 
Activity (SQUASH).[272] This short questionnaire asks respondents how much time, in hours and 
minutes, they have spent walking, cycling, or doing other activities (e.g. swimming, gardening) in 
the last seven days; and whether this activity was ‘slow’, ‘moderate’, or ‘fast’. 
The second primary outcome was the frequency of referrals to the PA pathway following the 
seminar. At Site A, this was measured by manually checking patients’ medical records six months 
following the seminar. All patients attending each type of seminar were examined, regardless of 
whether they had completed questionnaires. At Site B, patients who had opted to complete 
questionnaires were asked at T1 whether they had seen a cancer exercise physiotherapist within 
the trust (it was clarified that seeing the pelvic floor physiotherapist did not count). 
Control seminar Intervention seminar 
 
Instruction on how to 
perform the behaviour 
  
Instruction on how to 




 Information about 
antecedents 
 












 Information about 
emotional consequences 
 
Demonstration of the 
behaviour 
 Demonstration of the 
behaviour 
 
Framing/reframing  Framing/reframing  
  Information about health 
consequences 
 










4.3.4.2.2. Secondary outcomes 
4.3.4.2.2.1. Exercise motivation 
Exercise motivation was measured at both baseline and T1 using the Behavioural Regulations in 
Exercise Questionnaire-3 (BREQ-3).[273] The BREQ-3 measures six forms of exercise motivation 
that possess varying degrees of autonomy: amotivation (a lack of motivation); external regulation 
(least autonomous); introjected regulation; identified regulation; integrated regulation; and intrinsic 
motivation (most autonomous). Each form of motivation is measured by four items, each of which 
is scored from 0 (‘not true for me’) to 4 (‘very true for me’). 
4.3.4.2.2.2. Quality of life 
Quality of life was assessed at both baseline and T1 using the EQ-5D-5L.[207] The EQ-5D-5L 
contains five quality of life dimensions: ‘mobility’; ‘self-care’; ‘usual activities’; ‘pain/discomfort’; and 
‘anxiety/depression’. On each of these, respondents are asked to score the extent to which they 
are currently experiencing problems, on a 5-point scale from Level 1 (no problems) to Level 5 
(extreme problems). The EQ-5D-5L also contains a Visual Analogue Scale (VAS), on which 
participants are asked to rate subjectively how healthy they feel, on continuous scale from 0 (‘the 
worst health you can imagine’) to 100 (‘the best health you can imagine’). 
4.3.4.2.2.3. Fatigue 
Fatigue was measured using the FACIT-fatigue scale.[274] The scale contains 13 statements 
corresponding to various aspects of fatigue (e.g. ‘I need to sleep during the day’), asking 
respondents to score themselves on a 5-point scale for each item, indicating how much it applies 
to them in the last seven days, from 0 (‘not at all’) to 4 (‘very much). Total scores range from 0 (no 
fatigue) to a maximum fatigue score of 52. 
4.3.4.2.2.4. Clinical and demographic characteristics 
Each patient was also asked to provide some clinical and demographic characteristics (see Table 
16). At Site A, the number of days between radical prostatectomy and attendance at the post-
treatment seminar were calculated. Access to medical records provided further information on 




prostatectomy; whether they were on hormone therapy at either baseline or T1; and how many 
incontinence pads per day they were using at T1 (at Site B, patients were asked to self-report pad 
usage). 
4.3.4.3. Sample size calculation 
A sample size calculation was performed on the basis that I could expect to see participants 
reporting a baseline mean of 1,580 MET minutes, and standard deviation of 570 MET minutes, of 
PA per typical week, based on data from adult males retrieved from a previous application of the 
SQUASH questionnaire.[272] 
For the pre-surgery seminars, I assumed 5 participants per seminar from experience (these take 
place every 1-2 weeks). Hence, it was calculated that the expected standard deviation amongst 
self-reported PA data in this study would be 253 MET minutes. For the study utilising post-
treatment seminars, we assumed 20 participants per seminar from experience (these take place 
once a month). Therefore, it was calculated that the expected standard deviation amongst self-
reported PA data in this study would be 114 MET minutes. 
Our sample size calculation showed that, on the basis of the above assumptions, with a 2-sided 
alpha of 0.05 and 80% power, the amount of seminars required to detect a relative increase of 300 
MET minutes in those participants exposed to the intervention would be 9 seminars at Site A, and 
26 seminars at Site B. 
4.3.4.4. Analysis 
Responses on the SQUASH questionnaire were converted into MET minutes using the 2011 
Compendium of Physical Activities.[275] Self-reported MET minutes were analysed using repeated 
measures ANCOVA, with Study Site as a covariate, examining a Group*Time interaction to detect 
whether the control and intervention groups differed in how much they changed on the outcome 




between the groups using χ2 tests, to determine if there were differences between the control and 
intervention groups in how many referrals they subsequently produced. 
Scores on the BREQ-3, FACIT-fatigue scale, and EQ-5D-5L VAS were analysed using a repeated 
measures ANCOVA, with ‘Study Site’ as a covariate. For FACIT-fatigue scores, ‘Time of Year’ was 
also included as a covariate, to account for seasonal variation. The Time of Year variable divided 
the year up into six two-month segments; patients were allocated to a time of year according to 
either: when the intervention was delivered (Site A); or when the patient underwent radical 
prostatectomy (Site B) (i.e. 90 days prior to follow-up at both sites). Every ANCOVA model was 
tested with individual seminar as a covariate, omitting seminars with n<5. None of the models were 
sensitive to this variable, hence it was excluded from all models. 
Responses on the five dimensions of the EQ-5D-5L were collapsed into whether the patient 
improved, stayed the same, or deteriorated between baseline and T1. Outcomes for each 
dimension were analysed between experimental groups, using χ2 tests. Additional χ2 tests were 
performed to rule out Study Site as a covariate. Further, modified χ2 tests were also applied to two 
of the dimensions, to rule out effects of slight variance between groups at baseline on the findings 
(see Table 17). These further tests examined only patients who had reported ‘slight problems’ at 
baseline (i.e. accounting for the fact that patients who report ‘no problems’ at baseline cannot 
improve – only stay the same or deteriorate). 
Post hoc analyses were performed using χ2 tests to examine whether reported differences in 
fatigue and quality of life were clinically significant. These categorical variables were created using 
estimated numerical thresholds for clinical significance from the literature (FACIT-fatigue 
threshold: +/- 4 points; EQ-5D-5L VAS threshold: +/- 10 points).[276]  
As the sample size was relatively small, I collapsed some variables for analysis purposes. Ethnicity 
was collapsed into [White/Black/Asian]. Education status was collapsed into [Higher education/no 
higher education]. Marital status was collapsed into [Partnered/not partnered]. Employment status 




4.3.5. Qualitative methods 
4.3.5.1. Participants 
Fifteen men who had attended an intervention seminar, and were happy to be contacted regarding 
an interview, were successfully contacted. Fourteen of these were interviewed (one did not attend 
his appointment). All interviewees had at least a modest history of PA. Ethnicities of the 
interviewees were comparable to the ethnicity distribution of the quantitative sample (see Table 
16); and they were a mixture of retirees, and men who were still working. 
4.3.5.2. Procedures 
Interviews were semi-structured and were approximately 45 minutes in length. They were 
conducted by me and took place in a research office based on the hospital site (participants were 
offered flexibility on the interview location, but all opted to visit the hospital). Interviewees were 
offered refreshments and I made the effort to engage in friendly conversation for some time just 
prior to the interview, with the aim of making interviewees feel more comfortable before the 
interview commenced. The interviews followed a topic guide, which drew upon findings from the 
systematic review (see Section 3.2) and was developed by myself with the guidance of one of my 
academic supervisors (see Appendix 5). The topic guide primarily aimed to gain insight into: 1) the 
interviewee’s PA behaviour prior to their prostate cancer diagnosis; 2) their general attitude toward 
PA; 3) how the diagnosis and treatment had affected their PA behaviour; 4) how they experienced 
the intervention; and 5) what their PA behaviour had consisted of since the intervention. The topic 
guide was deviated from if something arose in conversation that seemed to be worth exploring. 
The patient’s quantitative questionnaire responses were brought into the interview and used to 
prompt discussion. Interviews were audio recorded and transcribed by a transcription service. 
4.3.5.3. Analysis 
Interview transcripts were analysed via inductive thematic analysis with elements of a grounded 
theory approach.[266,268] The analysis aimed to gain insight into the following question: ‘What are 




the presence or absence of these effects?’ The grounded theory-style analysis method followed 
the approach outlined by Charmaz.[266] Hence, coding was initially performed incident-by-incident, 
i.e. all text was coded into discrete one- or two-line segments that each represented a coherent 
concept or ‘incident’[266] (see Appendix 6). After three transcripts had been coded this way, the 
coding strategy moved to focused coding as per the advice of Charmaz.[266] During the focused 
coding phase, categories were developed to make conceptual sense of the data (see Appendix 7). 
Axial codes were then constructed that facilitated the analysis of relationships between concepts 
across these categories.[266] Theoretical codes were then established outlining the overarching 
conceptual relationships relevant to the above research question. Constant comparison was 
applied throughout this process. Memos were written after analysing each interview (see Appendix 
8).  Wider theoretical memos were written periodically throughout the analysis process, which 
occurred concurrently to the coding of interviews, in order to facilitate ongoing analysis throughout 
(see Appendix 9).[266] 
 
4.4. Results 
4.4.1. Quantitative results 
4.4.1.1. Data accrual 
Figure 23 shows the numbers and percentages of men undergoing radical prostatectomy that 
engaged with the intervention and provided data for the analysis. Delivery of the intervention in 
post-treatment seminars at Site A resulted in approximately 65% of all radical prostatectomy 
patients potentially being engaged with the intervention; and approximately 28% of all radical 
prostatectomy patients providing data for this analysis. Delivery of the intervention in pre-treatment 
seminars at Site B resulted in almost all radical prostatectomy patients potentially being engaged 
with the intervention; and approximately 45% of all radical prostatectomy patients providing data 
for this analysis. The ethnicity distribution of the final analysis sample at each site was roughly 





Figure 23 Numbers and percentages of men undergoing radical prostatectomy that were engaged by 
the intervention and provided data for the analysis. 
† ‘All’ in this case refers to all patients who do not have a specific reason that they are unable to attend 





4.4.1.2. Baseline characteristics 
Table 16 shows clinical and demographic characteristics of the final sample (n=148). Experimental 
groups did not differ on any clinical or demographic characteristics. The groups did also not differ 
at baseline for any of the patient-reported outcome measures, except for the ‘pain/discomfort’ 
dimension of the EQ-5D-5L, on which intervention group participants were overrepresented 
amongst those reporting ‘slight problems’ (as opposed to ‘no problems’) (see Table 17). A similar 
(but lesser) distribution pattern was seen for the ‘anxiety/depression’ dimension that was not 
significant (following this observation, both variables were subject to post hoc analyses to avoid 





  Control Intervention Total   
 Mean (SD) 
(n=79) (n=69) (n=148) 
p 
         
Age (yrs) 63.8 (6.8) 63.4 (6.4) 63.6 (6.6) 0.69 
    
 Days elapsed between baseline and T1 101.8 (17.4) 98.4 (17.7) 100.2 (17.6) 0.24 






  Study site 
Site A 36 (45.6) 35 (50.8) 71 (48) 
0.53 
  


















Had lymph node dissection? 
Yes 6 (7.6) 4 (5.8) 10 (6.8) 
0.75 
No 73 (92.4) 65 (94.2) 138 (93.2) 
Had bladder neck reconstruction? 
Yes 17 (21.5) 20 (29) 37 (25) 
0.34 
No 62 (78.5) 49 (71) 111 (75) 
On hormone therapy? 
Yes 2 (2.5) 1 (1.4) 3 (2) 
0.64 
No 77 (97.5) 68 (98.6) 145 (98) 
Hypertension? 
Yes 21 (26.6) 18 (26.1) 39 (26.4) 
0.95 
No 58 (73.4) 51 (73.9) 109 (73.6) 
Other non-hypertension comorbidity? 
Yes 9 (11.4) 9 (13) 18 (12.2) 
0.76 























Working full time 34 (43) 34 (49.3) 68 (45.9) 
0.18 Working part time 12 (15.2) 4 (5.8) 16 (10.8) 
Not working 33 (41.8) 31 (44.9) 64 (43.2) 
Marital status 
Partnered 73 (92.4) 63 (91.3) 136 (91.9) 
0.80 
Not partnered 6 (7.6) 6 (8.7) 12 (8.1) 
Education statusa 
Further education 40 (50.6) 33 (48.5) 73 (49.7) 
0.80 
No further education 39 (49.4) 35 (51.5) 74 (50.3) 
 Ethnicity  
White 66 (83.5) 56 (81.2) 122 (82.4) 
0.43 Black 7 (8.9) 10 (14.5) 17 (11.5) 
 Asian 6 (7.6) 3 (4.3) 9 (6.1) 
 






      Control Intervention Total   
    Mean (SD) 
(n=79) (n=69) (n=148) p 







 Amotivation 0.22 (0.56) 0.26 (0.55) 0.24 (0.55) 0.66 
  External regulation 0.65 (0.79) 0.72 (0.93) 0.68 (0.85) 0.65 
 Introjected regulation 1.88 (1.09) 1.85 (1.11) 1.87 (1.1) 0.84 
  Identified regulation 3.18 (0.86) 3.13 (0.75) 3.16 (0.81) 0.73 
 Integrated regulation 2.45 (1.36) 2.65 (1.25) 2.54 (1.31) 0.36 
  Intrinsic motivation 2.81 (1.04) 2.83 (1.09) 2.82 (1.06) 0.92 
       
 
FACIT-Fatigue 6.3 (7.3) 6.1 (6.8) 6.2 (7) 0.83 
  
EQ-5D-5L Visual Analogue Scale (QoL) 83 (11.4) 80.5 (14.1) 81.8 (12.7) 0.23 
 
Incontinence pads used per day (T1) 1 (1.4) 1.1 (1.2) 1.1 (1.3) 0.54 
  Self-reported MET minutes 3,207 (2,949) 3,251 (3,274) 3,228 (3,095) 0.93 
       
    n (%)         

















(no problems) Level 1 70 (88.6) 59 (85.5) 129 (87.2) 
0.58 
 Level 2 7 (8.9) 8 (11.6) 15 (10.1) 
Mobility Level 3 1 (1.3) 2 (2.9) 3 (2)  
 Level 4 1 (1.3) 0 1 (0.7)  
(extreme problems) Level 5 0 0 0  
  Level 1 79 (100) 69 (100) 148 (100) 
- 
  Level 2 0 0 0 
Self-care Level 3 0 0 0 
  Level 4 0 0 0 
  Level 5 0 0 0 
 Level 1 68 (86.1) 59 (85.5) 127 (85.8) 
0.78 
 Level 2 9 (11.4) 9 (13) 18 (12.2) 
Usual activities Level 3 2 (2.5) 1 (1.4) 3 (2)  
 Level 4 0 0 0  
 Level 5 0 0 0  
  Level 1 57 (72.2) 40 (58.0) 97 (65.5) 
0.05* 
  Level 2 17 (21.5) 25 (36.2) 42 (28.4) 
Pain/discomfort Level 3 3 (3.8) 4 (5.8) 7 (4.7)   
  Level 4 2 (2.5) 0 2 (1.4)   
  Level 5 0 0 0   
 Level 1 55 (69.6) 42 (60.9) 97 (65.5) 
0.40 
 Level 2 19 (24.1) 20 (29) 39 (26.4) 
Anxiety/depression Level 3 5 (6.3) 7 (10.1) 12 (8.1)  
 Level 4 0 0 0  
 Level 5 0 0 0  
              
 





4.4.1.3. Primary outcomes 
4.4.1.3.1. Self-reported physical activity 
Results for all continuous outcomes are shown in Table 18. There was no significant difference in 
changes in self-reported PA between the two groups. 
4.4.1.3.2. Referrals to physical activity pathway 
There were no significant differences between the groups in referrals to the physical activity 
pathway. Of 168 patients in total who attended the post-treatment seminar at Site A, there were 8 
intervention patients and 6 control patients who engaged with the PA pathway in the following 180 
days. At Site B, amongst patients who provided data for the study, 1 intervention patient and 2 
control patients engaged with the exercise physiotherapists at the hospital. 
4.4.1.4. Secondary outcomes 
4.4.1.4.1. Quality of life 
Results for the five quality of life dimensions of the EQ-5D-5L are shown in Table 19. χ2 tests 
showed that men exposed to the intervention were significantly more likely to improve, and less 
likely to deteriorate, between baseline and T1 on the dimensions of ‘usual activities’, 
‘pain/discomfort’, and ‘anxiety/depression’. A similar distribution was observed for the dimension 
of ‘mobility’, that was not significant. Additional χ2 tests showed that these changes were not 
associated with ‘Study Site’ on any of the five dimensions. 
In further χ2 tests performed on the dimensions of ‘pain/discomfort’ and ‘anxiety/depression’, 
including only men who had indicated ‘slight problems’ at baseline, the observed relationships 
were maintained (pain/discomfort: χ2=9.5, p<0.01; anxiety/depression: χ2=8.1, p<0.02). 
Scores on the VAS showed a beneficial effect of the intervention (see Table 18). Post hoc analysis 
showed that men in the intervention group were significantly less likely to cross the 10-point 
threshold for clinically significant deterioration on the VAS than control participants (χ2=4.2, 




  Baseline T1 Change T0 - T1 Interaction 
 M (SD) M (SD) M (SD) (Group*Time) 
  Control Intervention Control Intervention Control Intervention p 
Self-reported MET minutes† 3,207 (2,949) 3,251 (3,274) 3,915 (4,120) 3,505 (4,120) +708 (3,813) +254 (3,127) 0.38 
BREQ-3: Amotivation† 0.22 (0.56) 0.26 (0.55) 0.16 (0.47) 0.2 (0.44) -0.06 (0.57) -0.06 (0.5) 0.88 
BREQ-3: External regulation† 0.65 (0.79) 0.72 (0.93) 0.51 (0.82) 0.58 (0.87) -0.14 (0.69) -0.14 (0.69) 0.95 
BREQ-3: Introjected regulation† 1.88 (1.09) 1.85 (1.11) 1.68 (1.17) 1.67 (1.18) -0.20 (0.89) -0.18 (1.21) 0.86 
BREQ-3: Identified regulation† 3.18 (0.86) 3.13 (0.75) 3.07 (0.87) 3.0 (0.84) -0.11 (0.66) -0.13 (0.61) 0.81 
BREQ-3: Integrated regulation† 2.45 (1.36) 2.65 (1.25) 2.41 (1.37) 2.38 (1.33) -0.04 (0.75) -0.27 (0.99) 0.12 
BREQ-3: Intrinsic motivation† 2.81 (1.04) 2.83 (1.09) 2.63 (1.08) 2.65 (1.14) -0.18 (0.74) -0.18 (0.87) 0.92 
        
ED-5D-5L Visual Analogue Scale† 83 (11.4) 80.5 (14.1) 81.7 (17.5) 84.5 (11.4) -1.3 (16.4) +4 (12.4) 0.04* 
FACIT-fatigue‡ 6.3 (7.3) 6.1 (6.8) 9.7 (8.8) 6.7 (7.0) +3.4 (6.6) +0.6 (5.2) 0.01** 
                
 
Table 18 Unadjusted means and p-values from ANCOVA tests of continuous outcome variables. df (1, 145); MET, metabolic task equivalent; PA, physical 
activity. 
† Covariates: Study Site. 






  Improved Stayed the same Deteriorated χ2 p 
EQ-5D-5L dimensions      
 Mobility 
     
 Control 4 (5.1) 69 (87.3) 6 (7.6) 3.46 0.18 
 
Intervention 8 (11.6) 59 (85.5) 2 (2.9) 
 Self-care           
  Control 0 79 (100) 0 
2.32 0.13 
  
Intervention 0 67 (97.1) 2 (2.9) 
 Usual activities      
 Control 3 (3.8) 56 (70.9) 20 (25.3) 7.93 0.02* 
 
Intervention 8 (11.6) 54 (78.3) 7 (10.1) 
 Pain/discomfort           
  Control 10 (12.7) 54 (68.4) 15 (19.0) 
7.95 0.02* 
  
Intervention 21 (30.4) 41 (59.4) 7 (10.1) 
 Anxiety/depression      
 Control 6 (7.6) 59 (74.7) 14 (17.7) 6.68 0.04* 
  
Intervention 14 (20.3) 49 (71.0) 6 (8.7) 
 
Table 19 Frequency distributions of changes in quality of life dimensions between baseline and T1 






Figure 25 Histogram showing the numbers of men reporting an improvement or deterioration on the 
EQ-5D-5L Visual Analogue Scale (VAS) between baseline and T1 that was clinically significant, stratified 
by experimental group. 
Figure 24 Histogram showing the numbers of men reporting an improvement or deterioration on the 






Scores on the FACIT-fatigue scale showed a beneficial effect of the intervention (see Table 18). 
Post hoc analysis showed that men in the intervention group appeared to be less likely to cross 
the 4-point threshold for clinically significant deterioration on the FACIT-fatigue than control 
participants (see Figure 25); however, this difference did not meet the 0.05 threshold for statistical 
significance (χ2=3.5, p=0.06). 
4.4.2. Qualitative results 
The key insights that emerged from the analysis can be divided into four themes. Two themes, 1) 
reassurance from the future from someone with experience’ and 2) a sense of social solidarity, are 
not immediately related to physical activity. The two other themes, 3) positive disposition amongst 





1) Reassurance about the future from someone with experience 
This theme describes how many participants appreciated hearing from someone who had already 
been through the experience that they were currently struggling with. Some participants spoke of 
a sense of dread that had descended on them upon being diagnosed with prostate cancer, that 
seemed to make it difficult for them to visualise their situation improving. 
“I’m one of those people who … I can’t see myself dying. [The diagnosis] changes 
everything, you start planning your own funeral, it’s such a shock.” (Participant 3) 
“While you’re in it … you don’t think you’re ever going to get through it.” (Participant 7) 
However, many participants noted that the intervention helped to alleviate this somewhat:  
“You know, you heard someone who’s been through it speak to you and give you 
assurance. You’ve got to take it on board. So, that was very good, yes.” (Participant 6) 
Some participants framed this as attaining some degree of vision of hope for the future. 
“He persuaded me that there is hope, there is a future, you can make it.” (Participant 1) 
Some participants used similar metaphors to illustrate this: 
“I knew there was light at the end of the tunnel because I could see it increase [during the 
talk].” (Participant 1) 
“Yes, it did affect me, in the sense that it made me… How can I say? It gave me a light at 
the end of the tunnel.” (Participant 2) 
Participants seemed to link this reassurance to the fact that the speaker was a credible source, as 
someone who had been through the experience… 
“It was quite nice when they have someone rather than just a nurse, a clinician or someone 
like that, to have a real-life story. Then you come away thinking, ‘I’m going to get through 
this.’” (Participant 7) 




“But that was the most important thing he told us, because he told us what he experienced 
and he passed it on to us. So, I was saying to the guy next to me, I said, ‘He was the most 
important man here’” (Participant 6) 
…and some noted that this experience was accompanied by positive affect: 
“Fundamentally he was emphasising on the importance of being positive about your 
treatment … it was his sense of positivity that I got out of that, which was nice.” (Participant 
4) 
“You hear someone speak like that, and it was a genuine talk, then that’s it, you know, 
you really remove, mentally– any negatives you were thinking, it removed it from your 
mind.” (Participant 6) 
 
2) A sense of social solidarity 
Many participants suggested that a sense of relatability and solidarity between patients who have 
been through the same experience was a valuable resource to integrate into the patient pathway, 
and that clinical staff are not necessarily able to provide this type of support. 
“Forgive me, I mean, most of [the cancer nurses] are, as you said earlier, are female. They 
don’t understand. Well, they do understand, but they’ve not been through it.” (Participant 
12) 
“Your voluntary workers who work in the clinics … that’s what got me through. I think if it 
wasn’t for these guys, I might’ve been on edge thinking, like, ‘What have I done?’” 
(Participant 10) 
It was important to some participants to be provided with a sense that they weren’t alone, or to 
have feelings of anxiety alleviated. 




“I don’t know… what is it? Reassuring I suppose that other people have been through the 
same thing and, well, they’re still alive … [Interviewer: Do you think it alleviates anxiety?] 
Yes, yes.” (Participant 11) 
Interestingly, one participant said that he didn’t necessarily believe clinical advice from his 
consultant, but that he did believe advice from the patient speaker: 
“You don’t necessarily believe what the doctors and clinicians are saying … Then when 
you see the chap who’s giving you the real-life story you think, ‘Actually, this is something 
that’s coming from his mouth that he’s experienced.’” (Participant 7) 
Illustrating how important this interaction was to some interviewees, it was suggested by one 
participant that exposure to people who had been through the same experience could be beneficial 
to post-op patients: 
“I suppose, in a way, I was a little bit… I wouldn’t say scared, but nervous about the whole 
thing, and I would have liked probably to have had somebody when I was in the hospital 
or shortly after that, somebody who I could’ve spoken to, to sort of say, ‘This is what the 
issues are, this is what I’m going through at the moment.’ [Interviewer: Could I just clarify, 
that’s post-op?] Post-op, yes …  I think post-op support on an element like that would 
perhaps be useful.” (Participant 12) 
 
3) Positive disposition amongst impressionable individuals 
In an apparent validation of intervention efficacy, some of the interviewees drew a direct causal 
link between being exposed to the intervention and subsequently increasing their PA behaviour: 
“I made my decision from that moment to improve.” (Participant 1) 
“I just went, ‘I’m doing the gym now.’ Because I don’t forget what [patient speaker] told us. 
Exercise got him through it.” (Participant 2) 
“I didn’t know that [exercise] was so important, I didn’t know at all, and I must sincerely 




“That’s why I booked up for the exercising because of what he said … I did the exercising 
for the reason of this man, you know, convincing me I’ve got to do it.” (Participant 10) 
This was not the case for others, though. Some participants seemed indifferent to the intervention 
or felt that the physical activity dimension of it was irrelevant to them. 
“[Interviewer: Do you think seeing that talk affected your behaviour personally in any way?] 
No, not really. I was with him all the way. I understood exactly what he was saying, so I 
didn’t really… Maybe some of the guys took it in and thought, ‘Perhaps I ought to do 
something.’ I already knew.” (Participant 3) 
There were some consistent characteristics of those who reported that the intervention had 
changed their behaviour. First, a relatively modest history of PA: they weren’t highly active but 
weren’t inactive either. Second, possession of a positive disposition: 
“Every day’s a bonus, you know, and this operation has given me a bonus. As I said, life 
is sweet.” (Participant 10) 
“I’m very positive about everything.” (Participant 6) 
“Health doesn't seem to be a barrier to me. It's all down to the right mental attitude and 
the right physical attitude and everything.” (Participant 1) 
One participant drew a link between positivity and persuasion: 
“[Interviewer: What was it about that talk that made you think, ‘I need to sign up for 
exercise’?] Surviving, and he [patient speaker] understands life is sweet without saying 
it.” (Participant 10) 
  
4) Social comparison and attitude renewal 
This theme describes a process that was articulated in conversation with those patients who 
reported behavioural change as a result of the intervention. It can be described as a three-step 




empathic connection with him; resulting in 2) a revelatory moment; leading to 3) a renewed resolve 
to exercise. 
Step 1) The personal story told by the patient speaker created a space in which the recipients 
experienced empathy stemming from their own personal experience. 
“I could relate to him … You can put yourself in his shoes, because you feel exactly the 
same as he felt. Like I said, the physio was good, it was technical but with [patient 
speaker], I could be [him] at that moment because I could feel the same thing he felt.” 
(Participant 1) 
“Here was a chap who had been in it and had come through. Not tearful as such, but quite 
poignant to hear his story.” (Participant 7)  
Some participants described a social comparison process accompanying this empathic 
connection. 
“You reflect on your own behaviour. It makes you think. You look at it, ‘Well I could do 
more. It's for my own good.’ You realise that, ‘Well I could do better than I'm doing.’” 
(Participant 1) 
“It might sound a bit bad, but, oh, if he can do it, I can do it … that’s the way I was thinking” 
(Participant 6) 
Step 2) These participants described this process as a revelatory moment. 
“It was an eye opener to me, and I just went, ‘I'm doing the gym now.’” (Participant 2) 
“It was a lightbulb moment.” (Participant 10) 
Step 3) This process seemed to result in a renewed resolve to engage in PA. 
“It affected me. The fact that I realised that if I want to be here I've got to be a little bit 
more proactive in my health and strength.” (Participant 2) 




One of the participants implied that the intervention may have affected him on some level of which 
he was not consciously aware: 
“Yes, it did [change my attitude toward PA]. It did work. Subconsciously, it worked.” 
(Participant 10) 
4.5. Discussion and conclusions 
Aggregated results from this mixed methods pilot study indicate that the addition of a single 10-
minute presentation about PA, delivered by a previous prostate cancer patient in the style of a 
personal story alongside a talk by a cancer exercise specialist, can result in benefits to quality of 
life, fatigue, and psychological wellbeing, in men who have undergone a radical prostatectomy. 
Qualitative data indicate that the intervention can modify PA attitudes and behaviour in some 
individuals. In these individuals, the influence of the intervention can be provisionally characterised 
by social comparison processes,[277,278] facilitated by an affective response to the intervention, 
leading to a revelatory moment and renewed resolve to be physically active. In terms of the 
hypotheses put forward in Section 4.2.2, the study did not provide quantitative evidence that the 
intervention had an effect on self-reported PA, the likelihood of referral to a PA pathway, or exercise 
behavioural regulations. Hence, null hypotheses H1, H2, and H3 are not rejected. The study 
provided some evidence that the intervention had an effect on quality of life and fatigue. Hence, 
null hypotheses H4 and H5 can be rejected. 
As noted in the introduction to this chapter, research on peer-support based PA interventions for 
people with cancer is relatively scarce and the results of these studies are mixed.[163,256] As 
described above, Pinto et al.’s PA intervention study of people with breast cancer showed 
promising results,[256] whilst the results of Galvão et al.’s study on prostate cancer patients were 
much more limited, showing no effect on aerobic exercise.[163] The present study found that the 
intervention did not significantly affect PA measures at follow up, in contrast to the findings of Pinto 





First, the clearest difference compared with the above studies were the intervention content and 
delivery (summarised in the introduction to this chapter). The most prominent difference in this 
regard was the brevity of this intervention when compared with the intervention delivery models of 
the above two studies, which involved repeated contacts with the patients over a time period. The 
present intervention also did not include any self-management planning with regards to PA. 
Therefore, it is possible that the behavioural impact of the present intervention could have been 
attenuated by the minimally disruptive approach. 
Second, the present study, whilst limited in scope, attained a relatively broad sample within the 
locality. The sample represented approximately 35% of the entire cohort of radical prostatectomy 
patients at the NHS trusts where the study was conducted (see Figure 23). Similarly, in the study 
by Galvão et al., in which the intervention had very limited effectiveness, 1,501 potential participants 
were approached and 463 of these were included in the final analysis, or approximately 31% of 
those approached.[163] In contrast, the study by Pinto et al., in which the intervention was broadly 
effective, reported that 595 participants were approached and 76 of these were included in the final 
analysis, or approximately 11% of those approached.[256] It is conceivable that improved external 
validity might attenuate outcomes related to PA behaviour change. Prior qualitative research has 
indicated that individuals participating in clinical research often do so for altruistic reasons, or 
because they hope to obtain some personal clinical benefit from their participation.[279,280] Motives 
such as these could be associated with personality type, or illness perception. Taken together, the 
data from the present study, and from the two PA intervention studies cited above, do not rule out 
the possibility that overall study recruitment rate could be inversely associated with PA intervention 
outcomes in people with cancer. The report of my systematic review briefly examined this idea (see 
Section 3.2.4). Whether such an association exists and, if it does, what confounders are involved, 
is a pertinent question if PA support in standard cancer care is to be optimised. 
Both the quantitative and qualitative findings from this pilot study indicated that this intervention 
was beneficial to patients’ psychological wellbeing. Prior research into (non-PA) hospital-based 
peer-support interventions for people with cancer, integrated into standard care, have reported 




cancer, like the intervention reported here.[258,259] Ozier and Cashman qualitatively investigated 
experiences of a single one-to-one meeting between newly diagnosed brain tumour patients and a 
former brain tumour patient.[259] The resulting themes from their study, derived from interviews with 
the newly diagnosed patients, described the intervention as providing a sense of hope and 
alleviation of loneliness. Participants reported that they appreciated that the advice they received 
had come from someone they saw as a uniquely authoritative source. Ozier and Cashman’s 
themes are thus broadly consistent with the themes reported in the present study. The other study, 
conducted by Borregaard and Ludvigsen, qualitatively investigated experiences of an intervention 
in which hospitalised lung cancer patients were given the opportunity to speak with a former lung 
cancer patient.[258] They reported that “seeing someone who had recovered had a major, positive 
impact [on current patients]”[p.334], an observation that is also largely consistent with the findings of 
the present study. Thus, the study reported here provides further corroborating evidence that 
integrated peer-support interventions for patients on a cancer care pathway, delivered by a former 
patient, can have significant psychological benefits for patients. 
The notion that peer-support more generally is psychologically beneficial to cancer patients is 
relatively established and is not a new insight.[282,283] However, a strength of the delivery mode of 
this intervention was that I was able to systematically engage the vast majority of patients receiving 
radical prostatectomy (see Figure 23). The findings of the present study, along with the above two 
studies by Ozier and Cashman,[259] and Borregaard and Ludvigsen,[258] indicate that the benefits of 
peer-support for cancer patients do not necessarily need to come through external or formalised 
peer support groups; but can be delivered – to a degree – via integration into the regular care 
pathway, resulting in higher numbers of patients being engaged. Given that engagement with peer 
support amongst cancer patients is generally low,[284] this is a useful insight. The prostate cancer 
population could particularly benefit from this type of approach, as research has shown that men 
tend to be less likely to engage with cancer support groups than women.[285] 
As noted in the qualitative findings, some participants in the present study valued the ability of the 
patient speaker to provide useful information ‘from the future’. One participant described how, on 




than he did his consultant. These findings are consistent with existing research showing that some 
cancer patients perceive other patients to be a valuable source of actionable information.[286] A 
study by Hartzler and Pratt, in which online discussion boards dedicated to cancer were subject to 
a content analysis, concluded that patients and clinicians both offer expertise on the subject of 
cancer, but that this expertise differs qualitatively between these two sources.[287] These 
investigators reported that patient expertise was narrative in style, produced through day-to-day 
lived experiences, and related to personal contexts such as family life. On the other hand, clinician 
expertise was prescriptive in nature, focusing on information tied to healthcare delivery and 
biomedical research.[287] The provision of extra information offered by former patients may in some 
cases lead to better patient-reported outcomes. For instance, a study by Larson et al., examining 
patients with acute myocardial infarction, observed a positive association between the extent to 
which patients felt that their information needs were met, and self-reported quality of life.[288] 
Alongside these studies, the present study – which also observed benefits to quality of life 
outcomes – indicates that peer-support based interventions, even when very brief, could address 
unmet information needs of patients. Hence, the benefits to perceived quality of life seen in the 
present study may be attributable to certain information needs of patients being met by the patient 
speaker. 
Psychological theories can also provide some insight into the findings reported here. Insights from 
the social comparison literature seem particularly relevant to these findings. Social comparison 
processes have been investigated in health psychology as a means of understanding how 
individuals construct perspectives on health risks; and how they cope with threats caused by illness 
or injury.[277] According to social comparison theory, individuals self-regulate by comparing 
themselves to others on dimensions that are salient to them.[277] PA behaviour is an example of a 
potential comparison dimension. In a psychologically stressful situation (e.g. cancer diagnosis and 
treatment) the nature of these social comparisons is thought to be linked with the likelihood of an 
individual taking action to improve their situation (known as ‘problem-focused coping’).[278,289] 





In the social comparison literature, ‘upward comparison’ is thought to take place when individuals 
compare themselves against a target, that is perceived to be of a higher standing on a given 
dimension (for example, this could be health status).[278] There is evidence that the occurrence of 
upward comparison can promote future healthy behaviour.[290] Social comparison research 
suggests that people in stressful health situations tend to prefer upward comparison to downward 
comparison; and that this often takes the form of affiliation with similar others, who offer a useful 
cognitive prototype for how the comparer should frame their own attitudes toward their 
situation.[278,291] Social comparison thus provides a potential partial explanation for why this 
intervention was beneficial to patients’ psychological wellbeing: patients may have seen the patient 
speaker as both similar to them, and as demonstrating a healthy attitude to the situation that could 
confer a benefit, should they decide to adopt a similar attitude. Research examining such upward 
comparisons in breast cancer patients has shown that these comparisons are associated with lower 
depression scores.[292] 
A social comparison perspective is also useful in interpreting the present findings in terms of PA 
outcomes. Research in the field of social comparison has suggested that dispositional pessimism 
may be a factor in an individual’s perceived control over their health, correlating with a lesser 
tendency to engage with problem-focused coping.[293] In the present study, interviewees who 
reported changing their behaviour all appeared to possess a positive attitude towards their health 
in general, which would be consistent with this proposition. 
There were several strengths to the pilot study. The pragmatic trial approach and focus on service 
improvement meant that the intervention was able to be delivered in the clinic as part of the 
standard care pathway, giving the findings a strong degree of ecological validity. As noted above, 
the rate of data accrual was also relatively high, with around one-third of all radical prostatectomy 
patients opting to provide data for both timepoints of the study. Importantly, a cursory examination 
showed the study sample to be broadly ethnically representative of the catchment areas of the 
hospitals studied. This is particularly of concern in prostate cancer research, as Black men are 
commonly underrepresented in prostate cancer research,[294] despite being roughly twice as likely 




was the mixed methods design, which allowed for nuanced conclusions to be drawn about the 
effect of the intervention, thereby lowering the likelihood of Type I and Type II errors. The choice 
of one-to-one interviews as a qualitative method could perhaps also be regarded as a strength: 
the private conversation setting created space for interviewees to be open about their cognitive 
representations of the intervention, which provided insights that may not have been provided other 
settings, i.e. a focus group. Limitations of this study included the limited follow up time for the 
quantitative measures; and practical constraints on the qualitative sample which meant that I was 
not able to interview any previously sedentary individuals. 
In summary, this is the first study to demonstrate that a brief peer-support intervention for cancer 
patients, delivered once to many patients simultaneously and lasting just 10 minutes per contact, 
can have observable benefits to fatigue and quality of life that are clinically meaningful (when 
provided alongside cancer exercise specialist advice). Furthermore, this study provides limited 
evidence that, in terms of promotion of PA behaviour, some individuals may be responsive to a 
persuasive case for PA made by a former patient. 
4.5.1. Conclusions 
In conclusion, the addition to standard care of a brief one-off PA presentation, delivered by a former 
prostate cancer patient alongside advice from a cancer exercise specialist, can result in clinically 
significant benefits to fatigue and quality of life in men undergoing radical prostatectomy for prostate 
cancer. The intervention did not affect quantified self-reported PA at 100 days follow up. Qualitative 
data provided limited evidence that the intervention did influence the PA behaviour of some men 
with prostate cancer; but the likelihood of this effect may vary substantially at the individual level. 
Finally, results from this study indicate that the intervention did not affect behavioural regulations 





4.6. Chapter summary 
This chapter reported on the methods and results of a pilot study, designed to assess whether the 
intervention could affect PA in men undergoing curative treatment for prostate cancer. The pilot 
study took a mixed methods approach, in order to gather information on both variable-level findings 
and individual-level findings; and reduce the likelihood of Type II error. The intervention consisted 
of a single 10-minute PA presentation by a former patient, delivered alongside a 20-minute PA 
presentation by a cancer exercise specialist. 
The quantitative aspect of the study took the form of a pragmatic trial, to maximise the relevance 
of the findings to real-life clinical practice. The pragmatic trial compared the effects of two different 
types of educational seminar: one containing the intervention; and one not containing the 
intervention (i.e. cancer exercise specialist presentation only). The quantitative data was collected 
from two study sites, one of which applied the intervention pre-treatment; and one of which applied 
the intervention post-treatment. The qualitative aspect of the study used one-to-one interviews with 
men who had attended an intervention seminar, to gain insight into how these men had experienced 
the intervention and whether it had affected their behaviour. 
Aggregated results from the quantitative and qualitative findings showed that the intervention can 
be beneficial to quality of life and psychological wellbeing in men receiving radical prostatectomy 
for prostate cancer. The findings suggested that the intervention can promote PA in some men; but 





Chapter 5: Overall discussion, conclusions and 
future directions 
The following, concluding chapter consists of a summary of the overall conclusions of the thesis 
and its implications for clinical practice. There will also be a short discussion of potential future 
work to be taken forward in this area. 
5.1. Summary of previous chapters 
My thesis aimed to design and pilot an intervention, that could be used as part of standard clinical 
practice, to promote PA amongst men with prostate cancer. The design methodology followed 
existing guidelines pertaining to the ‘development’ phase of the Medical Research Council’s 
framework for the development and evaluation of complex interventions.[145] A preliminary analysis 
of local clinical data suggested that although the existing PA pathway may be somewhat effective 
at changing behaviour, systemic sociodemographic factors were affecting patients’ likelihood of 
PA pathway participation. Acknowledging this, Michie, van Stralen, and West’s Behaviour Change 
Wheel (BCW) framework[221] was followed to design the intervention, in collaboration with key 
clinical stakeholders. The process integrated key findings from a systematic review of barriers and 
facilitators to PA in men with prostate cancer, and other empirical evidence that was relevant to 
the specific context under study. 
One conclusion of the BCW process was that existing educational seminars could be used to 
deliver a brief behavioural intervention, using the principle that someone who is/has been in a 
similar health situation to current patients may be able to provide a source of PA motivation. Based 
on theories of behaviour and other literature, it was thought that the use of narrative storytelling 
could trigger cognitive mechanisms conducive to PA behaviour in men who are attending 
educational seminars as part of their standard prostate cancer care.  
A mixed methods pilot study of this intervention was conducted, which examined 38 educational 
seminars that either did or did not contain the intervention. Quantitative data on 148 patients and 
qualitative data on 14 patients were collected. All patients were undergoing, or had undergone, 




intervention, suggested that the intervention was statistically and clinically beneficial to quality of 
life and fatigue. Corroborating quantitative and qualitative data showed that the intervention was 
beneficial to psychological wellbeing – a finding that is consistent with prior studies of comparable 
interventions.[258,259] The quantitative findings of this pilot study showed no effect of the intervention 
on self-reported PA. However, some patients qualitatively reported that the intervention did cause 
an increase in their PA behaviour. Furthermore, the qualitative data indicated that inter-individual 
variability in personality could potentially be associated with behavioural responsiveness to the 
intervention. It was concluded that a brief peer-support intervention, integrated into the care 
pathway and delivered to many patients simultaneously, can have clinically beneficial effects on 
quality of life and fatigue in men undergoing radical prostatectomy for prostate cancer. A discussion 
of the findings of this pilot study, alongside existing research of peer-support interventions to 
promote PA in cancer patients,[163,256] considered the possibility that with regards to behaviour 
change, recruitment rate could be inversely associated with effect size in studies of this type. 
5.2. Overall discussion 
5.2.1. Interpretation of findings 
The findings reported in this thesis have some implications for the wider field of exercise 
intervention development in prostate cancer, and perhaps cancer more generally. Local analysis 
1 yielded the observation that men undergoing different types of treatment for their prostate cancer 
differed in their responsiveness to a structured exercise intervention, in terms of changes to self-
reported PA. Weller et al.[158], who studied a PA pathway very similar to the one studied here, have 
reported findings that were consistent with mine, in the sense that they found responsiveness to 
intervention to differ by treatment type. However, the wider literature on adherence to exercise 
interventions, including others cancers such as breast, has reported inconsistent findings on this 
point.[155,295–300] The findings of Weller and colleagues were also in another sense divergent to 
mine, in that they found that individuals undergoing surgery were more likely than others to 
increase PA; whereas my analysis indicated that those undergoing surgery may be less likely to 




findings alongside mine could perhaps indicate that it is not necessarily treatment type per se that 
affects responsiveness to an exercise intervention, but confounders associated with treatment 
type. Such an interpretation would be somewhat consistent with the other studies referenced 
above, which have often found psychosocial factors to be implicated more reliably in adherence 
than clinical factors.[155,295–300] Efforts to understand why men on different treatments may respond 
differentially to exercise interventions would perhaps benefit from the application of qualitative 
methods, which could unpick causal factors. 
Notwithstanding the above, the findings from Local Analysis 1 and those of Weller et al. highlight 
that effect of treatment type should be considered when designing exercise intervention studies 
for men with prostate cancer. Around half of the exercise intervention studies reported in my 
systematic review used samples containing a mixture of treatment types; yet it appears likely that 
treatment type could modify the effect of exercise interventions on PA outcomes. Hence, exercise 
intervention triallists may wish to consider the effect that this type of sample heterogeneity could 
have on trial results. 
The observation that patients undergoing different treatment types may respond differentially to 
supervised exercise may also have implications for health policy. The provision of such structured 
support, whilst relatively inexpensive in terms of monetary cost, requires the use of adequate 
facilities – which may not be readily available or may have limited capacity – and requires a 
substantial amount of contact time from specialist exercise physiotherapists. Constraints on 
available resources in some healthcare centres may mean that exercise services are best targeted 
at those patient groups who are likely to benefit more. Such decisions would ideally consider both 
clinical benefits of exercise for that patient group (as reflected in NICE guidelines, which 
recommend providing supervised exercise for men on ADT[301]), and the relative likelihood of 
behaviour change. However, further data is needed to inform the latter. 
Local Analysis 2 found that patients treated at Guy’s Hospital were less likely to participate in the 
hospital-based supervised exercise classes if they were older, of a lower socioeconomic status, or 
lived further from the hospital. The analysis also showed that there was a large disparity between 




demonstrates that many exercise intervention studies in individuals with prostate cancer are likely 
to be examining individuals that are the product of selection biases. Factors contributing to such 
selection biases might vary by healthcare centre and by country, which could provide a partial 
explanation why studies of adherence to structured exercise programmes have produced some 
inconsistent findings (for example with regards to the effect of treatment type, as noted above). In 
other words, caution should be exercised in any interpretation, or extrapolation, of behavioural 
outcomes from such studies. It should be noted that where studies show more consistency is in 
their identification of psychosocial antecedents to exercise adherence, as noted above[155,295–300]; 
hence, it is possible that this type of data could serve as a superior indicator of patients’ likelihood 
of behavioural response to an exercise intervention. 
The findings of the pilot study showed that brief peer-delivered interventions, based on narrative 
storytelling, have the potential to have persistent beneficial effects on a minority of patients. In the 
pilot study, these benefits came in the form of improved patient reported quality of life outcomes. 
Specifically, patients exposed to the intervention experienced benefits to the EQ-5D-5L measures 
of ‘usual activities’, ‘pain/discomfort’, and ‘anxiety/depression’, with approximately twice as many 
participants improving – and approximately half as many deteriorating – on these measures, 
compared with the control group. The intervention did not improve PA behaviour at the sample 
level. The wider significance of this finding is not immediately clear, as there are some competing 
interpretations for these findings. 
Before I use three competing interpretations to discuss these findings, it should be noted that it is 
well-established that the experiences of depression/anxiety and physical pain are known to be 
inextricable from one another in both cancer patients[302–306] and the general population.[307,308] This 
has implications for all three interpretations that I present here. 





The intervention had beneficial effects on psychological wellbeing; these benefits promoted 
motivational effects on the performance of usual activities and/or contributed to reductions in 
subjective experiences of pain, or discomfort. 
 
Interpretation one is supported by existing scientific knowledge, and the concurrent qualitative 
finding that many individuals found the intervention to be psychologically beneficial to them. It is 
also consistent with the quantitative finding that the intervention had a protective effect against the 
onset of fatigue, which is associated with depression in cancer patients.[309] 
Data supporting interpretation one comes from three sources: 1) qualitative data from my own 
study suggesting that the intervention was psychologically beneficial to these participants, and 
contributed to satisfaction of certain unmet information needs; 2) existing research showing that 
many men with prostate cancer have information needs relating to uncertainty about the future; 
and 3) the literature surrounding psychological resilience in cancer. 
The first source is my own qualitative data. One of the qualitative themes in my study was that the 
intervention was psychologically beneficial, due to the sense of hope and solidarity that it instilled 
in patients (see Section 4.4.2), which is consistent with existing research findings that narrative-
style peer support intervention during hospital visits can have strongly beneficial psychological 
effects on patients.[258,259] In the qualitative component of my study, patient’s perceived gains to 
their psychological wellbeing appeared to partly stem from satisfaction of information needs 
relating to their prostate cancer. To re-quote three of the interview participants: 
“But that was the most important thing he told us, because he told us what he experienced 
and he passed it on to us. So, I was saying to the guy next to me, I said, ‘He was the most 
important man here’” (Participant 6) 
“You don’t necessarily believe what the doctors and clinicians are saying … Then when 
you see the chap who’s giving you the real-life story you think, ‘Actually, this is something 




“I suppose, in a way, I was a little bit… I wouldn’t say scared, but nervous about the whole 
[surgery] thing, and I would have liked probably to have had somebody when I was in the 
hospital or shortly after that, somebody who I could’ve spoken to, to sort of say, ‘This is 
what the issues are, this is what I’m going through at the moment.’ [Interviewer: Could I 
just clarify, that’s post-op?] Post-op, yes …  I think post-op support on an element like that 
would perhaps be useful.” (Participant 12) 
The second source is data showing that many men with prostate cancer report unmet needs 
relating to uncertainty about their future. For example, a cross-sectional study of 316 men with 
prostate cancer in the UK by Watson et al. found that 32% of respondents reported unmet needs 
relating to ‘uncertainty about the future’.[209] Further research by Parker et al., studying 180 men 
on active surveillance for low-risk prostate cancer over 30 months, has reported illness uncertainty 
to be predictive of both general and prostate cancer-specific quality of life.[310]  
The third source concerns the literature around psychological resilience in cancer treatment and 
survivorship. Individual resilience has been shown to be associated with better quality of life 
outcomes in cancer.[311] I would suggest that the concept of resilience mechanisms may be useful 
in interpreting of the results of my intervention study. In their 2014 review of resilience across the 
cancer continuum, Molina et al. concluded that “positive outcomes may be enhanced by 
recognising and promoting [resilience] characteristics at any stage of the continuum … resilience 
mechanisms could be targeted for future interventions to foster resilience; for example, 
interventions may seek to increase social support during diagnosis and treatment to improve well-
being”.[311][p.7] It is possible that in my study, a mechanism of increased psychological resilience 
was a pathway via which the intervention experience translated into benefits to tangible quality of 
life outcomes, such as pain and ability to perform usual activities. 
5.2.1.2. Interpretation two 
 
The intervention may have had the desired effect of increasing patients’ physical activity levels – 




activities; however, the methods used lacked adequate sensitivity to detect increases in physical 
activity itself. 
 
Interpretation two is consistent with existing knowledge of the effects of PA on fatigue[10] and 
depression/anxiety.[81–83] It also acknowledges the limitations of the PA measure used, which 
produced an unexpectedly large degree of variance across responses and could therefore have 
been inappropriate for the sample size. However, this interpretation relies on an assumption (that 
PA increases went undetected) for which empirical evidence is lacking. It also does not account 
for the observed effects of the intervention on self-reported problems with pain/discomfort, for 
which evidence that PA is beneficial is limited and inconsistent.[312] 
I have contributed interpretation two to this discussion because there were indications from the 
qualitative interviews that the intervention had a positive effect on PA behaviour in some individuals 
(see Section 4.4.2). Out of fourteen individuals interviewed, three explicitly reported a causal link 
between experiencing the intervention, and subsequently increasing PA. However, given i) the 
absence of corroborating quantitative data from the same cohort; and ii) that the qualitative 
analysis showed this not to be a consistent theme (i.e. it was rebutted by other participants), there 
lacks a robust empirical basis to this interpretation. 
Despite this, it is worth highlighting two points relating to interpretation two. The first point is that 
data from the quantitative measure of PA used in the study yielded remarkably high variance, 
shown by the large standard deviations in the dataset (see Table 18; Section 4.4.1). The high 
variance across the sample highlights the possibility that the measure could have lacked the 
sensitivity required to detect sample-level changes in PA in a sample comprising 148 participants. 
The second point is that it is possible that this style of intervention is only effective at increasing 
PA for a small minority of individuals that fit a certain personality profile. The qualitative analysis 
did offer evidence in support for this idea, indicating that those individuals who reported that the 
intervention was efficacious all appeared to display optimistic personality traits. Another idea worth 
considering (and perhaps worth exploring with further work) is that seminar attendees may have 




them, in line with established theories of social comparison.[243,278] These two points are not 
inconsistent with interpretation one. 
5.2.1.3. Interpretation three 
 
The intervention had measurement effects, i.e. limited (if any) ‘real’ effect overall, except for 
causing differential ‘response shift’ effects between the experimental groups. 
 
‘Response shift’ is a concept used by patient-reported outcomes researchers.[313–315] It describes 
how there can be effects of temporal context on individuals’ interpretations of a patient reported 
outcome measure. For example, an individual may have a certain conceptualisation of what 
constitutes ‘moderately anxious or depressed’ whilst they are undergoing regular oncology clinic 
appointments; whereas after a transition to surveillance and more sporadic appointments, they 
may have a reconceptualisation, formed in the ‘shadow’ of their previous situation, of what 
constitutes ‘moderately anxious of depressed’. Interpretation three proposes that the apparent 
effects of the intervention on quality of life scores were grounded more in this cognitive reappraisal 
at follow up, than they were in any ‘real’ physical benefits to health. 
Interpretation three is important to consider, not only because acknowledgement of response shift 
effects is crucial to understanding changes in subjective quality of life,[315] but also because the 
nature of some of the qualitative data that was captured in this pilot study appeared to reflect a 
process of cognitive reappraisal, which is thought to be a core aspect of response shift effects.[314] 
Recent studies assessing response shift effects in men with localised prostate cancer have shown 
that this patient cohort do demonstrate response shift effects across the care trajectory,[313,316] and 
that these effects are more pronounced for measures of physical issues than for emotional or 
psychological issues.[316] Such an observation is consistent with the broader theoretical basis of 
response shift, as proposed by Sprangers and Schwartz, which suggests that measures of physical 
issues may be particularly prone to the effect of recalibration and reprioritisation.[317] Response 




would offer some explanation as to why these participants reported benefits over the control 
participants in terms of physical issues (like ability to perform usual activities). Such an explanation 
would be consistent with an interpretation that study participants did not substantially increase their 
PA, and yet reported benefits to both mental and physical quality of life issues. 
I would propose that of the above three interpretations, interpretation one is empirically the most 
credible, for the reasons outlined. Of course, there may have been some combination of the above 
described processes taking place, and the data from my study has not produced a reason to rule 
out either of the other two interpretations. 
5.2.2. Theoretical implications 
Section 3.5 explained how evidence has shown that narrative storytelling can be used to influence 
cognitive appraisals and behaviour in individuals with cancer. The section used the framework of 
the theory of planned behaviour and a model of dual processing to describe a theoretical 
mechanism with which this might occur in the intervention studied here. The mechanism described 
a process of attitude change toward physical activity, precipitated by the intervention’s influences 
on implicit processing. Alterations to implicit processing were postulated to take place over time 
following the intervention which would be, in theory, a persuasive and memorable event. 
The data collected in the pilot study are consistent with some aspects of this theoretical 
mechanism, but do not support other aspects. For the sake of this discussion, the mechanism 
described in Section 3.5 can be divided into four key Postulates, all of which are situated within a 
framework of the theory of planned behaviour and theories of dual process. 
1. An intervention using narrative storytelling can have effects on individuals diagnosed with 
cancer that are beneficial to wellbeing. 
2. An intervention using narrative storytelling can have persuasive effects on individuals 
diagnosed with cancer that can lead to healthier lifestyles, i.e. behaviour change. 
3. An intervention using narrative storytelling can have effects on implicit attitude towards a 




4. The effect of a narrative storytelling intervention on attitude change is a function of the way 
in which that intervention is psychologically contextualised by the individual receiving the 
intervention. 
Support for Postulate 1 was provided by my study, in the form of data suggesting a causal 
relationship between the intervention and improvements to self-reported quality of life outcomes. 
It was also provided by qualitative findings that the intervention was psychologically beneficial to 
many. Section 5.2.1 discussed competing interpretations for this finding. As noted in that 
discussion, response shift effects, and undetected behavioural effects on PA, cannot be ruled out. 
However, the interpretation that the intervention was psychologically beneficial to patients appears 
to be the one most consistent with the data, and therefore this study appears to provide 
confirmation of this aspect of theory. 
The findings of my study did not support Postulate 2. Whilst there was some qualitative data 
suggesting PA behaviour change in certain individuals, this was not observed at the sample level, 
and therefore this postulate is unsupported by the findings of my study. There is a caveat to be 
noted in this regard, relating to Postulate 4, which will be discussed further below. 
My study was unable to confirm or disconfirm Postulate 3, as I did not implement a measure of 
implicit attitude for practical reasons. Established experimental protocols for measuring implicit 
attitudes (such as the ‘implicit association test’[318]) require a laboratory setting; this approach was 
considered to be impractical and unnecessary for my central aims. Whilst this type of data may 
have been informative, the experimental protocols required would have exerted selection pressure 
on the sample, which would have made it challenging to draw generalisable conclusions about 
implicit processing as a psychological mechanism for the observed outcomes in the wider sample. 
However, if I were to repeat this study again, I would implement a longer follow up period (in 
addition to re-assessing the PA measure used), in order to examine the possibility of a ‘lag time’ 
in effects on PA behaviour change, as predicted by the theory used. It should be noted that the 
intervention could have theoretically had effects on implicit attitude that took longer to manifest as 
behaviour than the follow up protocol (i.e. 90 days) allowed for. Regular data collection timepoints 




behavioural effects could be seen in the longer term, but not necessarily the shorter term, which 
would be theoretically consistent with effects on implicit attitude (which rely on repeated activation 
of the relevant neurocognitive networks over a time period, as outlined in Section 3.5). 
To an extent, Postulate 4 was supported by the findings from my study, in the sense that there was 
evidence from the qualitative data that psychological/behavioural responses to the intervention 
appeared to coincide with certain personality characteristics, for example optimism. Such an 
observation is consistent with the idea that the nature of individuals’ contextualisation of the 
intervention is related to their responsiveness to it. Hence, the interpretation that this intervention 
is absolutely ineffectual at causing PA behaviour change would perhaps be misplaced; a more 
nuanced reading of the data would suggest broad inefficacy for behaviour change, but the potential 
for substantive inter-individual variance in this regard. In line with this interpretation, it could be 
suggested that exercise interventions in this population – particularly those utilising social aspects 
– could perhaps be better refined by delineating the role of certain personality traits in 
responsiveness to interventions. 
 
5.2.3. Study limitations 
There were important limitations to the intervention. First, it cannot be concluded that the benefits 
experienced by men who provided data for this study – who were all undergoing curative surgical 
procedures – would be similarly conferred to patients undergoing non-curative treatment for 
prostate cancer. Much of the psychological benefit that was conferred by the intervention appeared 
to be due to participants feeling a sense of hope for the future; this mechanism would not 
necessarily apply in a non-curative context. 
Second, the fact that the intervention was only delivered by a single individual in this study raises 
important questions about the quality control, and sustainability, of such an intervention. These 
could be challenges for wider implementation. The individual that volunteered to deliver this 
intervention is an adept public speaker and has a backstory of personal struggle with his cancer 




delivery, but they are not necessarily possessed by just any individual. Hence, finding individuals 
who suitable and are willing to commit the time and energy to deliver talks to patients regularly 
could be a challenge. Encouragingly, whilst undertaking this work I have met individuals who would 
potentially fulfil these criteria. Some of those interviewed for the pilot study indicated that they 
would like to partake in this type of activity, illustrated by the quotes below: 
“If he hadn’t been there, I’d like to have thought … I could have brought up the subject and 
spoken” (Participant 3) 
“[Interviewer: If you were to be asked to volunteer for some kind of role like that, is that 
something that would interest you?] I think, yes, I think it would, but also, I think in a way, I 
feel I’ve got an obligation as well to help people.” (Participant 12) 
Whilst the speaker I collaborated with in this study seemed adept at delivering the intervention, 
there is no reason to assume that he is unique in his ability to be able to have the beneficial effects 
reported. The qualitative findings from my study indicated that patients primarily benefitted from 
solidarity with the speaker and information ‘from the future’, so it could be said that anyone who 
can provide these aspects could potentially be able to deliver this intervention. Further, it could 
reasonably be speculated that the use of patient speakers with a personal/cultural/socioeconomic 
background that is aligned with the local community could render the intervention more effective at 
improving wellbeing, or perhaps even PA (in my study, the speaker and audiences backgrounds 
were often not aligned in this manner). 
The other issue is sustainability. Although some individuals might be keen to put themselves 
forward for this type of role, it requires both time commitment and a repeated discussion of one’s 
cancer history that can be emotionally depleting. Such sustainability factors are important to 
consider in the context of wider implementation of this style of intervention. Wider implementation 
would require administration (and therefore ‘buy-in’) from healthcare staff to ensure that there are 
volunteers available to speak with patients. There would also be a need to ensure that volunteers 
are not overburdened. These issues could perhaps be approached by partnering with prostate 
cancer support organisations who may be able to assist with the co-ordination of suitable 




and sustainability issues. Such work would ideally focus on the use of more than one patient 
speaker. It could examine training needs, assess consistency of delivery and patient outcomes, 
and examine the logistics and acceptability of setting up a system for having patient speakers on 
a rota for providing their services. 
The third limitation regards intervention fidelity. In my study, the patient speaker was given creative 
free reign over the content of the talk, as I thought that placing external constraints on the 
presentation content was not conducive to the aims pursued by the use of narrative storytelling (he 
was however clearly instructed not to make any unfounded scientific claims). The downside of this 
approach is that the intervention tested here lacked a clear procedural framework, so fidelity could 
not be formally assessed. Therefore, any other clinical team that wished to implement this style of 
intervention would have to make a localised judgement as to whether they think that similar 
benefits will be conferred by the patient speaker(s) they are using. This again points to the need 
for more research that could assess the comparative efficacy of the use of different speakers (as 
noted above). Using that data, perhaps a flexible training framework could be developed, that could 
formalise aspects of the intervention without compromising the narrative quality of the content. 
Fourth, a limitation of the pragmatic trial method used was that patients had not committed to be 
part of a formalised study protocol, and therefore there was a significant amount of participant 
attrition at the follow up data collection timepoint. The attrition rate at follow up – roughly one third 
of participants – reduced the final sample size overall and introduced the potential for sample bias. 
However, it is important to note that this approach also facilitated good rates of data collection at 
baseline (63% of those approached at Site A; 82% at Site B), and that the final sample was also 
broadly ethnically representative. Therefore, I would conclude that the pragmatic trial approach 
has both strengths and limitations with regards to sampling. 
5.3. Overall conclusions 
This PhD thesis documents the design and pilot testing of a peer-support intervention to promote 
PA in men with prostate cancer, delivered by a former prostate cancer patient, as part of standard 




intervention development[145,221] and supporting evidence relevant to the context under 
study.[142,157,212] 
The following conclusions are drawn from the work that has been described in this thesis: 
1. The work described here adds further support to existing evidence that, to an extent, the 
benefits of peer-support interventions for people with cancer can be provided to a higher 
proportion of patients via the integration of peer-support interventions delivered by former 
patients into standard clinical care pathways. 
2. The work described here is the first study to report that such an integrated peer-support 
intervention can be very brief (i.e. 10 minutes) and delivered to many patients 
simultaneously, and still confer quality of life benefits to some patients that are clinically 
meaningful. 
3. Existing qualitative evidence, including limited evidence from the pilot study reported here, 
indicates that in certain contexts, patients can be a source of PA motivation for one another. 
The original qualitative data reported here has given some preliminary indication that this 
may be more likely in those with a tendency toward optimism. 
4. This thesis has provided evidence from local clinical data that supervised, hospital-based 
exercise programmes are less likely to engage patients who live further from the hospital, 
who are older, and who are of a lower socioeconomic status. 
5.4. Implications for clinical practice 
The conclusions drawn here have some potential implications for clinical practice. First, structured 
PA interventions should be provided because they seem to be effective at promoting PA. However, 
these structured PA interventions can tend to be favoured by certain clinical teams and hence 
require the appropriate organisational connectivity with all the relevant clinical teams, to maximise 
their benefits. Structured PA interventions might also not be entirely egalitarian; evidence has been 
presented in this thesis that those who live closer to the hospital and are of a higher socioeconomic 




discrepancy could be to work with local authorities or primary care trusts to arrange for community 
facilities to be arranged, to increase the geographic spread of structured PA programmes. 
Second, findings from the pilot study reported here suggest that brief peer-support interventions 
provided by former cancer patients (in this case, lasting 10 minutes and delivered to up to 30 
patients simultaneously) can potentially have meaningful effects on psychological wellbeing and 
quality of life.[252] Therefore, clinical teams that have the capacity to provide this type of intervention 
may want to consider doing so, because in addition to the benefits for patients, favourable patient-
reported outcomes may be associated with a lower subsequent utilisation of healthcare services 
by patients.[319] 
5.5. Implications for health policy 
National Institute for Health and Care Excellence (NICE) guidelines for the management of men 
with prostate cancer (NICE guideline [NG131])[27] state that for “advice on communication and 
patient-centred care throughout the patient journey, follow the recommendations in NICE service 
guidelines [CSG2] and [CSG4]”. Guidelines CSG2 (‘Improving outcomes in urological cancers’) 
and CSG4 (‘Improving supportive and palliative care for adults with cancer’) have not been updated 
since 2002 and 2004 respectively. In terms of psychosocial support these guidelines are, broadly 
speaking, predominantly focused on either: a) specialist intervention, requiring highly qualified 
professionals trained in psychotherapeutic techniques; or b) community social support facilitated 
by social services or community support groups. Such aspects of care are indeed vital to those 
that require or desire them. However, it is likely that many patients diagnosed with prostate cancer 
will not perceive themselves as requiring these services and, as noted in Chapter 2 of this thesis, 
may be unlikely to seek such services out, even if they do have psychosocial needs (particularly 
men). Moreover, these types of services are costly and are a limited resource. 
From the data I have analysed as part of the work in this thesis, it seems probable that many 
individuals who do not feel compelled to access such specialist services may still have unmet 
needs relating to psychosocial support. The work described in this thesis has attempted to address, 




proportion of prostate cancer patients undergoing a curative procedure can derive psychological 
benefit from a ‘low intensity’ psychosocial intervention that is, in theory, deliverable to all patients 
as standard care. 
Macmillan Cancer Support, the National Institute of Health Research (NIHR), and the Royal 
College of Anaesthetists have produced guidelines relating to ‘prehabilitation’ of individuals with 
cancer,[320] recommending that supportive intervention should take place prior to treatment for 
cancer in order to promote physical and psychological resilience. According to the guidelines, 
prehabilitation “enables people with cancer to prepare for treatment by promoting healthy 
behaviours in order to maximise resilience to treatment and improve long-term health”[p.10]. It is 
recommended in this guidance that prehabilitation interventions include support for lifestyle 
modification, as well as general psychosocial support. Some NHS trusts are implementing 
prehabilitation guidelines as part of the clinical care pathway for prostate cancer (both of the NHS 
trusts I worked within during the course of this research project are implementing prehabilitation 
strategies, and the intervention I studied was delivered via a prehabilitation seminar at one of the 
study sites). The prehabilitation framework offers the advantages of early intervention, combined 
with systematic delivery to all patients as part of standard care. 
It follows from the findings of my study that the type of peer-support intervention I have described 
here could contribute to prehabilitation strategies, by conferring extra psychological resilience in 
patients, if delivered alongside existing services provided by allied healthcare professionals. 
Further research may be needed to give greater confidence to the effectiveness of this type of 
intervention as part of a prehabilitation strategy, before a formalised recommendation could be 
made in this regard. However, the pilot study reported here has provided some encouraging initial 
findings. Whilst the challenges to wider implementation that have been outlined above should be 
acknowledged, there are also potential advantages to this intervention in terms of low costs and 
cultural adaptability (given that individuals delivering the intervention are drawn from the local 
community). The prehabilitation approach could therefore offer a framework both for further 
research and the wider implementation of this intervention as of health policy in the UK and beyond, 




5.6. Future directions 
As noted above, the intervention described in this thesis may have the potential to lower costs for 
healthcare providers, whilst also conferring benefits to patients. Were this intervention to be further 
developed, some issues should be considered. A potential next step could be to conduct a study 
that used more than one patient speaker. Such a study could examine training needs, assess 
consistency of delivery and patient outcomes, and perhaps examine the logistics and acceptability 
of setting up a system for having patient speakers on a rota for providing their services. 
Alternatively, these issues might be circumvented by delivering this type of intervention via 
recorded video, as has been already proposed and studied by Cockle-Hearne et al.[321]. A video 
medium would reduce demand on patient volunteers; hence this could be preferable if this medium 
has comparable effectiveness to an in-person intervention. Qualitative research undertaken by 
Cockle-Hearne and colleagues has provided a useful insight into what the content of such a 
resource might wish to include.[321] 
Should an in-person intervention be preferable, there are encouraging signs that volunteers could 
be readily found. Walshe et al. have recently reported that “it is feasible to recruit and train people 
with lived experience of cancer to be peer mentors”[322][p.1]. Notably, whilst undertaking this work I 
have met individuals who would potentially be suitable for the role (as described in Section 5.2.3). 
In addition to the above, future work may wish to consider the following lines of inquiry that were 
highlighted in this thesis. First, further examination of the brief peer-support intervention described 
in this thesis may wish to investigate patients’ information needs, and whether the meeting of these 
needs is the mechanism by which the intervention can confer benefits to patients’ perceived quality 
of life. Second, it may be useful to investigate whether statistical relationships can be observed 
between certain personality characteristics and cancer patients’ responsiveness to exercise 
interventions. The work reported in this thesis suggests that potentially useful indicators of 
responsiveness could be high trait optimism, and low task self-efficacy. Third, it would be useful to 
investigate PA intervention studies for men with prostate cancer using meta-analytic techniques, 
to discern whether there is a relationship between study recruitment rate, and intervention effect 




possibility. If such a relationship exists, delineation of potential confounding variables in this 
relationship may facilitate further understanding of how to design interventions that reach higher 
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Appendix 1: Full search strategy for the systematic review 
MEDLINE / Embase / PsycINFO 
1. exp prostatic neoplasms/ or exp prostatic neoplasms, castration-resistant/ 
2. (prostate or prostatic).mp. 
3. (cancer or neoplas* or malignan* or adenocarcinoma or tumour or tumor or carcinoma or sarcoma).mp. 
4. 2 and 3 
5. 1 or 4 
6. exp Exercise/ 
7. exp Exercise Movement Techniques/ 
8. exp Exercise Therapy/ 
9. exp Circuit-Based Exercise/ 
10. Physical Fitness/ 
11. (physical* adj5 (fit* or activ*)).mp. 
12. (exercis* or "physical activity" or lifestyle or "physical exertion" or "aerobic training" or "resistance 
training" or sedentary).mp. 




17. Patient Compliance/ 
18. Patient Dropouts/ 
19. exp Attitude to Health/ 
20. Health Behavior/ 
21. (barrier* or facilitat* or attitud* or experien* or perspective? or perception? or perceived or antecedent? 
or opinion or view? or motivat* or "individual differences" or psycho* or personal* or feel* or think or 
thoughts or behav*).mp. 
22. Interview, Psychological/ 
23. Focus Groups/ 
24. (qualitative or interview? or "focus group?").mp. 
25. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
26. 5 and 13 and 25 
 
Web of Knowledge 
TS=(prostate OR prostatic) 
AND 
TS=(cancer OR neoplas* OR malignan* OR tumor OR tumour OR adenocarcinoma OR sarcoma OR 
carcinoma) 
AND 
TS=((physical* NEAR (fit* OR activ*)) OR exercis* OR "physical activity" OR lifestyle OR "physical exertion" 
OR "aerobic training" OR "resistance training" OR sedentary) 
AND 
TS=(barrier OR facilitator OR attitud* OR experien* OR opinion OR view OR motiv* OR "individual 
differences" OR personal* OR psycho* OR perceive* OR perception* OR perspective* OR feel* OR think OR 
thoughts OR behav* OR adhere* OR engage* OR comply OR compliance OR retention OR attrition OR 











TX cancer neoplas* malignan* adenocarcinoma tumour tumor carcinoma sarcoma 
AND 
TX exercis* "physical activity" lifestyle "physical exertion" "aerobic training" "resistance training" sedentary 
AND 
TX barrier facilitator attitud* experien* opinion perceive* perception perspective view motivat* "individual 
differences" psycho* personal* feel* think thoughts behav* adhere* engage* comply compliance retention 





(any of these words) cancer neoplas* malignan* adenocarcinoma tumour tumor carcinoma sarcoma 
AND  
(any of these words) exercis* "physical activity" lifestyle "physical exertion" "aerobic training" "resistance 
training" sedentary 
AND 
(any of these words) barrier facilitator attitud* experien* opinion perceiv* perception perspective view 
motivat* "individual differences" psycho* personal* feel* think thoughts behav* adhere* engage* comply 
compliance retention attrition "drop out" "dropout" "drop-out" 
 
WorldCAT  
Two searches (searching theses and dissertations only): 
Search 1: kw:prostate "physical activity" 





Appendix 2: Appraisal of study quality for studies 





- Not applicable 

























































































































































Was true randomisation used for assignment of 
participants to treatment groups? ✓ ✓ ✓ ✓ o ✓ ✓ ✓ ✓ o 
Was allocation to treatment groups concealed? ✓ x ✓ ✓ x x ✓ o x o 
Were treatment groups similar at baseline? ✓ x ✓ ✓ x ✓ ✓ ✓ ✓ ✓ 
Were participants blind to treatment 
assignment? 
x x x x x x x ✓ x x 
Were those delivering treatment blind to 
treatment assignment? 
x x x x x x x x x x 
Were outcomes assessors blind to treatment 
assignment? 




Were treatment groups treated identically other 
than the intervention of interest? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Was follow up complete and if not, were 
differences between groups in terms of their 
follow up adequately described and analysed? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Were participants analysed in the groups to 
which they were randomised? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Were outcomes measured in the same way for 
treatment groups? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Were outcomes measured in a reliable way? ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Was appropriate statistical analysis used? ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Was the trial design appropriate, and any 
deviations from the standard RCT design 
(individual randomisation, parallel groups) 
accounted for in the conduct and analysis of 
the trial? 











































































Were the two groups similar and recruited from 
the same population? - - - - 
Were the exposures measured similarly to 
assign people to both exposed and unexposed 
groups? 
✓ ✓ ✓ ✓ 
Was the exposure measured in a valid and 
reliable way? ✓ ✓ ✓ ✓ 
Were confounding factors identified? ✓ ✓ ✓ ✓ 
Were strategies to deal with confounding 
factors stated? ✓ ✓ x x 
Were the groups/participants free of the 
outcome at the start of the study (or at the 
moment of exposure)? 
- ✓ - - 
Were the outcomes measured in a valid and 
reliable way? ✓ ✓ ✓ ✓ 
Was the follow up time reported and sufficient 
to be long enough for outcomes to occur? ✓ ✓ ✓ ✓ 
Was follow up complete, and if not, were the 
reasons to loss to follow up described and 
explored? 
✓ ✓ ✓ ✓ 
Were strategies to address incomplete follow 
up utilised? - ✓ ✓ - 



























Is it clear in the study what is the 'cause' and 
what is the 'effect' (i.e. there is no confusion 
about which variable comes first)? 
✓ 
Were the participants included in any 
comparisons similar? ✓ 
Were the participants included in any 
comparisons receiving similar treatment/care, 
other than the exposure or intervention of 
interest? 
✓ 
Was there a control group? ✓ 
Were there multiple measurements of the 
outcome both pre and post the 
intervention/exposure? 
✓ 
Was follow up complete and if not, were 
differences between groups in terms of the 
follow up adequately described and analysed? 
✓ 
Were the outcomes of participants included in 
any comparisons measured in the same way? ✓ 
Were outcomes measured in a reliable way? ✓ 








































Were the criteria for inclusion in the sample 
clearly defined? ✓ ✓ 
Were the study subjects and the setting 
described in detail? ✓ ✓ 
Was the exposure measured in a valid and 
reliable way? ✓ x 
Were objective, standard criteria used for 
measurement of conditions? x x 
Were confounding factors identified? x ✓ 
Were strategies to deal with confounding 
factors stated? x x 
Were the outcomes measured in a valid and 
reliable way? o ✓ 
































































































































































































































Is there congruity between the stated 
philosophical perspective and the research 
methodology? 
o o o o o ✓ o o o o o o o o o 
Is there congruity between the research 
methodology and the research question or 
objectives? 
✓ ✓ ✓ x ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ x 
Is there congruity between the research 
methodology and the methods used to collect 
the data? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Is there congruity between the research 
methodology and the representation and 
analysis of data? 
✓ ✓ ✓ ✓ o ✓ ✓ ✓ ✓ ✓ x ✓ ✓ ✓ x 
Is there congruity between the research 




Is there a statement locating the researcher 
culturally or theoretically? x x ✓ ✓ x x ✓ x x x x x x x x 
Is the influence of the researcher on the 
research, and vice-versa, addressed? x ✓ ✓ x ✓ x x x ✓ x ✓ ✓ ✓ ✓ ✓ 
Are participants, and their voices, adequately 
represented? ✓ x ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ x ✓ ✓ ✓ ✓ 
Is the research ethical according to current 
criteria or, for recent studies, is there evidence 
of ethical approval by an appropriate body? 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Do the conclusions drawn in the research 
report flow from the analysis, or interpretation, 
of the data? 





Appendix 3: Details of studies included in the systematic review 
Table A: Randomised controlled trials 
 
   Participant characteristics   









Summary of study conditions        
Author(s) 




















12-week intervention consisting of 30min of 
aerobic and resistance exercise, twice weekly in 
weeks 1-6, then once weekly in weeks 7-12, 
taking place in a dedicated suite under 
supervision of an exercise physiotherapist; 
instruction to undertake 30 mins of self-directed 
exercise once weekly in weeks 1-6, then twice 
weekly in weeks 7-12 (with advice on what to do). 
Barriers to exercise explored with participant; 







baseline; T1: 12 


















(1.4%); RT and 
ADT (14.3%); 
RP, RT and 
ADT (5.4%) 











12-week intervention consisting of 50min of 
aerobic and resistance exercise, twice weekly, in 
a group exercise class at local community gym, 
supervised by exercise physiotherapists; 
instruction to undertake 1 self-directed exercise 
session weekly (with advice on what to do). 
Clinician advice to be physically active during 
routine follow-up consultation, and referral for 
exercise programme, consisting of a standard 
verbal script and handing participants a 
referral slip. Discussion with exercise 
physiotherapist upon commencement of the 
exercise programme, involving discussion of 
PA self-efficacy; PA preferences; outcome 
expectancy; goal setting; and provision of an 
individualised exercise programme. Regular 
counselling from exercise physiotherapist 
through the 12 weeks, during structured PA 
sessions, to follow up on the above. 
Participants encouraged to socialise during 
group sessions. Provision of discounted gym 












factors; goals. T0: 
baseline; T1: 12 
weeks; T2: 6 
months 
       vs.   
       Follow up by clinical team as per usual care. Usual care, consisting of advice to be 



















the last 6 
months 
12-week intervention consisting of 1hr of 
supervised aerobic and resistance exercise, twice 
per week, for the first six weeks, then adopting 
phased-out approach – one supervised session 
per week in weeks 7 and 8; zero supervised 
sessions in weeks 9 to 12 (but given access to 
facilities). Encouragement to gradually increase 
independent exercise alongside supervised 
sessions, in order to attain and maintain 150min of 
moderate (or equivalent vigorous) PA per week. 
Six group-mediated, cognitive behavioural 
counselling sessions delivered once per week 
following an exercise session, during months 
1-2 of the intervention. Sessions designed to 
facilitate the application of theory-based self-
regulatory skills for initiating/maintaining 
exercise, whilst providing motivation to change 
via the utilisation of the group structure as an 
agent of behavioural change (e.g. group-
problem solving, peer-initiated barrier 
solutions, developing ingroup identity and 
social norms). Additionally, four brief 20min 
individualised activity counselling sessions 











T0: baseline; T1: 2 
months weeks; T2: 
3 months 
vs.  
Follow up by clinical team as per usual care. Biweekly 20min phone contacts focusing on 








































Provision of elastic exercise device (Gymstick, 
Finland). 
Self-management materials and monthly peer 
group support delivered via teleconference, 
led by 2 peer support volunteers and involving 
a specialist nurse, for 6 months; 1 session 
focusing on exercise, and the other 5 sessions 
focusing on other topics but each involving a 
discussion of participants' progress with PA 
goals. Nurse counselor providing 1 hour of 
supervision of participants per teleconference, 
and further quarterly group supervision 
meetings. Baseline assessment undertaken 
and feedback provided identifying target areas 
for improvement, evaluating participants' 
concerns, and setting self-management goals 
(it is not specified whether this baseline 
feedback pertained to exercise or not). Online 
web-based material also available to 
participants. Provision of watch with heart rate 








T0: baseline; T1: 3 
months; T2: 6 
months; T3: 12 
months 
vs.   
Follow up by clinical team as per usual care. Provision of a set of published patient 



























(1.4%); RT and 
ADT (14.3%); 
RP, RT and 
ADT (5.4%) 











12-week intervention consisting of 50min of 
aerobic and resistance exercise, twice weekly, in 
a group exercise class at local community gym, 
supervised by exercise physiotherapists; 
instruction to undertake 1 self-directed exercise 
session weekly (with advice on what to do). 
Clinician advice to be physically active during 
routine follow-up consultation, and referral for 
exercise programme, consisting of a standard 
verbal script and handing participants a 
referral slip. Discussion with exercise 
physiotherapist upon commencement of the 
exercise programme, involving discussion of 
PA self-efficacy; PA preferences; outcome 
expectancy; goal setting; and provision of an 
individualised exercise programme. Regular 
counselling from exercise physiotherapist 
through the 12 weeks, during structured PA 
sessions, to follow up on the above. 
Participants encouraged to socialise during 
group sessions. Provision of discounted gym 







baseline; T1: 12 
weeks; T2: 6 




Follow up by clinical team as per usual care. Usual care, consisting of advice to be 































None. Provision of computer-tailored, theory-driven 
PA advice. Advice is automatically generated 
using a message library, questionnaire data, 
and a data-driven decision-making algorithm 
that utilises data returned by the participant via 
questionnaires provided at baseline, and at 2 
months. Advice is provided at three timepoints 
over a three-month duration (baseline; 2 
months; 3 months). Participants also receive a 
pedometer, and access to interactive content 









T0: baseline; T1: 3 
months; T2: 6 
months; T3: 12 
months vs.  
None. Follow up by clinical team as per usual care 




























None. 12-week intervention focusing on 8 different 
healthy behaviours, of which vigorous exercise 
was one. Participants provided with a report at 
baseline containing personalised 
recommendations, based on self-reported data 
on current behaviour. Participants given a 
Fitbit one activity tracker, access to a study-
only community forum on the Fitbit website, 
and access to the study website, which 
included a ‘get active’ section. Participants 
then receive 4-5 SMS messages per week 
incorporating constructs/strategies from the 
theory of planned behaviour. Additionally, 
every 2 weeks participants receive an e-mail 
from the principle investigator about blog 

















None. Follow up by clinical team as per usual care 
(lifestyle-related guidance accessible to 
anyone as part of this). 
Kim et al. 
(2018) 
41 1:1 (groups 
stratified by 
age, <70yr or 
≥70yr) 
70.8 Stage I, II, 




















Home-based intervention consisting of a core 
programme of at least 150 minutes of weight-
bearing and resistance exercise per week, for 6 
months; and an optional extra programme of 
stabilisation/balance exercise and circuit resistive 
calisthenics). Intensity of exercise was increased 
as appropriate over the 6 months. 
Two 30min educational sessions preceding the 
start of the exercise programme. Ten 15min 
sessions of telephone counselling from either 
a cancer exercise physiotherapist, or a nurse 
experienced in exercise research (weekly in 
month 1, then monthly thereafter); 
standardised counselling manual used. 
Participants shown how to create an exercise 
log in the second telephone session, and 
asked to keep one going forward. Self-
reported adherence to exercise monitored at 
each telephone call. Instruction DVDs or a 38-
page photographic workbook provided to 





T0: baseline; T1: 6 
months 
vs.  
Home-based intervention consisting of 20min of 
whole body stretching (9 movements), performed 
3 to 5 times per week. 
Ten 10min telephone sessions (weekly in 
month 1, then monthly thereafter), in which 
participants were checked for programme 






































None. Provision of 2-page summary fact sheet of PA 
guidelines. Self-administered implementation 
intention intervention, consisting of goal setting 
(S.M.A.R.T.); reflection on current PA levels; 
the construction of a detailed implementation 
plan (where, when, how, with whom they are 
going to engage with PA); reflection on 
personal PA barriers and construction of 
strategies to address them; creation of a 
summary sheet to be displayed in a visible 






baseline; T1: 1 
month; T2: 3 
months 
vs.   
None. As above but with the addition of 1 follow up 
telephone call (~12min), designed to help 
participants to achieve their PA goals by 
helping them to develop a realistic plan of 
action that best suits their needs and abilities, 
with a focus on: 1) modifying PA goal; 2) 
developing a more detailed plan; and/or 3) 
identifying further potential PA barriers, and 
strategies to overcome them. Telephone calls 
followed a semi-structured script to maintain 




























Not reported Pre-surgery intervention consisting of 60min of 
home-based, moderate intensity aerobic and 
resistance exercise, 3-4 days per week. Instructed 
to perform daily pelvic floor exercises. 
Participants provided with an exercise 
manual/online videos, a stability ball, resistance 
bands, a yoga mat, and a heart rate monitor. 
Given prostate cancer-specific lifestyle 
booklet. Weekly communication with study 
team, to facilitate programme compliance and 






baseline (mean 77 
days prior to RP); 
T1: pre-surgery 
(mean 49 days 
after baseline); T2: 
4 weeks post-op; 
T3: 12 weeks post-
op; T4: 26 weeks 
post-op 
vs.   
Pre-surgery intervention consisting of instruction 
to do daily pelvic floor exercises. 
Given prostate cancer-specific lifestyle 
booklet. Weekly communication with study 
team, to facilitate programme compliance and 
progression with activities. 
 
  
Table A Randomised controlled trials included in the review. ADT, androgen deprivation therapy; RP, radical prostatectomy; RT, radiotherapy; EBRT, external 
beam radiotherapy; PA, physical activity; Godin-LSI, Godin Leisure Score Index; MOOES, Multidimensional Outcome Expectations for Exercise Scale; LTEQ, 
Leisure-Time Exercise Questionnaire; SQUASH, Short Questionnaire to Assess Health Enhancing Physical Activity; CHAMPS, Community Health Activities 
Model Program for Seniors. 





Table B: Prospective cohort studies 
   Participant characteristics    









   
Author(s) 
and date n Study context Setting 
Exposure variable(s) related to prostate cancer 











ADT Various PA 
levels, sample 
not described 
12 weeks of supervised resistance 
training; three sessions/week; two 
sets of 8-12 repetitions of nine 
different resistance exercises; not 
group exercise but some informal 
interaction between participants. 
Prostate cancer-specific quality of life (FACT-P 
score); fatigue (subscale of FACT-P); cancer 
stage (I-IV); time since diagnosis (days); previous 
RP (yes/no); previous RT (yes/no); treatment 
intent (curative/palliative); type of ADT 
(monotherapy/combined therapy); time receiving 
ADT (days). 
Adherence to 
intervention (number of 














Mixed, all curative 
intent: RP (30.8%); 
RP and RT 










Clinician referral to exercise 
programme, consisting of 12 weeks 
of aerobic, resistance, balance, and 
flexibility exercises, three 
times/week; two sessions/week 
supervised, one session/week non-
supervised; discussions about 
exercise during sessions 
incorporating principles of SCT. 
Cancer-specific quality of life (QLQ-C30 scores 
and QLQ-PR25 scores); depressive symptoms 
(CES-D score); prostate cancer-related anxiety 
(MAX-PC score); cancer stage (I-III); time since 
treatment completion (weeks); treatment type 




supervised sessions out 






















Standard clinical follow-up after RP 
procedure, or RP with adjuvant RT. 
Incontinence (first day after catheter removal; 
mean urine loss per day over 7 days, measured 
at 6 weeks, 3 months, 6 months, and 12 months 
after RP); type of RP (open/robotic); nerve-
sparing status (bilateral/unilateral/non-nerve 
spare); surgical margins status; adjuvant RT 
during first year post-op (yes/no). 
Self-reported PA 
(measured using 
FPACQ). T0: basline 
(preoperative); T1: 6 
weeks; T2: 3 months; T3: 














Mixed: RP (65%); 
RT (18%); ADT 








Participants either posted 
standardised diet and exercise 
print materials already available in 
the public domain; or posted 
sequentially-tailored diet and 
exercise print materials, tailored to 
the participants' personal barriers, 
stage of readiness, progress 
toward goal attainment, cancer 
coping style, and demographic 
characteristics. 
Cancer-specific concerns (scores on each 
individual item on the 'additional concerns' 
subscale of FACT-P). 
PA levels (7-DPARQ); 
measured 1 year after 
baseline 
Table B Prospective cohort studies included in the review. RCT, randomised controlled trial; ADT, androgen deprivation therapy; RP, radical prostatectomy; RT, radiotherapy; 
PA, physical activity; SCT, social cognitive theory; FACT-P, Function Assessment of Cancer Therapy-Prostate; 7-DPARQ, 7-day Physical Activity Recall Questionnaire; CES-
D, Center for Epidemiologic Studies Depression Scale; MAX-PC, Memorial Anxiety Scale for Prostate Cancer; FPACQ, Flemish Physical Activity Computerized Questionnaire. 
† Study shares a sample with Gaskin et al. (2017) (see Table A). 





Table C: Non-randomised controlled trials 
   Participant characteristics    
   
Age, 
mean (SD 
or range) Disease status Treatment 
Baseline 
exercise status 
Summary of study conditions  
        
Author(s) 














on baseline SF-36 
score, BMI, time 








stage of disease) 










intensity PA, 3 or 
more times per 
week for >6 
months 
46 Occasional brief 
(5min) periods of 
walking; one 
session devoted to 







6-month lifestyle support programme consisting of 
an orientation session, followed by 20 sessions 
(approximately weekly), each lasting 1.5 hours. 50 
minutes of each session deliver a physical activity 
curriculum (modified Project Active‡ curriculum), 
teaching cognitive and behavioural skills related to 
the adoption of PA behaviour (predominantly based 
on SOC model, incorporating elements of SCT). Key 
components are reported as self-monitoring of PA; 
goal setting (amended over time); and reflection on 
barriers to achieving PA goals. Participants 
encouraged to accumulate 30min of moderate 
intensity PA per day for most days of the week. The 
remaining time in each session either delivers: a) a 
talk by a speaker with expertise in that day's non-
exercise prostate cancer topic; or b) further 
facilitated discussion of a non-exercise prostate 
cancer topic. Provision of information materials 






baseline; T1: 6 




51 None. 6-month educational support programme consisting 
of an orientation session, followed by 20 sessions 
(approximately weekly), each lasting 1.5 hours. 50 
minutes of each session deliver a facilitated 
discussion on a non-exercise prostate cancer topic. 
The remainder of each session either delivers: a) a 
talk by a speaker with expertise in that day's topic; 
or b) further facilitated discussion of that day's topic. 
Provision of information materials detailing available 
community resources for prostate cancer patients. 
vs. 
 
37 None. Provision of information materials detailing available 
community resources for prostate cancer patients 
only. 
Table C Non-randomised, controlled trials included in the review. BMI, body mass index; ADT, androgen deprivation therapy; PA, physical activity; SCT, social cognitive 
theory; SOC, stages of change; 7-DPARQ, 7-day Physical Activity Recall Questionnaire; SF-36, Short Form (36) Health Survey. 
† See Pocock et al. (1983). 






Table D: Cross-sectional studies 










date n Variable 1 Variable 2 
Min et al. (2019) 111 64 (6.5) Stage II (62%), Stage III or 
above (38%) 
All received RP. Mixed: 
RP only (32%); with ADT 
(57%); with chemotherapy 
(1%); with chemotherapy 
and ADT (1%); with RT 
and ADT (10%) 
15.4% meeting 
PA guidelines 
Participant response to 21 potential exercise 
barriers on a 5-point likert scale ranging from 
‘strongly agree’ to ‘strongly disagree’ (measured 
using modified Exercise Barrier Questionnaire for 
Older Adults) 
Whether meeting PA guidelines (measured 
using Korean translated version of Godin-LSI) 
Ottenbacher et 
al. (2011)† 
193 62 (8.3) Stage I (40%); II (52%); or 
unknown (8%) 
Mixed: RP (65%); RT 
(18%); ADT (14%); 7% of 




or vigorous PA) 
Participant response to 14 personal, social, and 
environmental barriers, when asked whether or not 
they apply to them (yes/no). 





Table D Cross-sectional studies included in the review. RP, radical prostatectomy; RT, radiotherapy; ADT, androgen deprivation therapy; PA, physical activity; 
Godin-LSI, Godin Leisure Score Index; 7-DPARQ, 7-day Physical Activity Recall Questionnaire. 




Table E: Qualitative studies 
Author(s) and 
year Design n 








framework Treatment type 
Disease 
status Intervention (if applicable) 




12 Not reported Purposive 
 
Sedentary men; on 




ADT T3 or T4 12-week combined supervised (group) and self-directed 
aerobic and resistance exercise, and diet; supervised 1 
hour sessions: twice/wk for 6 wks, then once/wk for 6 wks. 
 








ADT Not reported n/a 











12 weeks of outdoor supervised football training: 45 mins 
twice weekly for 4 weeks, increasing to 1 hr twice weekly 
for a further 4 weeks, then thrice weekly in the final 4 
weeks 





12 75.3 (4.5) Purposive Involved with 
exercise 
intervention for >3 
months; mixed 
physical activity 










Not reported Structured, clinic based, group exercise programme (1 hr 
sessions, twice/wk), resistance and aerobic. 




















(n=4); ADT (n=4) 
and radiotherapy 
(n=3) 
Not reported n/a 
          
Culos-Reed 
et al. (2019) 
Focus groups 
(2) 
11 (60–79) Convenience Caucasian men 
only; all retired; all 
married; had 

















(n=2); previous or 
current ADT (n=2) 
Any 12-week supervised, community-based lifestyle 
management programme, conducted in twice-weekly 
60min group sessions, of up to 15 participants. Circuit-
based resistance exercise and gentle yoga. Emphasis 
placed on behaviour change. Some classes limited to men 
with prostate cancer only; some included other support 
persons e.g. spouse (which type of class was attended by 
men in this sample was not specified). 






14 69.6 (52–80) Purposive African Caribbean 
men only; sampled 
across age, 
socioeconomic 
status, marital status 





ADT (n=9), radical 
prostatectomy 




















Purposive Separate focus 
groups for men on 
ADT for >6 months 
already, and men 





















44 70.3 (9.2) Purposive On ADT for >12 
months; completed 
involvement with a 
24-week exercise 
intervention, as part 
of a study (various 
levels of physical 




ADT Not reported 24-week, home-based intervention of either aerobic or 
resistance exercise (depending on study arm). Aerobic 
exercise programme consisted of 60 minutes of 
moderate/vigorous aerobic exercise, 3 to 5 times a week. 
Resistance exercise programme consisted of 60 minutes 
of exercise using a resistance band and stability ball, 3 to 
5 times a week. 


































Community pharmacy intervention to improve PA 
behaviour, based upon the NHS Health Check‡, but with 
additional fitness and strength assessments, immediate 
personalised feedback, lifestyle prescription with 
pharmacist support, and a reassessment 12 weeks later. 











of white and African 
American men; 
mixture of urban 






Not reported Localised 
disease only 
n/a 










months prior and 
















12-week, hospital-based, supervised exercise programme 
that is implemented as part of standard care and offered 
to all eligible prostate cancer patients undergoing ADT 
(publicly funded i.e. free for participants). One educational 
session, then an individualised, progressive resistance 
training programme, supplemented by aerobic activity. 
Sessions are twice weekly in groups of 10-15 men. Final 
two sessions take place in a community-based fitness 
centre. 





20 71 (8.5) Convenience Metastatic cancer 
only; no history of 
radical 
prostatectomy; no 












[Enrolled in exercise intervention study but interviews took 




























12 61 (9.4) Purposive African American 















          
 
Table E Qualitative studies included in the review. ADT, androgen deprivation therapy; NHS, National Health Service; PA, physical activity; PRECEDE, 
‘Predisposing, Reinforcing, and Enabling Constructs in Educational Diagnosis and Evaluation’; PSA, prostate-specific antigen. 
† See Green (1974). 





Appendix 4: Behaviour Change Wheel process 
 
Step 1: Define the problem in behavioural terms 
What behaviour? 
Take one’s preferred decisive action to 
increase physical activity to recommended 
levels for people with cancer 
Where does the behaviour occur? 
Everywhere: in the home, outdoors, at the 
gym, at the hospital gym 
Who is involved in performing the behaviour? 
Men with prostate cancer, their families, their 
peers, and their clinical care team 
 
Step 2: Select the target behaviour 
(NB: Michie et al. suggest developing a ‘long list’ of very specific behaviours. However, it was 
decided that physical activity is a behaviour that can take so many potential different forms that 
creating such a list was not practical or particularly useful.) 
List of target behaviours 
Intervention aim: improve physical activity engagement in men diagnosed with prostate 
cancer 
Behaviours centred on individual: 
• Create an exercise plan with goals 
• Choose active modes of transport 
• Choose the stairs over lifts or escalators 
• Initiate a hobby that involves physical activity (e.g. outdoor photography) 
• Initiate a hobby that centres around physical activity (e.g. squash) 
• Join a sports team 
• Attend community gym 
• Sign up for a gym class 
• Use pads as needed to protect against episodes of incontinence 
• Perform pelvic floor exercises 
• Provide information on pelvic floor exercises 
• Time exercise engagement consciously in the context of the cancer treatment received 
• Actively manage time to accommodate physical activity 
• Perform physically demanding household tasks 
• Articulate to self the reasons why engaging with physical activity would be beneficial 
Social dynamics: 
• Inform friends/family about intention to do more physical activity 
• Approach a friend or family member and ask them to be an exercise/gym buddy 




• Interact socially with other men with prostate cancer who have a positive attitude 
toward exercise 
• Join a community initiative that involves physical activity 
• Ask active friends or family what they do to maintain activity 
• Routinely prompt individual to engage in physical activity 
Engagement with the healthcare system: 
• Sign up for the NHS physical activity pathway 
• Issue referral to NHS physical activity pathway 
• Ask consultant about physical activity 
• Consultant issue physical activity advice 
• Ask nurse about physical activity 
• Nurse issue physical activity advice 
• Cancer exercise physiotherapist issue physical activity advice 
• Reassure patient that engaging with physical activity is appropriate 
• Read available exercise literature provided by NHS 
• Attend NHS health and wellbeing day 
• Seek psychotherapeutic support 
• Remotely prompt patient to engage in physical activity 
Environmental facilitators: 
• Obtain exercise equipment e.g. weights, pull up bar, stretch band 
• Use exercise equipment 
• Obtain physical activity app 
• Use physical activity app 
• Obtain wearable tech 
• Obtain gym membership 






































Create an exercise 
plan with goals 






walking or cycling) 












Choose the stairs 





































Very promising Unpromising but 
worth 
considering 
Promising Very promising 
Sign up for a gym 
class 
Very promising Unpromising but 
worth 
considering 
Promising Very promising 
Use pads as 
needed to protect 
against episodes of 
incontinence 










Promising Promising Promising 
Time exercise 
engagement 
consciously in the 




































would be beneficial 
Promising Unpromising but 
worth 
considering 





intention to do more 
physical activity 






Approach a friend 
or family member 















Engage socially with 
others who have a 
healthy attitude 
toward exercise 
Promising Unpromising but 
worth 
considering 
Promising Unpromising but 
worth 
considering 




Very promising Unpromising but 
worth 
considering 
Very promising Promising 
Ask active friends 
or family what they 












individual to engage 
in physical activity 
Promising Unpromising but 
worth 
considering 




of the importance of 
physical activity for 
men with prostate 
cancer 
Promising Promising Very promising Promising 
Sign up for the NHS 
physical activity 
pathway 
Very promising Unpromising but 
worth 
considering 
Very promising Very promising 
Offer referral to 
NHS physical 
activity pathway 
Promising Unpromising but 
worth 
considering 











Promising Unacceptable Promising Unpromising but 
worth 
considering 
Ask nurse about 
physical activity 


















that engaging with 
physical activity is 
appropriate 





provided by NHS 
Promising Unpromising but 
worth 
considering 




Attend NHS health 
and wellbeing day 













patient to engage 
with physical 
activity 
Promising Promising Promising Promising 
Obtain exercise 
equipment e.g. 
weights, pull up bar, 
stretch band 















Promising Very promising Very promising 
Use physical activity 
app 
Very promising Unpromising but 
worth 
considering 
Very promising Very promising 
Obtain gym 
membership 






Promising Unacceptable Very promising Promising 
Hire a personal 
trainer 
Very promising Unacceptable Very promising Promising 
 
Note: 
At this point, a practical decision was made to deviate from the suggested process slightly. There 
is a large variety of different forms that increased physical activity can take, and there is much 
evidence that there exist substantial individual preferences in the way in which people wish to 
develop or maintain a physically active lifestyle. If one intends to increase physical activity 
behaviour for all men with prostate cancer, this creates considerable complexity in terms of 
potential target behaviours. This is because these men are only unified on the characteristics of 
being male and mostly over 50 years old. They otherwise possess vast variability in terms of 
psychosocial and physical circumstances that affect capability, opportunity and motivation to 
engage with physical activity behaviour, which is likely to affect physical activity preferences. 
Hence, many of the suggested target behaviours must necessarily be categorised as having an 




‘unpromising’ likelihood of changing the primary target behaviour, because it is likely to only appeal 
to a small subsection of the cohort (Table B illustrates this by displaying the many target behaviours 
from Table A that are ‘promising’ or ‘very promising’ in terms of having a behavioural effect in an 
individual, but ‘unpromising’ or ‘unacceptable’ in terms of the likelihood of changing this behaviour 
across the cohort). 
Thus, to facilitate the intervention design process, the target behaviour has been defined as an 
individual taking a decisive action of their preference to increase their physical activity levels. This 
enables a consideration of techniques that facilitate the target behaviour whilst also giving patients 
total freedom of choice in their approach to the target behaviour, and thus broadening the likelihood 
of behaviour change across the cohort. Although this somewhat deviates from Michie et al.’s advice 
to aim for incremental change by targeting one or two specific behaviours at a time, in the present 
























Create an exercise 
plan with goals 





walking or cycling) 
Promising Unpromising but 
worth 
considering 





Promising Unpromising but 
worth 
considering 




Very promising Unpromising but 
worth 
considering 





Very promising Unpromising but 
worth 
considering 
Sign up for a gym 
class 











Promising Unpromising but 
worth 
considering 




would be beneficial 
Promising Unpromising but 
worth 
considering 
Engage socially with 
others who have a 
healthy attitude 
toward exercise 














individual to engage 
in physical activity 
Promising Unpromising but 
worth 
considering 
Voluntarily sign up 
for the NHS 
physical activity 
pathway 
Very promising Unpromising but 
worth 
considering 
Offer referral to 
NHS physical 
activity pathway 





provided by NHS 





weights, pull up bar, 
stretch band 





Very promising Unpromising but 
worth 
considering 
Use physical activity 
app 











Hire a personal 
trainer 
Very promising Unacceptable 
 
  
Table B Potential target behaviours that were categorised as ‘promising’ in terms of the impact on 
individual behaviour, but ‘unpromising’ or ‘unacceptable’ in terms of the likelihood of behaviour 




Step 3: Specify the target behaviour 
Target behaviour: Take a decisive action in the pursuit of engaging with more physical activity 











they do it? 
Where will 




























clinic) or at 
home 
Once With an 
exercise 
physiotherapist, 
cancer nurse, a 
consultant, a 
family member, 
or a friend 
 
Step 4: Identify what needs to change 
COM-B components What needs to happen for 
the target behaviour to 
occur? 
Is there a need for change? 
Physical capability Individual needs to be 
physically capable of 
engaging in physical activity, 
when all comorbidities are 
considered 
Change needed 
Individualised exercise plans 
are already offered as part of 
the NHS physical activity 
pathway‡ 
 
However, change needed as 
guidance could probably be 
delivered by a nurse or 
consultant in many cases 
 
Individual needs to be 
unobstructed by fatigue 
problems 
Change needed 
Patients are already 
systematically provided with 
advice on managing fatigue 




However, there may be a role 
for early intervention in this 
regard, before treatment 
commences 
Individual needs to not be 
hindered by incontinence 
issues 
Change not needed 
Patients are already 
systematically provided with 
advice on incontinence and 




offered further specialist help 
if necessary 
Psychological capability Individual needs to be 
reassured with knowledge 
that exercise is not 
contraindicated for them 
Change not needed 
Patients are already 
systematically provided with 
reassurance by a cancer 
exercise physiotherapist† 
 
Some patients may have very 
specific concerns; these 
concerns can be addressed 
via the NHS physical activity 
pathway‡ 
 
Individual needs to have 
knowledge of exercise 
techniques 
Change not needed 
Training is available to all 
prostate cancer patients 
should they be referred (or 
self-refer) to the NHS physical 
activity pathway‡ 
 
Individual needs to know what 
constitutes moderate and/or 
vigorous physical activity 
Change not needed 
Patients are already 
systematically provided with 
an interactive demonstration 
of what moderate physical 
activity feels like by a cancer 
exercise physiotherapist† 
 
Individual needs to have 
knowledge of the benefits of 
physical activity, specifically 
with regards to cancer 
Change not needed 
Patients are already 
systematically provided with 
empirical information about 
physical activity benefits, and 
asked as a group to 
themselves reflect on the 
benefits, by a cancer exercise 
physiotherapist† 
 
Individual needs to 
understand how to manage 
fatigue with physical activity 
Change needed 
Patients are already 
systematically provided with 
advice on managing fatigue 




However, there may be a role 
for early intervention in this 
regard, before treatment 
commences 
 Individual needs to be aware 
of community facilities 
available to them 
Change needed 
Many people are likely to be 




There already exist 
signposting services provided 
by Cancer Exercise 
Physiotherapy; these are 
provided to men on the NHS 
physical activity pathway. 
These resources might need 
to be made more broadly 
accessible 
Physical opportunity Individual ideally needs to 
have access to useful 
equipment, facilities, or 
communities 
Change needed 
On-site facilities already 
available as part of NHS 
physical activity pathway; not 
everyone’s preference 
however, and only made 
available for a 12-week period 
due to capacity 
 
Work with local authorities to 
enable access to facilities for 
patients 
 
Provide patients with low-cost 
equipment e.g. stretch band 
Individual needs to be able to 
adapt to adverse weather 
conditions 
Change needed 
Work with local authorities to 
enable access to indoor 
facilities for patients 
 
Train patients in simple 
exercises they can do 
indoors, encourage them to 
do physically demanding 
housework 
Individual needs to have 
available time in the week to 
allocate to physical activity 
Patients are already 
systematically provided with 
advice on how to manage 
their time to accommodate 
physical activity† 
 
Further support to do this is 
provided by the NHS physical 
activity pathway‡ 
Social opportunity Individual may need support 
from friends or family 
Change needed 
Partner/family members need 
to also be counselled on 
physical activity 
 
If no partner, advice should 
be given on engaging friends 
or other family, so that they 
may be supportive 
Individual needs to be given 
the impression that engaging 
Difficult to say how much 




in healthy amounts of 
physical activity is a socially 
normative thing to do for 
someone in their 
circumstances 
change, but engaging 
patients with others like them 
who are physically active may 
be beneficial 
Individual may need to be 
influenced by observing the 
physical activity behaviour of 
significant others 
Change needed 
Patients need to be exposed 
to behavioural role models 
that they respect 
Individual may need to have 
behaviour facilitated by being 
a member of a team 
Change needed 
Patients should be advised to 
join community sports teams 
if they feel so inclined, and 
signposted 
 
There already exist 
signposting services provided 
by Cancer Exercise 
Physiotherapy; these are 
provided to men on the NHS 
physical activity pathway. 
These resources might need 
to be made more broadly 
accessible 
Reflective motivation Individual needs to believe 
that physical activity will 
benefit them in a tangible way 
Change needed 
Patients are already 
systematically provided with 
empirical information on the 
benefits of physical activity by 
a cancer exercise 
physiotherapist†; but the 
associated health 
consequences of behaviour 
could possibly be made more 
salient 
 
Individual needs to possess 
physical activity self-efficacy 
Change not needed 
Patients are already 
systematically provided with 
advice on how to gradually 
increase activity by a cancer 
exercise physiotherapist† 
 
This is also related to feeling 
reassured about engaging 
with exercise, see 
Psychological capability 
 
Individual’s physical activity 
behaviour may need to be 
periodically scrutinised by 
another 
Change needed 
Periodic telephone follow-up 
is already provided by the 






Partner/family members need 
to also be counselled on 
physical activity 
 
Individual needs to reflect on 
their own reasons why would 
want to engage with physical 
activity 
Change not needed 
Motivational interviewing is 
already provided as part of 
NHS physical activity 
pathway‡ 
 
Also already provided 
systematically to all patients, 
to a lesser extent, in a group 
setting† 
 
Individual needs to formulate 
intention by creating physical 
activity plans and goals 
Change not needed 
Goal setting, time 
management advice, and 
guidance on implementation 
intentions already provided 
by NHS physical activity 
pathway‡ 
 
Automatic motivation Individual needs to have 
activities available to them 
that are not boring 
Change not needed 
Patients are already 
systematically provided with 
advice that they should find 
an activity that they find fun 
or interesting† 
Individual needs to associate 
the prospect of physical 
activity with positive emotions 
Change needed 
Patients need to be 
convincingly persuaded of the 
positive case for physical 
activity as a force for feeling 
fit, strong, and positively self-
determined 
Individual may need adjunct 
emotional support to alleviate 
depressive symptoms 
Change not needed 
Patients are already 
systematically encouraged to 
seek available support from 
NHS psychological services† 
 
Individual needs to develop a 
habit of physical activity 
behaviour 
Change not needed 
Difficult to change without 
active intervention; behaviour 
change support already 
provided by NHS physical 
activity pathway‡ 
Behavioural diagnosis of 
relevant COM-B 
components:  
Physical capability, psychological capability, physical 
opportunity, social opportunity, reflective motivation, and 
automatic motivation all need to change to maximise 





† There is a need to maximise the number of patients reached by the educational seminar in 
which this is provided. As there are already efforts by Cancer Exercise Physiotherapy to this end, 
this project will not be concerned with this and so this has need classified as ‘Change not 
needed’. 
‡ There is a need to maximise the number of patients participating in this pathway. As there are 
already efforts by Cancer Exercise Physiotherapy to this end, this project will not be concerned 
with this and so this has need classified as ‘Change not needed’. 
 
Step 5: Identify intervention functions 
Candidate intervention functions Does the intervention function meet 
the APEASE criteria? 
Education 
Unlikely to be very effective as there is 
already a good quality system in place 




Not affordable and discriminates against 
individuals struggling to make progress 
Coercion Not acceptable to patients or staff 
Training 
Unlikely to be effective as there is 
already a good quality system in place 
for providing training to patients 
Restriction Not practicable 
Environmental restructuring 
In the context of this project, anything 

























criteria in the 








Unlikely to be effective 
unless delivered via 
telephone (not 
practicable) or webinar 
(not acceptable to many 
patients and requires 
technological literacy) 






Communication/marketing As above 
Guidelines Not practicable 
Regulation 
Not acceptable or 
practicable 
Legislation 
Not acceptable or 
practicable 













Fiscal measures Not relevant 
Regulation Not currently practicable 













At this point, the process has produced two candidate intervention types (see ‘Intervention 1’ and 
‘Intervention 2’ below). For this doctoral project, one type of intervention (Intervention 2) has been 
chosen from these for further examination. 
 
Intervention 1 
Primary target behaviour 
Take one’s preferred decisive action to 
increase physical activity to recommended 
levels for people with cancer (patient 
behaviour) 
Change(s) needed that are targeted by 
intervention 
To broaden engagement with NHS physical 
activity pathway across the patient cohort 
Target behaviours selected 
Offer referral to NHS physical activity pathway 
at every appropriate opportunity (clinician 
behaviour) 
Intervention function Enablement 
Policy categories 
▪ Guidelines 
▪ Environmental/social planning 
Behaviour change techniques 
▪ Instruction on how to perform the 
behaviour 
▪ Prompts/cues 







Primary target behaviour 
Take one’s preferred decisive action to 
increase physical activity to recommended 
levels for people with cancer (patient 
behaviour) 
Change(s) needed that are targeted by 
intervention 
 
To broaden engagement with NHS physical 
activity pathway across the patient cohort 
 
To make associated health consequences of 
behaviour more salient 
 
To convincingly persuad of the positive case 
for physical activity as a force for feeling fit, 
strong, and positively self-determined 
 
To provide exposure to behavioural role 
models that patients respect 
 
Target behaviours selected 
Generalised behaviour as described in the 
primary target behaviour, enabling many 
manifestations of the behaviour to 
simultaneously be targeted 
Intervention function Persuasion and Modelling 
Policy categories ▪ Service provision 
Behaviour change techniques 
▪ Information about health consequences 
▪ Information about emotional 
consequences 
▪ Salience of consequences 






Mode of delivery 
Does the mode 
of delivery meet 
the APEASE 
criteria in the 













TV Not relevant 
Radio Not relevant 
Outdoor media 
Billboard Not relevant 
Poster Not relevant 
Print media 
Newspaper Not relevant 
Leaflet 












Phone helpline Not practicable 
Mobile phone text Not effective 
Individually accessed computer 
programme 
Lacks equity due 
to requirement of 
tech access and 
literacy, and 
unlikely to be 









Appendix 5: Topic guide for qualitative interviews 
 
Introduction to researcher; reiterate premise of study; what it’s about; what we want to 
know; stress that there are no right or wrong answers; we want to know/understand their 
perspective. Can stop at any time without giving a reason or just take a break; confidential; 
not shared with clinical team; does not affect treatment or care. 
 
To begin, would you like to say a little bit about yourself and your background? 
 
Could you tell me a bit about how active you were before you underwent radical 
prostatectomy? What kinds of physical activity did you do? 
 
Could you tell me about your experience of the pre-treatment seminar? 
- How did the seminar environment make you feel? 
- How did you feel about other men with prostate cancer being there? 
- Was there one thing that you remember ‘taking away’ from that seminar? 
- Would you describe the pre-surgery seminar as psychologically supportive? 
 
What is your memory of the patient speaker, [patient speaker name]? 
- What did [patient speaker]’s talk make you think? 
- What did [patient speaker]’s talk make you feel? 
- Did [patient speaker]’s talk have an effect on the way you view the prostate 
cancer experience? 
- Was [patient speaker]’s talk persuasive? 
- Did [patient speaker]’s talk cause you to reflect on your own behaviour? 
- (If yes to above) In what way? 
- (If no to above) Why not? 
- Was [patient speaker]’s talk valuable to you? Why? 
 
Can you tell me about your attitude to exercise since your surgery? 
- Do you think that the pre-surgery seminar influenced your attitude toward 
exercise? Healthy behaviours in general? 
 
How important do you think it is that men undergoing surgery for prostate cancer 
have contact with other men who are experiencing – or have experienced – the same 






In the few months since the seminar, to what extent have you had access to facilities 
and services that have helped you to be physically active? 
- Do you think this has affected your exercise behaviour? Why? 
 















































































































Appendix 7: Coding categories 
Categories used to conceptually organise codes created from interview transcripts (final 








































Appendix 8: Example of a memo written following the 
coding of each interview 
 
I010 is a 61 year old vicar, since age 32. Before that, he worked on the London Underground. He 
has experienced a local recurrence following his prostatectomy. At the time of interview, he is 
undergoing adjuvant radiotherapy and ADT. 
He describes himself as someone who is not naturally a person who gravitates toward 'sports'. 
However he has played a bit of badminton and squash, and describes himself as 'fit'. He 
describes how in recent years, he has done a little more exercise, in the form of squats and press 
ups. He says he is strong enough 'for the daily stuff of life'. 
He is not oriented towards pushing himself. He only does enough exercise to ensure that he can 
get the 'stuff of life' done. 
He is information-oriented. He says that from the seminars, he is much more likely to remember 
instrumental information about things than he is to remember what actually happened in the 
seminar. 
I010 does not really remember much of the intervention. It doesn't seem to have made much of a 
cognitive impression upon him. 
I010 bases much of his physical activity behaviour around what he feels is necessary to maintain 
the ability to engage is the activities he feels are important. He is not someone who is physical 
activity-averse. However he does clearly state that it is not really his 'identity' to be someone who 
is deeply engaged in physical activity or sports. He is quite happy to engage in significant 
intensity activity if he feels as though he will get either a) a necessary benefit; or b) enjoyment out 
of it. 
I010 strikes me as someone who's attitude toward physical activity is relatively stable. Despite his 
recurrence and multimodal treatment, he does not make any mention of changing his behaviour 
or attitude as a result of diagnosis or treatment. He seems to have been more likely to change his 





Appendix 9: Example theoretical memo 
 
FRAMEWORK 1 
Memory and cognitive impression 
Of the nine individuals interviewed so far, there are three for whom the intervention had a 
significant psychological impact, that they report affected their behaviour. A common 
characteristic of these individuals seems to be that they have some pre-existing moderate level 
understanding of the importance of doing exercise; and that all of them possessed a relatively 
positive disposition and what I would describe as a healthy life philosophy. 
One of these individuals makes quite a strong assertion that every time he thinks about anything 
to do with prostate cancer, he thinks of Chris, and that this subsequently acts as a motivator for 
healthy behaviours. This is consistent with a sentiment expressed by one of the first interviewees, 
who described a sort of social comparison process. 
Those who did not cite any response to the intervention were those who were highly physically 
active, or seemed to have quite an established, unmalleable attitude toward physical activity. For 
example, expressing these sentiments: 
 
'I just do enough to get the stuff of life done, that's it' 
'I'm not really an exercise person' 
'I will only do it if I decide for myself to do it, someone telling me is not going to change my 
behaviour' 
 
The intervention was not memorable for everyone. It seems particularly unmemorable for those 
individuals with a stable(?) attitude to physical activity. Having said this, it seems that on the 
whole, it tends to be the most memorable segment of the seminar for these individuals. 
 
FRAMEWORK 2 
Psychosocial experience of diagnosis and treatment 
- The diagnosis is a shock. The treatment then creates a new physical reality, caused by a new 
and alien situation, in which the individual is now unsure of themselves in terms of physicality. 
Some of the things that these interviewees are saying seem to imply that they lack 'reference 
points'. 
This observation has not been refuted by further data. See below for some elaboration. 
- There is a distinct agreement that having someone else to talk to who has been through it, in 
order to create some of those reference points, is very beneficial. This is expressed by one man 
as being incrementally more beneficial than just speaking with nurses, suggesting that the 





This observation has continued to be supported by further data, and was actually drawn into 
sharper focus by a man who said that being told by his consultant that he would be dry in 6 
months or so was unconvincing; however, hearing Chris saying it was convincing, and was 
beneficial for his psychological wellbeing. 
Related to the previous observation within Framework 4, there is a conceptual overlap between 
the psychologically and physically disorienting effect of diagnosis and treatment, which 
participants implicitly acknowledge breeds a sort of dread, and the way in which a patient 
speaker can tell people with authority that they might just be ok. This is a common refrain of 
these participants, getting value from someone who has been through what they have and can 




Attitude or beliefs towards personal engagement in the target behaviour 
[Revised] Attitudes and beliefs around physical activity seem to be primarily framed around: 
- Benefits, which can be learnt through social experience IF the individual is ‘self-primed’ for 
attitude modification 
- Potential pitfalls, such as straining onself or getting addicted - however this is generally not a 
huge concern 
- The life context, in which getting older is generally seen as an impetus to be more physically 
active; related to a recognition of mortality. This continues to be supported by the data, even 
amongst individuals who seem to have a weak relationship with physical activity behaviour. 
- An incumbent attitude toward exercise which creates the reference points from which all 
subsequent influences on physical activity are framed within. This continues to be the case, to a 
certain degree. However it might be the case that the mdeical context provides cues that make 
individuals particularly amenable to attitude change (teachable moment). For example, one of the 
participants who is positively affected by the intervention says 
'I honestly thought people did exercise for fun. I didn't realise it was so important' 
- An openness, in some participants, to attitude change via an intervention such as the one 
piloted. So far, this seems to be associated with a pro-active and positive disposition, combined 
with a sort of social comparison process. 
 
FRAMEWORK 4 
Affective dimensions of the intervention experience 
There was no negative feedback from the talk, apart from one individual who had some quite 
idiosyncratic views of things that were not reproduced by other participants. He took issue with 
the 'prostate community' slant of the whole thing. This man was very opinionated and had a 






There are certain participants (n=3) who describe the intervention as having a very strong 
psychological effect on them. Most others are relatively indifferent in terms of exercise, but there 
are a few who express gratitude for the talk, because it was reassuring in a more general sense. 
 
FRAMEWORK 5 
The environmental context 
Whilst the seminars are broadly appreciated, there were some criticisms from participants about 
how they are a bit impersonal. Some participants described it as a bit conveyor belt-like and too 
strong on the PowerPoint. Others described it as 'vital' information.  
In particular reference to physical activity, it seems as though the way in which the physical 
activity messages in the seminar are universal can feel a little patronising for some. 
The seminar does seem to serve an important function for the participants in terms of information 
provision. One of the participants told a story of how, when you're in the midst of the treatment 
process, you can feel like you can't see the exit. He describes how he didn't believe his 
consultant about the recovery of continence, but he did believe Chris. it seems that the 
overwhelming nature of the experience can create a kind of cognitive bias that results in a 
situation where the patient can't imagine recovering. A talk of the nature of Chris' seems to have 
to ability to cut through this a little. 
 
FRAMEWORK 6 
Actual physical activity behaviour 
- All participants so far were at least fairly physically active prior to diagnosis. Two of them have 
increased exercise since, despite the usual barriers of time constraints and competing priorities. 
All participants suffered some kind of setback after the operation, but none found it a particularly 
huge challenge to return to prior physical activity levels (and as noted above, some increased). 
This drive seems to be related to prior exercise attitude. 
The above broadly continues to be supported by the data. It seems like activity behaviour can be 
influenced by the intervention for some. It seems as though whether or not this can be the case is 
dependent upon the individual's prior attitude and behaviour. Those who exercise for reasons of 
perceived necessity seem to be less likely to say they were influenced by the intervention. On the 
flip side, those who exercise for reasons of perceived importance were the ones who claimed that 




- Competitiveness (not affected) 
- Positivity (a tendency to be affected) 
- A need for activity (affected) 




- Identity strongly intertwined with physical ability (not affected) 
- Physical activity not part of identity (not affected) 
- A tendency to plan or record activity, or set goals (affected, n=2) 
- Spiritual fatalism (affected) 









Research into physical activity/exercise support at The Royal Marsden Hospital 
 
The Royal Marsden Hospital is proud of being a cancer research institution, with more than 
80% of our patients involved in research aimed at improving treatments and support for 
people diagnosed with cancer. 
We are currently undertaking a study aimed at improving physical activity support for men 
with prostate cancer (project number: QIPSAG2). As someone who is undergoing a surgical 
treatment for prostate cancer, you can help us. 
You are booked to attend a pre-surgery education seminar, which provides you with 
information on what to expect and what you need to do before, during, and after your 
surgery. The seminar also helps you recover as quickly as possible following your surgery. 
We are interested in how useful this seminar is in supporting men with prostate cancer to be 
physically active. Before the seminar, you will be given some short questionnaires to 
complete. These questionnaires ask about physical activity/exercise, quality of life, fatigue, 
and general health. These questionnaires ensure that we have a baseline to measure against 
after your surgery. 
You can opt out of completing these questionnaires, and your care will remain exactly the 
same whether you complete the questionnaires or not. No-one will be able to identify you 
from your answers, apart from your clinical team and the research team.  
If you choose to complete the questionnaires, you will receive a letter 90 days following your 
surgery, and will be asked to answer the questions again. You can also opt out at this point if 
you do not wish to answer the questions again. 







































































You are being invited to provide data for a quality improvement project examining physical activity 
behaviour in men who have been diagnosed with prostate cancer (project number: QIPSAG2). This is 
because you have previously completed some questionnaires at the pre-surgery seminar before you had 
your radical prostatectomy operation, and we would like to know if anything has changed. 
This does not require much involvement from you – just that you complete some short questionnaires. The 
information that you provide will contribute towards better care for men with prostate cancer. This is the 
last time we will contact you to provide data for this project. 
If you agree to provide data for this quality improvement project, then please complete the following 
tasks: 
1) Complete the four enclosed questionnaires: 
a. Physical activity questionnaire 
b. Exercise regulations questionnaire 
c. Fatigue questionnaire 
d. Quality of life questionnaire 
2) Return the questionnaires by post, in the stamped and addressed envelope provided. 
Please do not write your name on any of the questionnaires – this is to protect your 
confidentiality. 
The above steps are all that you need to do to participate, no further action is required. If you have any 
queries, please contact Louis Fox using the contact details below. 
Thank you for your time and co-operation – your contribution is greatly valued. 
Louis Fox, BSc 
PhD student 






Appendix 13: Publications contained in this thesis 
NB: At the time of writing one further publication, reporting the findings of the pilot study, is in 
press in Supportive Care in Cancer. 
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